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L.E. Okamoto, J.E. Celedonio, A. Diedrich, C.A. Shibao, A. Gamboa, B.K. Black, S. Paranjape, D. Robertson, I. Biaggioni
Nashville, TN, USA
10:00–10:15 AM Norepinephrine transporter inhibition with atomoxetine prevents tilt-induced vasovagal syncope: a randomized, placebo-
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L. Lei, J.C. Guzman, T. Kus, F. Araya-Paredes, J. Angihan, G. Bennett, C. Maxey, R.S. Sheldon, S.R. Raj
Calgary, AB, Canada
10:15–10:30 AM Is cerebrovascular autoregulation (CA) impaired during head-up tilt (HUT)-induced vasovagal syncope (VVS)? Inferences
derived from selective falls in total peripheral resistance (TPR) or cardiac output (CO)
R. Schondorf, S. Balegh, J. Benoıˆt, B. Ditto
Montreal, QC, Canada
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11:00–11:45 AM MSA Plenary Lecture
Multiple system atrophy: are we ready to tame the beast?
Gregor Wenning, M.D., Ph.D
Innsbruck, Austria
Session 4: Multiple System Atrophy
Chairs: William Cheshire and Wolfgang Singer
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Daniel Claassen, M.D., M.S
Nashville, TN, USA
Session 5: Autonomic Regulation of Heart and Vasculature
Chairs: Saharnaz Balegh and Victoria Clayden
9:15–9:30 AM Cortical morphometric predictors of autonomic dysfunction in generalized anxiety disorder
L. Carneval, M. Mancini, J. Koenig, E. Makovac, D.R. Watson, F. Meeten, H.D. Critchley, C. Ottaviani
Rome, Italy
9:30–9:45 AM Active forelimb exercise mitigates susceptibility to cardiac arrhythmia compared to passive hindlimb cycling in rats with
high-level spinal cord injury
V.E. Lucci, E.L. Harrison, K.M. DeVeau, K.A. Harmon, J. Liu, J. Squair, A. Krassioukov, D. Magnuson, C.R. West, V.E.
Claydon
Burnaby, BC, Canada
9:45–10:00 AM Autonomic dysreflexia (AD) in individuals with SCI: the association between elevations in blood pressure and symptoms of
AD over a 30 day observation period
C.G. Katzelnick, T.A. Dyson-Hudson, W.A. Bauman, S. Kirshblum, N.D. Chiaravalloti, J.M. Wecht
Bronx, NY, USA
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Salt Lake City, UT, USA
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William P. Cheshire, M.D.
President, American Autonomic Society
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POSTER SESSION I
WEDNESDAY, OCTOBER 24, 2018
6:30–9:00 PM
Trainee Poster Competition* Judges: AAS Board Members
Autonomic Failure
Poster #1* Non-motor symptoms and gender differences in multiple system atrophy
S. Eschlbo¨ck, T. Benke, S. Bo¨sch, M. Delazer, A. Djamshidian-Tehrani, A. Fanciulli, R. Granata, B. Ho¨gl, C. Kaindlstorfer,
G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, G. Wenning
Innsbruck, Austria
Poster #2* Alpha-synuclein deposition in sympathetic noradrenergic nerves and cardiac noradrenergic deficiency distinguish Lewy
body from non-Lewy body forms of neurogenic orthostatic hypotension
R. Isonaka, P. Sullivan, A. Corrales, A.Z. Rosenberg, C. Holmes, D.S. Goldstein
Bethesda, MD, USA
Poster #3 The impact of supine hypertension on target organ damage and mortality in patients with neurogenic orthostatic hypotension
J.A. Palma, G. Redel-Traub, A. Porciuncula, D. Samaniego-Toro, Y.W. Lui, L. Norcliffe-Kaufmann, H. Kaufmann
New York, NY, USA
Poster #4* Relationship between cardiac sympathetic modulation and inflammation after repetitive automatic mechanical
somatosensory stimulation (AMSS) in Parkinson’s disease
D. Shiffer, F. Barbic, M. Minonzio, A.R. Zamuner, C.P. Andrade, B. Bottazzi, C. Garlanda, R. Leone, B. Cairo, A. Porta, A.
Mantovani, R. Furlan
Rozzano, Italy
Poster #5* Early onset of autonomic failure distinguishes the parkinsonian variant of multiple system atrophy from Parkinson’s disease
A. Fanciulli, G. Goebel, G. Lazzeri, C. Scherfler, E.R. Gizewski, R. Granata, G. Kiss, S. Strano, C. Colosimo, F.E. Pontieri,
H. Kaufmann, K. Seppi, W. Poewe, G.K. Wenning
Innsbruck, Austria
Supine Hypertension and Neurogenic Orthostatic Hypotension
Poster #6* Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the
American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS)
A. Fanciulli, J. Jordan, I. Biaggioni, G. Calandra-Buonaura, W.P. Cheshire, P. Cortelli, S. Eschlboeck, G. Grassi, M.J. Hilz, H.
Kaufmann, H. Lahrmann, G. Mancia, G. Mayer, L. Norcliffe-Kaufmann, A. Pavy Le Traon, S.R. Raj, D. Robertson, I. Rocha, W.
Struhal, R. Thijs, K.P. Tsioufis, J.G. Van Dijk, G.K. Wenning
Innsbruck, Austria
Autonomic Regulation: Basic Science and Animal Studies
Poster #7* Unresponsiveness of baroreflex sympathetic regulation leads to orthostatic intolerance in a rat model of type 2 diabetes
mellitus
K. Kamada, K. Saku, H. Tsutsui, K. Sunagawa
Fukuoka, Japan
Poster #8 Human deep brain stimulation as a tool to study the neural control of blood pressure and heart rate
P. Kumar, J.A. Palma, A. Mogilner, H. Kaufmann, M. Pourfar
New York, NY, USA
Poster #9 Susceptibility to cardiac arrhythmia increases with sympathetic stimulation in rodents with high-thoracic spinal cord injury
V.E. Lucci, E.L. Harrison, K.M. DeVeau, K.A. Harmon, J. Liu, J. Squair, A. Krassioukov, D. Magnuson, C.R. West, V.E. Claydon
Burnaby, BC, Canada
Poster #10* Heart rate variability and gastric myoelectric activity in women with chronic pelvic pain: a pilot study
D.P. Williams, E.R. Muth, C. Ustine, P. Simpson, T. Chelimsky, J.F. Thayer, G.Chelimsky
Columbus, OH, USA
Cardiovascular Disease, Obesity and Aging: Human Studies
Poster #11* The association between cardiac parasympathetic activity and the lipid accumulation product
D.P. Williams, M.N. Jarczok, J.E. Fischer, J. Koenig, D. Boschiero, E. Poggiogalle, J.F. Thayer
Columbus, OH, USA
Poster #12* Determining sex-specific waist circumference cut-off values for cardiovascular disease risk in individuals with spinal cord
injury
M.C. Dorton, S. de Groot, M. Post, V.E. Claydon
Burnaby, BC, Canada
Poster #13 Arterial stiffness and spontaneous baroreflex sensitivity in African American women
P. Latchman, G. Gates, R. Thiel, T. Yue, R. Axtell, Q. Yang, K, Gardner, R. De Meersman
New Haven, CT, USA
Poster #14 Significance of efferent autonomic innervation and reactivity of arterial pressure in prognosis of patients with arterial
hypertension
O.V. Mamontov, A.V. Kozlenok, A.A. Kamshilin, I.S. Brodskaya, E.V. Shlyakhto
St. Petersburg, Russia
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Cardiac Autonomic Innervation: Humans
Poster #15* Assessing individual human baroreflex-chemoreflex interactions using an n-of-1 trial design
H. Kronsbein, K. Heusser, D. Gerlach, A. Hoff, F. Hoffmann, H. Ehmke, J. Jordan, J. Tank
Cologne, Germany
Poster #16 Stress response and role of autonomic nervous system in Takotsubo cardiomyopathy
K. Sato, H. Akagawa, T. Nakaoka, Y. Kubo, T. Komiyama, H. Kobayashi, H. Sakura
Tokyo, Japan
Poster #17 Attention and information processing impairment in individuals with chronic SCI: role of autonomic dysfunction
J.M. Wecht, J.P. Weir, C.G. Katzelnick, G. Wylie, W.A. Bauman, N.D. Chiaravalloti
Bronx, NY, USA
Diabetic, Autoimmune and Other Autonomic Neuropathies
Poster #18 Sudomotor dysfunction in diabetic autonomic neuropathy is not a frequent finding
A. Barboi, S. Pocica, V. Patel
Evanston, IL, USA
Gastrointestinal and Urogenital Systems, IBS, Cystitis
Poster #19 Fingolimod does not seem to affect autonomic bladder function in patients with relapsing–remitting multiple sclerosis
M.J. Hilz, K.M. Ho¨sl, M. Liu, S. Roy, K. Winder, R. Linker, D.-H. Lee, R. Wang
Nuremberg, Germany
Poster #20* Uroflowmetry and bladder ultrasonography non-invasively quantify slightly impaired autonomic bladder function in patients
with relapsing–remitting multiple sclerosis
R. Wang, S. Roy, M. Liu, K.M. Ho¨sl, K. Winder, R. Linker, D.-H. Lee, M.J. Hilz
Erlangen, Germany
Sympathovagal Balance and Spectral Analysis
Poster #21* Persistent baroreflex dysfunction in patients with a history of moderate or severe traumatic brain injury
S. Roy, M. Liu, R. Wang, F. Ammon, K.M. Ho¨sl, J. Markus, D. Murasenu, M.J. Hilz
Erlangen, Germany
Poster #22 Psychological and physiological effects of 12 weeks of slow breathing exercise on healthy subjects
A. Gamboa, S. Paranjape, A. Diedrich, K. Nelson, A. Coppola, R. Abraham, H. Nian, K. Wallston, G. Birdee
Nashville, TN, USA
Poster #23 Prediction of systolic blood pressure responses to orthostasis in persons with spinal cord injury
M.F. La Fountaine, J.P. Weir, C.G. Katzelnick, A.T. Lombard, M.T. Maher, J.M. Levine, J.M. Wecht
Bronx, NY, USA
Poster #24* Optimization of heart rate variability testing
S. Rajan, M. Campagnalo, V. Galvis, C.H. Gibbons
Boston, MA, USA
Microneurography and Cardiovascular Reflexes in Humans
Poster #25 Reproducibility of Valsalva maneuver derived baroreflex parameters
C. Ustine, J. De Los Santos, P. Simpson, G. Chelimsky, T. Chelimsky
Milwaukee, WI, USA
Poster #26 Ventilatory and cerebrovascular response to metaboreflex activation while supine or upright in men and women
H. Joshi, H. Edgell
Toronto, ON, Canada
Poster #27* The effect of habitual physical activity on sympathetic vascular transduction
A.T. Robinson, M.C. Babcock, J.C. Watso, K.U. Migdal, W.B. Farquhar
Newark, DE, USA
Poster #28 Stimulation of the dorsal root ganglion (DRG) for medicine refractory chronic neuropathic pain: Is there sympathetic involvement?
Y.B. Sverrisdottir, J. Fitzgerald, A. Kent, J. Kramer, A.L. Green
Oxford, UK
Poster #29* Heightened sympathetic neural and blood pressure responses to cold pressor test in women with PTSD
J.-K. Yoo, M.B. Badrov, R.S. Parker, E.H. Anderson, A.M. Suris, Q. Fu
Dallas, TX, USA
Neuroimaging in Brain and Heart
Poster #30* Resting state fMRI functional connectivity of the PAG in healthy adolescents and adolescents with functional
gastrointestinal disorder
C. Ustine, L. Conant, S. Rausch, D. Bierer, K. Yan, P. Simpson, T. Chelimsky, G. Chelimsky
Milwaukee, WI, USA
Poster #31 Distinguishing multiple system atrophy and Parkinson’s disease using resting state functional MRI: a pilot study
M. Sklerov, N. Browner, E. Dayan
Chapel Hill, NC, USA
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Poster #32* Evidence of cortical autonomic impairment in the pathophysiology of neurogenic orthostatic hypotension associated with
peripheral autonomic dysfunction
J. Baker, J. Paturel, K. Kimpinski
London, ON, Canada
Orthostatic Hypotension and Syncope
Poster #33* The Orthostatic Discriminate and Severity Scale (ODSS): a tool to discriminate orthostatic from non-orthostatic
symptomatology
J. Baker, J.R. Paturel, D.M. Sletten, P.A. Low, K. Kimpinski
London, ON, Canada
Poster #34* Can head-up tilt (HUT) be used to distinguish between clinical sub-groups of vasovagal syncope (VVS): the Heisenberg
principle at play
S. Balegh, J. Benoit, B. Ditto, R. Schondorf
Montreal, QC, Canada
Poster #35 Effects of droxidopa treatment for neurogenic orthostatic hypotension in patients concomitantly on dopa decarboxylase inhibitors
S. Kymes, C. Franc¸ois, C. Sullivan, K. McLeod, A. Duhig, A. Ogbonnaya, A. Quillen, J. Cannon, I. Biaggioni, C.A. Shibao, B.
Yue, R.A. Hauser
Palm Harbor, FL, USA
Poster #36* Diagnosis of orthostatic hypotension: contribution of diastolic blood pressure
S. Galvis, M. Campagnalo, S. Rajan, C.H. Gibbons
Boston, MA, USA
Poster #37 Can the Valsalva maneuver serve as a biomarker for syncope diagnoses?
B.C.D Hockin, C. Johnston, E. Williams, M.G. Lloyd, V.E. Claydon
Burnaby, BC, Canada
Poster #38 The relationship between changes in orthostatic blood pressure and symptoms in patients with orthostatic hypotension
B.M.W. Illigens, R. Lapusca, M. Campagnolo, A. Abuzinadah, D.I. Sinn, L. Walsh, J. White, C.H. Gibbons, R. Freeman
Boston, MA, USA
Pediatric Autonomic Disorders
Poster #39* Validation of finger blood pressure monitoring in children
N.D. Heeney, F. Habib, G. Brar, G. Krahn, D.A. Campbell, S. Sanatani, V.E. Claydon
Burnaby, BC, Canada
Poster #40* Menstrual irregularities in pediatric postural orthostatic tachycardia syndrome
K.N. Leopold, K.M. Klaas, A. Javed, E.E. Bolen, W.D. Bunn, S.H. Hasan
Rochester, MN, USA
Postural Orthostatic Tachycardia Syndrome (POTS)
Poster #41 Silicone breast implant rupture as a cause of postural orthostatic tachycardia syndrome (POTS)
W. Almardini, S.B. Alam, M.A. Nasri, H. Mistry, N. Noor, S. Alam, Z. Rehman, M. Rajumon, L.B. Gaied, B. Sheikh, A.
Suleman
McKinney, TX, USA
Poster #42 Postural tachycardia syndrome and pregnancy: insights from a cross-sectional community based survey
K. Bourne, L. Stiles, B.H. Shaw, C.A. Shibao, L.E. Okamoto, E.M. Garland, A. Gamboa, A. Peltier, A. Diedrich, I.
Biaggioni, D. Robertson, S.R. Raj
Calgary, AB, Canada
Poster #43 Small fiber neuropathies and related autoimmunity in postural orthostatic tachycardia syndrome
G.A. Cook
Bethesda, MD, USA
Poster #44* POTS patients vs. healthy controls: similar postural tachycardia, different symptom burden
E. Golden, M. Bryarly, L. Phillips, M. Vernino, S. Vernino
Dallas, TX, USA
Poster #45 Is pseudobulbar affect unique to PoTS? Emotional lability in orthostatic intolerance
R.K. Khurana
Baltimore, MD, USA
Poster #46 Antimuscarinic autoimmunity in postural tachycardia syndrome
H. Li, X. Yu, G. Zhang, D.C. Kem
Oklahoma City, OK, USA
Poster #47 Impaired glucose homeostasis in lean women with postural tachycardia syndrome
S.E. Mehr, S.Y. Paranjape, S. Scudder, S. Lonce, J. Celedonio, B. Preheim, B. Plunkett, C.A. Shibao
Nashville, TN, USA
Poster #48 Prevalence and treatment of small intestinal bacterial overgrowth (SIBO) in patients with postural orthostatic tachycardia
syndrome (POTS)
Z. Rehman, M. Rajumon, S.B. Alam, W. Almardini, H. Mistry, A. Khan, N. Noor, L.B. Gaied, S. Alam, B. Sheikh, M.A.
Nasri, A. Suleman
McKinney, TX, USA
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Poster #49 Postural hyperventilation as a cause of POTS
J.M. Stewart, P. Pianosi, M.A. Shaban, C. Terilli, M. Svistunova, P. Visintainer, M.S. Medow
Valhalla, NY, USA
Poster #50 A rabbit model of autoimmune postural tachycardia syndrome
X. Yu, H. Li, G. Zhang, L. Zhou, D.C. Kem
Oklahoma City, OK, USA
POSTER SESSION II
THURSDAY, OCTOBER 25, 2018
11:45–2:00 PM
Autonomic Failure
Poster #51 Inter-rater agreement of thermoregulatory sweat testing (TST)
A. Arvantaj, J. Robinson, C. Geiger, B. Katirji
Cleveland, OH, USA
Poster #52 Quantification of thermoregulatory sweat testing (TST)
A. Arvantaj, J. Robinson, C. Geiger, B. Katirji
Cleveland, OH, USA
Poster #53 Neurogenic orthostatic hypotension unawareness in multiple system atrophy compared to peripheral autonomic neuropathy
W.P. Cheshire
Jacksonville, FL, USA
Poster #54 Symptom burden within one year differentiates rapidly progressive multiple system atrophy
E.A. Coon, D.M. Sletten, J.N. Mandrekar, M. Suarez, J.E. Ahlskog, J.H. Bower, P. Sandroni, E.E. Benarroch, P.A. Low, W. Singer
Rochester, MN, USA
Poster #55 Pure autonomic failure with sick sinus syndrome of reduced striatal DAT binding
M. Sugiura, K. Sato, Y. Nishimura, Y. Kubo, T. Nakaoka, K. Shibata, H. Sakura
Tokyo, Japan
Cardiac Autonomic Innervation: Humans
Poster #56 Neuroimaging evidence for decreased cardiac sympathetic innervation and a vesicular storage defect in residual nerves in
Lewy body forms of neurogenic orthostatic hypotension
D.S. Goldstein, C. Holmes, Y.-S. Ding, Y. Sharabi
Bethesda, MD USA
Poster #57 Effects of different classroom temperatures on cardiac autonomic control and cognitive performance in students
M. Minonzio, F. Barbic, B. Cairo, D. Shiffer, A. Dipasquale, L. Cerina, A. Vatteroni, P. Verzeletti, F. Badilini, M. Vaglio,
R. Iatrino, A. Porta, M. Santambrogio, R. Gatti, R. Furlan
Rozzano, Italy
Poster #58 Central acetylcholinesterase inhibitor, galantamine, prevents lipid-induced oxidative stress in African Americans
J.E. Celedonio, S.E. Mehr, S.Y. Paranjape, A. Diedrich, C.A. Shibao
Nashville, TN, USA
Cerebral Blood Flow Regulation
Poster #59 Comparison of cerebral oxygen saturation patterns in adolescents with autonomic dysfunction who experience syncope
versus convulsive syncope during head up tilt testing
E.M. Smith, S.S. Hashmi, A. Gourishankar, M.T. Numan, I.J. Butler, J.E. Lankford
Houston, TX, USA
Poster #60 Hypocapnic cerebral hypoperfusion: a biomarker of orthostatic intolerance
P. Novak
Boston, MA, USA
Poster #61 Prevalence of convulsions in the pediatric population with orthostatic intolerance and neuro-cardiogenic syncope
M.T. Numan, H. Varner, J.E. Lankford, I.J. Butler
Houston, TX, USA
Comorbidities of Fibromyalgia, Migraine, Depression
Poster #62 What chronic disorders overlap with the migraine complex?
D. Bierer, E. Awe, A. Mueller, A. Husain, G. Chelimsky*, T. Chelimsky*
Milwaukee, WI, USA
Diabetic, Autoimmune and Other Autonomic Neuropathies
Poster #63 Quality improvement and practice-based research in autonomic neuropathy using the electronic medical record
A. Barboi, V. Patel, O. Kincaid, D. Randall, S. Pocica, L. Gardun, M. Szela, S
Evanston, IL, USA
Poster #64 Autoimmune component of diabetic autonomic gastroparesis
M.C. Yu, H. Li, S. Li, D.C. Kem
Oklahoma City, OK, USA
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Exercise, Temperature Regulation and Hypoxia
Poster #65 A new approach in assessing vasomotor reactivity in response to cold stress using non-contact optical technology
O.V. Mamontov, V.V. Zaytsev, E.V. Shlyakhto, A.A. Kamshilin
St. Petersburg, Russia
Genetic Autonomic Disorders
Poster #66 Impaired sensorimotor control of the hand in congenital absence of functional muscle spindles
L.J. Smith, J.A. Palma, L. Norcliffe-Kaufmann, H. Kaufmann, V.G. Macefield
New York, NY, USA
Poster #67 Disturbed proprioception at the knee but not the elbow in hereditary sensory and autonomic neuropathy type III
V.G. Macefield, L.J. Smith, J.A. Palma, L. Norcliffe-Kaufmann, H. Kaufmann
New York, NY, USA
Novel Therapies and Clinical Trials
Poster #68 Transdermal vagal stimulation in postural tachycardia syndrome
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Robertson Plenary Lecture
The norepinephrine transporter and human cardiovascular
disease
J. Jordan
Institute for Aerospace Medicine, German Aerospace Center (DLR),
Cologne and Chair for Aerospace Medicine University of Cologne,
Cologne, Germany
Much of the norepinephrine released from adrenergic neurons is
reclaimed through the neuronal norepinephrine transporter and either
repacked or enzymatically degraded. Yet, the norepinephrine trans-
porter has been neglected in cardiovascular medicine. Observations in
familial norepinephrine transporter dysfunction highlighted the
importance of the mechanism in human norepinephrine homeostasis
and in cardiovascular control. The dominant negative norepinephrine
transporter mutation (A457P) segregated with increased upright heart
rate and biochemical evidence for impaired norepinephrine uptake.
Subsequent studies using selective pharmacological norepinephrine
transporter inhibition reproduced the phenotype and provided insight
in human cardiovascular physiology with implications for pharma-
cotherapy. Norepinephrine transporter inhibition attenuates
sympathetic activity in the brain, tends to augment sympathetic
activity in peripheral tissues, and redistributes sympathetic activity
towards the heart. The clinical implication is that medications
inhibiting norepinephrine transport increase cardiac sympathetic
activity, which can be unmasked by measuring upright heart rate.
Paradoxically, individuals with higher centrally generated sympa-
thetic activity are less likely to exhibit a pressor response on such
medications. Pharmacological norepinephrine transporter inhibition
can serve as human model for increased cardiac sympathetic activity.
Moreover, norepinephrine transporter inhibition influences on the
sympathetic nervous system can be therapeutically exploited. For
example, norepinephrine transporter inhibition prevented neutrally
mediated presyncope and syncope during head-up tilt testing. Nore-
pinephrine transporter inhibition also ameliorates orthostatic
hypotension in autonomic failure patients with residual sympathetic
function.
Functional brainstem imaging reveals brainstem nuclei governing
human baroreflex function
D.A. Gerlach1, J. Manuel2, A. Hoff1, H. Kronsbein1,3, F. Hoffmann1,
K. Heusser1, F. Beissner2, J. Tank1
1Division of Cardiovascular Aerospace Medicine, Institute of
Aerospace Medicine, German Aerospace Center (DLR), Cologne,
Germany; 2Hannover Medical School, Somatosensory and
Autonomic Therapy Research, Institute for Neuroradiology,
Hannover, Germany; 3Institute of Cellular and Integrative
Physiology, University Medical Center Eppendorf, Hamburg,
Germany
Introduction: Brainstem nuclei mediate baroreflex adjustments in
efferent sympathetic and parasympathetic traffic. Yet, human brain-
stem physiology is poorly understood given the lack of
suitable methodology. We developed a novel approach combining
pharmacological testing, beat-by-beat cardiovascular monitoring, and
high-resolution functional magnetic resonance imaging (fMRI) to
assess human baroreflex regulation at the level of the brainstem.
Methods: In 10 healthy men (29.7 ± 6.9 years; 80.1 ± 9.9 kg), we
monitored continuous finger arterial blood pressure and ECG using
customized hardware during multiband fMRI brain acquisitions. We
applied repeated intravenous phenylephrine (PHE, 25 and 75 lg,
n = 8) and nitroprusside (NTP 25 and 75 lg, n = 8) boluses using a
remote controlled injector. Brainstem and hypothalamus fMRI images
were analyzed to identify brainstem nuclei involved in baroreflex-
mediated blood pressure control using tensorial masked Independent
Component Analysis (mICA). BP changes were correlated with the
time-courses of blood-oxygen-level dependent (BOLD) signals by
mixed-effects general linear model.
Results: Pharmacological testing yielded reliable baroreflex sensitiv-
ity measurements in the MRI scanner. fMRI combined with the
measurement of baroreflex-mediated changes in heart rate and blood
pressure revealed nuclei regulated through baroreflex input. The
strongest correlations between BOLD time-course and BP was
observed in the left solitary tract (NTP: deactivation P\ 0.001;
z-score: 6.9), the caudal ventrolateral medulla (NTP: activation, right
side: P = 0.0012; z-score: 4.11, left side: P\ 0.001; z-score: 5.05),
the rostral ventrolateral medulla (NTP: activation, right side
P\ 0.001; z-score: 7.25) and in the left paraventricular nucleus
(PHE: activation P\ 0.001; z-score: 9.00; NTP: activation
P\ 0.001; z-score: 7.11). P-values were Bonferroni corrected for 60
independent components.
Conclusion: We developed novel approach testing baroreflex regu-
lation at the level of the brainstem in humans. The methodology
identified baroreflex-mediated activation and deactivation patterns
consistent with previous investigations in animal models. The
methodology can be applied to elucidate human physiology and
mechanisms of autonomic cardiovascular disease.
Sex and age differences in sympathetic vascular baroreflex
function: insights from neck collar stimulation and an orthostatic
stress test
M.G. Lloyd, V.E. Claydon
Department of Biomedical Physiology and Kinesiology, Simon Fraser
University, Burnaby, BC, Canada
The baroreflex buffers rapid changes in blood pressure by altering
vascular resistance and heart rate (HR). Age-related changes in
baroreflex function appear to be sex-dependent, but are incompletely
understood. We investigated age- and sex-related changes in barore-
flex function. We hypothesized that baroreflex responses would
decrease with age, and cardiac baroreflex control would predominate
in women. We measured forearm vascular resistance (FVR: mean
arterial pressure [finger plethysmography]/brachial blood flow
velocity [Doppler ultrasound]) and HR (electrocardiography) in 49
participants (26 females, aged 19–84 years) during carotid baroreflex
stimulation (neck collar) and maximal orthostatic stress (head-up tilt
with combined lower body negative pressure continued until
presyncope). Neck suction/pressure was applied at - 60, - 40, - 20,
0, 20, 40, and 60 mmHg. Baroreflex sigmoid curves were fitted, and
cardiac (cBRS) and vascular (vBRS) baroreflex sensitivities calcu-
lated from the first derivative. vBRS (younger -
2.2 ± 0.2% mmHg-1, older -1.5 ± 0.2% mmHg-1, p = 0.03) and
cBRS (younger 7.7 ± 0.5% mmHg-1, older 5.3 ± 0.6% mmHg-1,
p = 0.0009) were larger in younger (19–45 years) than older
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(45–84 years) participants. The vascular baroreflex centering point
was left-shifted in younger compared to older participants (-
14 ± 6 mmHg, p = 0.01), despite similar operating points (p = 0.08).
cBRS was larger in women (7.5 ± 0.9 ms mmHg-1) than men
(5 ± 0.9 ms mmHg-1, p = 0.065), but vBRS was not different
between sexes. Vascular baroreflex centering points were left-shifted
compared to cardiac baroreflex curves (p\ 0.0001) independent of
age and sex. Independent of age and sex, buffering of hypotensive
stimuli was predominantly achieved by changes in vascular resis-
tance, while buffering of hypertensive stimuli was predominantly
achieved though changes in cardiac output (p\ 0.0001). In older
participants, the vascular predominance to simulated hypotension was
exacerbated (?20 ± 6%, p = 0.01). The maximum FVR response
during orthostasis was smallest in younger women (all p\ 0.03). HR
responses to orthostasis were smaller in older participants (younger
DHR = 47 ± 3 bpm, older DHR = 35 ± 4 bpm, p = 0.0095). We
describe age- and sex-related changes in baroreflex function and the
relative importance of vascular and cardiac responses in the mainte-
nance of blood pressure.
Sex-differences in the sympathetic neural recruitment
and hemodynamic response to head-up tilt in elderly
hypertensives
M.B. Badrov1,2, Y. Okada1,2, M.M. Galbreath1,2, J.-K. Yoo1,2, W.
Vongpatanasin2, J.K. Shoemaker3,4, B.D. Levine1,2, Q. Fu1,2
1Institute for Exercise and Environmental Medicine, Texas Health
Presbyterian Hospital Dallas, Dallas, Texas, USA; 2University of
Texas Southwestern Medical Center, Dallas, Texas, USA; 3School of
Kinesiology, Western University, London, Ontario, Canada;
4Department of Physiology and Pharmacology, Western University,
London, Ontario, Canada
The current study tested the hypothesis that elderly hypertensive (HT)
women have exaggerated blood pressure (BP) and sympathetic neural
responses to orthostasis compared to elderly HT men. We measured,
in 12 HT men (71 ± 2 years; mean ± SE) and 12 HT women
(67 ± 2 years), BP (SunTech), heart rate (HR; ECG), cardiac output
(CO; acetylene rebreathing), and multi-unit muscle sympathetic nerve
activity (MSNA; microneurography) at baseline (supine; 3-min) and
during graded head-up tilt (HUT; 30 for 5-min and 60 for 20-min).
Sympathetic action potential (AP) discharge patterns were studied
using wavelet-based methodology. Mean arterial BP increased during
HUT (P\ 0.001); however, the increase was greater in HT women at
10-min (D13 ± 2 vs. 5 ± 3 mmHg) and 20-min (D14 ± 3 vs.
3 ± 4 mmHg; both P 0.05). COi (indexed to body surface area)
decreased similarly in both sexes throughout HUT (P[ 0.05); yet,
values were lower in HT women (P\ 0.05). TPRi increased during
HUT (P\ 0.001); however, the increase was greater in HT women at
10-min (D2435 ± 240 vs. 1094 ± 241 dyns/cm5/m2) and 20-min
(D2759 ± 244 vs. 1501 ± 211 dyns/cm5/m2; both P 0.05). However,
the number of sympathetic APs per integrated burst increased in HT
women (all P 0.05), at 5-min (D6 ± 1 vs. 1 ± 1 spikes/burst), 10-min
(D7 ± 1 vs. 1 ± 1 spikes/burst), and 20-min (D8 ± 2 vs. 2 ± 1
spikes/burst) of 60 HUT. As such, sympathetic AP firing frequency
was greater in HT women during 60 HUT (all P\ 0.05). Thus,
elderly HT women display enhanced pressor and peripheral vaso-
constrictor responses to orthostasis than elderly HT men, which is
likely attributable to augmented sympathetic neural recruitment,
rather than burst frequency, in the upright posture.
Funding: NIH R01 HL091078.
Norepinephrine transporter dysfunction contributes to increased
sympathetic tone in a mouse model of hypertrophic
cardiomyopathy
R.A. Larson1, Y. Lu1, L.K. Balcziak1, M.W. Chapleau1,2
1Internal Medicine, University of Iowa, Iowa City, IA, USA;
2Veterans Affairs Medical Center, Iowa City, IA, USA
Sarcomere gene mutations cause hypertrophic cardiomyopathy
(HCM). Hallmark features include cardiac hypertrophy, fibrosis,
excessive cardiac sympathetic tone, and increased risk of arrhythmias
and sudden death. Our group has previously reported that cardiac
sympathetic tone is increased in transgenic mice with cardiac-specific
expression of mutated alpha-tropomyosin (Glu180Gly), a model of
human HCM. Studies in patients suggest that decreased reuptake of
norepinephrine into sympathetic nerve terminals contributes to
increased cardiac sympathetic tone in HCM. In the present study, we
tested the hypothesis that decreased neuronal norepinephrine trans-
porter (NET) activity contributes to increased sympathetic tone in
HCM mice. NET activity was assessed by measuring acute mean
arterial pressure (MAP) and heart rate (HR) responses to intravenous
injection of the selective NET inhibitor reboxetine (3.3 lg/g) in
anesthetized, vagotomized mice; and the rate of uptake of a fluores-
cent NET substrate (Molecular Devices) into individual sympathetic
neurons isolated from stellate ganglia. Baseline MAP and HR were
not significantly different in anesthetized HCM and WT littermate
control mice. As expected, reboxetine increased MAP and HR in both
groups of mice. While reboxetine-induced increases in MAP were
significantly less in HCM (?20.3 ± 4 mmHg, n = 5) vs. WT
(?42.5 ± 5 mmHg, n = 5) mice (P\ 0.05), increases in HR were
not significantly different in the two groups (?104 ± 9 vs.
?119 ± 15 bpm, respectively). NET activity measured in isolated
sympathetic neurons was significantly less in HCM (4.5 ± 0.3 a.u. *
min-1, n = 115 neurons, from 4 mice) vs. WT (5.3 ± 0.4 a.u. *
min-1, n = 98 neurons, from 4 mice). mRNA expression of NET
measured in stellate ganglia by qPCR was not different in HCM
(n = 6) vs. WT (n = 6) mice. In conclusion, HCM mice exhibit
decreased NET activity that contributes to increased sympathetic
tone.
Funding: NIH HL14388, F32HL140880, T32HL007121, AAS-
Lundbeck Fellowship.
Effects of 60-day head-down tilt bed rest on skeletal muscle-pump
baroreflex
M.F. Tremblay, D. Xu, R. Ruedl, N. Goswami, A.P. Blaber
Department of Biomedical Physiology and Kinesiology, Simon Fraser
University, Burnaby, BC, Canada
Post-spaceflight orthostatic intolerance relates to compromised auto-
nomic cardiovascular and deteriorating postural control. During quiet
standing, the skeletal muscle-pump baroreflex (MPBR) works with
the arterial baroreflex (A-BR) to regulate blood pressure. The effects
of microgravity on muscle-specific MPBR is unknown. We assessed
the effects of a 60-day 6 head-down tilt bed rest (HDBR) on MPBR.
Previous data suggested that MPBR responses changed with A-BR.
We hypothesized that MPBR activation would decrease post-HDBR.
Nineteen physically-fit males completed a supine-to-stand test (STS)
with 5-min supine and 6-min quiet stand 12 and 2 days before, and
90-min (R0) and 8 days (R8) after HDBR. Continuous beat-to-beat
systolic arterial pressure (SAP), electrocardiography (ECG), and
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electromyography (EMG) recordings of tibialis anterior (TA), medial
and lateral gastrocnemius (MG, LG), and soleus (S) muscles were
made. SAP and ECG were also recorded during HDBR. MPBR and
A-BR activity was assessed using wavelet transform coherence
analysis (response gain and percent-time-active) in (HF) and low (LF)
frequency bands between SAP and EMG (MPBR) and SAP and ECG
(A-BR). Mean heart rate increased over HDBR (p\ 0.0001) showing
cardiovascular deconditioning. A-BR gain was lower on R0 compared
to pre-HDBR (p\ 0.001; 1.8 ± 0.8 vs. 7.7 ± 0.8 ms mmHg-1) with
a corresponding reduction in percent-time-active (p\ 0.001; 29 ± 3
vs. 45 ± 3%). Across all muscles, MPBR response gain was unaf-
fected by bedrest (p = 0.260); however, percent-time-active was
reduced on R0 (p\ 0.001; 29 ± 5 vs. 54 ± 5%). Response gain was
highest in MG and TA and lowest in LG and S at all timepoints
(p\ 0.05). HDBR has pronounced effects on cardiovascular
responses to standing. Here we show a link between decreased acti-
vation rate of A-BR and MPBR along with decreased A-BR gain.
Similar reductions in percent-time-active suggest blood pressure
regulation changes, possibly at the level of cardio-postural integration
within the brainstem.
Hot Topic Plenary Lecture
Neuromodulation focused therapeutics for cardiac disease:
structure/function foundations
J.L. Ardell
University of California, Los Angeles (UCLA) Cardiac Arrhythmia
Center, and UCLA Neurocardiology Research Program of
Excellence, David Geffen School of Medicine, Los Angeles, CA,
USA
Cardiac control is mediated via interdependent neural networks
involving intra-thoracic intrinsic cardiac and extra-cardiac autonomic
ganglia, spinal cord, brainstem and higher centers. Each of these
processing centers contains afferent, efferent and local circuit neurons
which interact locally and with the other levels to coordinate regional
cardiac electrical and mechanical indices on a beat-to-beat basis.
While these neural networks are optimized to respond to normal
physiological stressors, they can be disrupted by cardiac pathology.
Autonomic dysregulation, central to the evolution of both heart failure
and arrhythmias, involves adverse remodeling in multiple levels of
the hierarchy for cardiac control. Neuromodulation based approaches
that target select nexus points within this hierarchy for cardiac control
offer unique opportunities to positively impact therapeutic outcomes.
Novel therapeutic interventions can target central and/or peripheral
aspects of the cardiac neuroaxis to render cardiomyocytes stress
resistant. For surgical and neural ablation interventions, it is the
mitigation of destabilizing reflex processing within the cardiac ner-
vous system that is central to cardioprotection. For bioelectronic
interventions, the characteristics of the electrode-nerve interface, the
stimulation protocol utilized, and the disease process itself are all
relevant factors in determining the ultimate efficacy of neuromodu-
lation. Taken together, it is the understanding the anatomical and
physiological basis for such control in normal and pathological con-
ditions that is necessary to implement effectively novel
neuromodulation therapies.
Streeten Plenary Lecture
The art and science of clinical autonomic research
R. Freeman
Department of Neurology, Beth Israel-Deaconess Medical Center,
Harvard Medical School, Boston, MA, USA
Clinical research begins with the patient and the clinical method—the
history, examination and testing that underlies the development of a
differential diagnosis and a final diagnosis. The unanswered questions
that emerge in that interaction—the mysterious symptom, the unex-
plained sign, the puzzling combination of symptoms and signs, the
disease without pathophysiological explanation, and above all, the
suffering patient—it is these that motivate the clinical researcher to
develop and refine questions and seek answers.
Sweat gland nerve fiber density: development of a novel unbiased
reconstruction methodology
K. Minota, A.M. Schmeichel, J.D. Schmelzer, J. Mandrekar, P.A.
Low, W. Singer
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Background and Objective: Dermal structures are densely innervated
by autonomic nerve fibers. Thus, it comes as no surprise that over the
past decade, skin biopsies have sparked great interest in the evalua-
tion of autonomic disorders. A number of groups have reported on
sweat gland nerve fiber density (SGNFD) as a means to quantitate
sudomotor innervation. However, methodologies vary significantly
from imaging to analyzing techniques and although conventional
stereology techniques are most commonly used, no standard tech-
nique has been established. In an attempt to bridge this gap, we sought
to develop a reliable and reproducible technique to quantify SGNFD
using 3D reconstruction of dermal nerve fibers.
Methods: Four-millimeter skin punch biopsies were collected from
healthy individuals. Biopsies were cut by freezing microtome. Each
section was stained with PGP 9.5 and Collagen IV antibodies to
visualize nerve fibers and sweat gland (SG) basement membranes,
respectively. SGs were imaged using confocal and wide-field
microscopy. Image stacks were taken at 209 objective at 1-lm
intervals. Volume was determined using a contouring function at the
top and bottom of the Z-stacks. Images were optimized using
deconvolution algorithms. Nerve fibers were reconstructed and nerve
fiber length (NFL) was quantified using an automated 3D software
platform (NL360). SGNFD was calculated by dividing NFL by vol-
ume. SGNFD was also assessed using grid-matrix stereology for
comparison.
Results: Thus far, a total of 104 SGs derived from 5 subjects have
been analyzed using both microscopy techniques. All images were
analyzed by two independent observers to evaluate reproducibility.
Using confocal microscopy, the software reliably traced nerve fibers
surrounding sweat glands and required minimal operator adjustment.
The rendering of nerve fibers was clearly inferior when using wide-
field microscopy, often raising questions about true nerve signal
versus artifact and requiring more operator input and adjustments to
analysis settings. This is reflected in the intraclass correlation coef-
ficient (ICC) for inter-reviewer reliability, which was ICC = 0.99
using confocal images versus ICC = 0.815 using wide-field images.
Correlation between the optimized 3D-reconstructon and grid-matrix
stereology was poor (ICC = 0.385).
Conclusions: The newly developed technique of SGNFD quantitation
using deconvolution algorithms, 3D reconstruction of sweat gland
nerve fibers and confocal microscopy, reliably traces sweat gland
nerve fibers, shows outstanding reproducibility between observers, is
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almost completely unbiased, and arguably superior to conventional
stereology methods.
Funding: NIH (R01NS092625, U54NS065736, K23NS075141,
UL1TR000135) and Mayo Funds.
Familial amyloid polyneuropathy: impact of biopsies
and mutations on diagnostic considerations
C.H. Gibbons1, A. Gonzalez-Duarte2, F. Barroso3, M. Campagnalo1,
S. Rajan1, J.Y. Kim1, R. Freeman1
1Center for Autonomic and Peripheral Nerve Disorders, Beth Israel
Deaconess Medical Center, Harvard Medical School, Boston, MA,
USA; 2Instituto Nacional de Ciencias Me´dicas y Nutricio´n, Salvador
Zubira´n, Mexico City, Mexico; 3Institute for Neurologic Research
Rau´l Carrea, FLENI, Buenos Aires, Argentina
Introduction: Familial amyloid polyneuropathy is due to one of many
mutations in the transthyretin (TTR) gene, resulting in a progressive
fatal disease with sensory, motor and autonomic involvement.
Objective: To characterize the symptoms, signs and skin biopsy
neuropathological findings in a cohort of individuals with TTR
Mutations.
Methods: Individuals with a variety of TTR mutations underwent
detailed neurological examinations including the Neuropathy
Impairment Score in the Lower Limb (NIS-LL), the Utah Early
Neuropathy Score (UENS), Coutinho staging, autonomic testing,
symptom scores (using the EuroQol, Brief Pain Symptom Inventory,
and the orthostatic hypotension Questionnaire). All subjects had
3 mm punch skin biopsies at the distal leg and distal thigh with
analysis of amyloid burden by Congo Red, and neuropathy severity
by staining with protein gene product 9.5.
Results: A total of 88 subjects participated with the following TTR
mutations: 43- Val30Met, 30- Ser50Arg, 6- Gly47Ala, 5- Ser52Pro, 2-
F64L, 1- I73 V and 1 with Y136H. Coutinho staging included 47 stage
0, 32 stage 1, 8 stage 2 and 1 stage 3. The diagnostic sensitivity for
amyloid detection from a single skin biopsy was 72%, the diagnostic
yield increased to 89% with 2 biopsies. Biopsies were positive for
amyloid in 78% of individuals with no clinical evidence of neuropathy
(NIS-LL scores of 0) and 94% for individuals with any evidence of
neuropathy. Amyloid burden was inversely correlated with nerve
density at the distal leg (R = 0.59, P\ 0.01) and distal thigh (R = -
0.53, P\ 0.01), and correlated with the NIS-LL (R = 0.48, P\ 0.05),
and UENS (R = 0.49, P\ 0.05).
Conclusion: Skin biopsy is a sensitive and specific pathological
marker for tissue diagnosis of familial amyloid polyneuropathy across
multiple mutations, even in individuals with no clinical evidence of
disease. Amyloid burden correlates with neuropathy severity, both
pathologically and by examination criteria; skin biopsies may prove
informative for studies that seek to alter the natural history of the disease.
Funding: Pfizer (RF).
Impact of patisiran on autonomic neuropathy in hereditary
transthyretin-mediated (hATTR) amyloidosis patients
A. Gonzalez-Duarte1, D. Adams2, M. Mauermann3, T. Coelho4, C.C.
Yang5, M. Polydefkis6, A. Kristen7, I. Tournev8, H. Schmidt9, J.L.
Berk10, K.P. Lin11, P.J. Gandhi12, M. Sweetser12, M. White12, J.
Gollob12, O. Suhr13
1Instituto Nacional de Ciencias Me´dicas y Nutricio´n, Salvador
Zubira´n, Mexico City, Mexico; 2National Reference Center for FAP
(NNERF)/APHP, INSERM U 1195, CHU Biceˆtre, Le Kremlin
Biceˆtre, France; 3Mayo Clinic, Rochester, MN, USA; 4Hospital de
Santo Anto´nio, Porto, Portugal; 5National Taiwan University
Hospital, Taipei, Taiwan; 6Johns Hopkins, Baltimore, MD, USA;
7Heidelberg University Hospital, Heidelberg, Germany; 8University
Multiprofile Hospital for Active Treatment, Sofia, Bulgaria;
9University Hospital Muenster, Muenster, Germany; 10Amyloid
Treatment and Research Program, Boston University, Boston, MA,
USA; 11Taipei Veterans General Hospital, Taipei, Taiwan; 12Alnylam
Pharmaceuticals, Cambridge, MA, USA; 13Department of Public
Health and Clinical Medicine, Umea˚ University, Umea˚, Sweden
Introduction: hATTR amyloidosis is a rare, multi-systemic, life-
threatening disease with heterogeneous clinical presentation including
sensory, motor and autonomic neuropathy, and cardiac involvement.
Clinical manifestations of autonomic dysfunction include chronic
diarrhea and nausea/vomiting, orthostatic hypotension, and urinary
tract infections. In the Phase 3 APOLLO study, patisiran, an inves-
tigational RNAi therapeutic, showed improvement in primary,
secondary and exploratory endpoints compared to placebo; generally
well-tolerated in hATTR amyloidosis patients. Here, data on mea-
surements of autonomic symptoms from APOLLO are presented.
Methods: APOLLO was a multi-center, international, randomized
(2:1), double-blind study of patisiran 0.3 mg/kg or placebo IV q3W in
hATTR amyloidosis patients with polyneuropathy (NCT01960348).
COMPASS-31, a 31-item questionnaire (range 0–100 points), was
used to evaluate patient-reported autonomic neuropathy symptoms on
six domains: orthostatic intolerance, vasomotor, secretomotor, gas-
trointestinal, bladder, and pupillomotor. Subjective perceptions of
autonomic nerve function were captured within the Norfolk QOL-
DN, a 35-item patient-reported scale. Postural blood pressure (PBP)
was captured in the mNIS ? 7 score. Among all 3 tools, higher scores
are indicative of worsening autonomic symptoms.
Results: APOLLO enrolled 225 patients: mean age 61 (24–83), 74%
males and 43% V30M. Overall, COMPASS-31 showed a least
squares (LS) mean decrease (improvement) of - 5.29 points with
patisiran compared to an LS mean increase (worsening) of 2.24 points
with placebo, for an overall treatment difference of - 7.53 points at
18-months (p = 0.0008). Patisiran-treated patients experienced ben-
efit compared to placebo across all COMPASS-31 domains, showing
improvement relative to baseline in orthostatic intolerance and gas-
trointestinal domains. Similarly, autonomic improvement with
patisiran and worsening with placebo was observed in autonomic
domain of Norfolk QOL-DN and PBP component of mNIS ? 7 with
an LS mean change (SEM) compared to baseline for patisiran, pla-
cebo: [- 0.3 (0.19), 0.8 (0.39)] and [- 0.2 (0.06), 0.1 (0.11)],
respectively. These findings were accompanied by a lower frequency
of AEs of syncope, nausea, and urinary tract infection in the patisiran
group compared to placebo group.
Conclusions: In APOLLO, multiple measures of autonomic symp-
toms and function showed a consistent benefit with patisiran versus
placebo as well as an improvement compared to baseline resulting in
lowering of GI symptoms (e.g., diarrhea and constipation) and
orthostatic intolerance (e.g., inability to stand upright).
Funding: Study sponsored and funded by Alnylam Pharmaceuticals.
Adrenal gland stimulation is intact in patients with postural
tachycardia syndrome
S. Paranjape1, E.M. Garland1, V. Nwazue1, B.K. Black1, J.
Celedonio1, C.A. Shibao1, L.E. Okamoto1, A. Gamboa1, A. Diedrich1,
I. Biaggioni1, D. Robertson1, S.R. Raj1,2
1Department of Medicine, Division of Clinical Pharmacology,
Autonomic Dysfunction Center, Vanderbilt University Medical
School, Nashville, TN, USA; 2Libin Cardiovascular Institute of
Alberta, Department of Cardiac Sciences, University of Calgary,
Calgary, AB, Canada
466 Clin Auton Res (2018) 28:453–505
123
Background: Many patients with postural tachycardia syndrome (POTS)
have hypovolemia with a plasma volume deficit of 10–30%. Paradoxi-
cally, some patients with hypovolemia have low levels of aldosterone,
and adrenal hormones, and consequently some POTS patients receive a
diagnosis of ‘‘adrenal fatigue’’. The adrenal gland is stimulated by
Angiotensin II to release aldosterone, and stimulated by adrenocorti-
cotropin hormone (ACTH) to release aldosterone and cortisol. We sought
to compare effects of IV ACTH stimulation on the adrenal release of
aldosterone and cortisol in POTS patients and healthy volunteers.
Methods: While on a low Na? diet (* 10 mEq/day), 8 female POTS
patients and 5 female healthy subjects (HS) received low dose ACTH
(1 lg) IV following a baseline blood sample. Venous aldosterone and
cortisol levels were sampled every 30 min for 2 h. After 60 min,
ACTH 249 lg IV was administered to ensure a maximal response.
Aldosterone level at 60 min was the primary outcome, with a cortisol
level at 60 min and maximal aldosterone and cortisol as secondary
outcomes. Data are presented as mean ± SD.
Results: Baseline aldosterone was not different between POTS
(33.7 ± 14.9 ng/dL) vs. HS (33.4 ± 18.6 ng/dL; P = 1.0). Aldos-
terone increased in both groups in response to ACTH, but was not
different in POTS vs. HS at 60 min (52.5 ± 15.7 ng/dL vs.
57.9 ± 26.4 ng/dL; P = 0.7) or maximally (68.0 ± 21.6 ng/dL vs.
61.9 ± 24.3 ng/dL; P = 0.7). Baseline cortisol was not different
between POTS (25.0 ± 7.5 lg/dL) vs. HS (22.3 ± 3.9 lg/dL;
P = 0.5). Cortisol increased in both groups in response to ACTH, but
was not different in POTS vs. HS at 60 min (41.5 ± 5.8 lg/dL vs.
40.7 ± 5.9 lg/dL; P = 0.8) or maximally (48.4 ± 10.4 lg/dL vs.
46.6 ± 6.8 lg/dL; P = 0.7).
Conclusions: ACTH injection appropriately increased the aldosterone
and cortisol levels in POTS patients. These data suggest that stimu-
lated adrenal function is normal in patients with POTS.
Funding: NIH Grant R01 HL102387.
Epidemiology of postural tachycardia syndrome
M.A. AbdelRazek, P.A. Low, W. Rocca, A. Chamberlain, B. Abbott,
W. Singer
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Background and Objective: Although demographic and clinical
characteristics of the postural tachycardia syndrome (POTS) have
been well described, reliable epidemiological data are lacking. A
perceived increase in incidence underlines the need for careful epi-
demiologic studies. We therefore sought to investigate the incidence
of POTS in Olmsted County and its evolution over time.
Methods: We identified all patients in the clinical autonomic labo-
ratory database of Mayo Clinic Rochester from January 1st 2000
through December 31st 2016, who fulfilled heart rate criteria for
POTS during head-up tilt (increment C 30 bpm if C 20 years of
age, C 40 bpm if B 19 years). Using the Rochester Epidemiology
Project, we narrowed this search to those who fulfilled heart rate
criteria while residents of Olmstead County. The identified records
were carefully reviewed to confirm the laboratory and clinical diag-
nosis of POTS per 2011 consensus statement criteria. Census counts
for the Olmstead County population from 2000 to 2016 were gathered
from government records. Incidence was defined as the number of
new cases per year among 100,000 residents.
Results: We identified 58 patients diagnosed with POTS while living
in Olmsted County during the defined timeframe, 48 of which were
female (86%). Mean age at diagnosis was 22.5 years, ranging from 11
to 50 years. The mean duration of documented orthostatic symptoms
was 3 years. The most recent (2016) incidence rate was 6/100,000
person-year for the entire population (10.5/100,000 for women). The
incidence rate among the population at risk (10–54 years of age) in
2016 was 10.1/100,000 person-year (17.6/100,000 for women). Both
incidence rate for the total population and the population at risk
showed a near fourfold increase from the year 2000, with the most
dramatic increase noted between 2002 and 2005, and subsequently
approaching a plateau.
Conclusion: Our epidemiologic data confirm as expected POTS as a
disorder affecting predominantly young women. The rather abrupt rise
of incidence based on laboratory diagnosis between 2002 and 2005 is
intriguing, may reflect increased awareness of the syndrome among
patients and physicians, but a true rise in incidence cannot be excluded.
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A novel autosomal recessive orthostatic hypotension syndrome:
a new kid on the block
R.A. Wevers
Professor in Clinical Chemistry, Translational Metabolic Laboratory,
Department Laboratory Medicine, Radboud University Medical
Centre, Nijmegen, The Netherlands
We describe two independent families, with four patients in total,
experiencing severe life-threatening orthostatic hypotension because
of a novel cause. As in dopamine b-hydroxylase deficiency, con-
centrations of norepinephrine and epinephrine in the patients were
low. Plasma dopamine b-hydroxylase activity, however, was normal,
and the DBH gene had no mutations. Molecular genetic analysis was
performed to determine the underlying genetic cause. Homozygosity
mapping and exome and Sanger sequencing revealed pathogenic
homozygous mutations in the gene encoding cytochrome b561
(CYB56). The CYB561 gene was found to be expressed in many
human tissues, in particular the brain. The CYB561 protein defect
leads to a shortage of ascorbate inside the catecholamine secretory
vesicles leading to a functional dopamine b-hydroxylase deficiency.
The concentration of the catecholamines and downstream metabolites
was measured in brain and adrenal tissue of CYB561 knockout mice.
The concentration of norepinephrine and normetanephrine was
decreased in whole-brain homogenates of the CYB561(-/-) mice
compared with wild-type mice (P\ 0.01), and the concentration of
normetanephrine and metanephrine was decreased in adrenal glands
(P\ 0.01), recapitulating the clinical phenotype. The patients
responded favorably to treatment with L-dihydroxyphenylserine,
which can be converted directly to norepinephrine. This study is the
first to implicate cytochrome b561 in disease by showing that
pathogenic mutations in CYB561 cause an as yet unknown disease in
neurotransmitter metabolism causing orthostatic hypotension.
Congenital CYB561 deficiency causing isolated noradrenergic
failure
I. Biaggioni, E. Garland, B. Black, D. Robertson, C.A. Shibao
Autonomic Dysfunction Center, Division of Clinical Pharmacology,
Department of Medicine, Vanderbilt University Medical Center,
Nashville, TN, USA
We previously described patients with congenital deficiency of
dopamine-beta-hydroxylase (DBH), the enzyme that converts dopa-
mine (DA) into norepinephrine (NE). Biochemically, plasma NE is
virtually absent and DA greatly increased. Clinically these patients
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have isolated sympathetic failure and intact parasympathetic function.
We recently reported patients who had mutations in the gene
encoding cytochrome b561 (van der Berg et al., Circ Res 2018), the
enzyme that ascorbate, a crucial cofactor for DBH, within the nora-
drenergic secretory vesicles. Here we report the clinical and
biochemical characteristics of one of the families (2 sisters) previ-
ously reported, and an additional newly discovered male patient with
a different mutation. All three patients had disabling orthostatic
hypotension (OH) since infancy and episodes of hypoglycemia, but
without ptosis (prominent in DBH deficiency). Valsalva maneuver
(VM) was typical of sympathetic failure with exaggerated hypoten-
sion during phase 2 and absence of blood pressure overshoot during
phase 4. Heart rate ratio to sinus arrhythmia and VM were normal.
Cardiovagal response to neck suction and phenylephrine were intact.
Plasma NE and its metabolite DHPG were undetectable but plasma
DA was normal. Droxidopa restored NE and improved OH. Patients 1
and 2 (sisters) were homozygous for a nonsense mutation in Exon 2,
c.131G[A, p.Trp44. Patient 3 was a compound heterozygous; one
allele had a mutation in Exon 2, c157C[T, p.His.52Tyr, and the
other had an Exon 2 deletion. Thus, we report patients with congenital
CYB51 deficiency, the enzyme that generates ascorbate, which is
critical for DBH activity. Therefore these patients have a clinical
presentation similar to DBH deficiency with life-long OH (but
without ptosis), virtual absence of plasma NE (but without increase in
plasma DA), and who respond to droxidopa treatment.
Funding: NIH Autonomic Rare Diseases Clinical Research Consor-
tium NS065736.
Familial autonomic ganglionopathy caused by rare CHRNA3
genetic variants. Novel genetic cause of neurogenic orthostatic
hypotension
C.A. Shibao, J.A. Phillips, J.D. Cogan, J.H. Newman, R. Hamid, J.H.
Sheehan, B. Black, D. Robertson, I. Biaggioni; Collaborators of
Undiagnosed Diseases Network (UDN)
Department of Medicine, Vanderbilt University Medical Center,
Nashville, TN, USA
Objective: To identify and determine the molecular basis of a new
Mendelian cause of familiar case of neurogenic orthostatic hypoten-
sion (nOH).
Methods: The proband developed disabling nOH at 39 years of age. He
was evaluated at the Vanderbilt Autonomic Dysfunction Center and was
diagnosed with severe autonomic failure and small nonreactive pupil.
Plasma norepinephrine were abnormally low while supine (34 pg/dl),
and upon standing (156 pg/dl), dopamine levels were wnl. Of note, his
sister had onset of nOH and miosis in her late teens. Their parents, brother
and the proband’s three children were healthy.
Results: Patient was referred to the UDN where whole exome
sequencing of DNAs from the proband and his affected sister showed
that both were compound heterozygotes for c.907_908delCT
(p.L303Dfs*115)/c.688G[A (p.D230N) variants in the acetyl-
choline receptor, neuronal nicotinic, alpha 3 subunit (CHRNA3) gene.
CHRNA3 is a subunit of nicotinic acetylcholine receptors (nAChRs)
that regulates blood pressure through modulation of synaptic trans-
mission in the autonomic ganglia. The fs and missense CHRNA3
variants were inherited from the sibs’ mother and father, respectively,
and their non-affected brother was a nl/p.D230N heterozygote. The fs
variant is obviously pathogenic and the p.D230N variant is predicted
to be damaging (SIFT)/probably damaging (PolyPhen2). Further-
more, we predict from structural modeling that the p.D230N variant
lies on the interface between CHRNA3 and other nAChR subunits
and that it would destabilize the nAChR pentameric complex. Inter-
estingly, homozygous knock-out mice without detectable Chrna3 had
autonomic failure and dilated pupils. In humans, the presence of
nAChR autoantibodies against the alpha 3 subunit is associated with
nOH and dilated pupils.
Conclusions: We report sibs affected with autonomic failure and
miosis of unknown etiology who are compound heterozygotes for
CHRNA3 variants that co-segregate with and have predicted effects
on nAChR structure that suggest they likely cause this family’s nOH.
Funding: Vanderbilt Autonomic Disorders Consortium, NIH,
U54NS065736; Vanderbilt Undiagnosed Disease Network (Clinical
Site), NIH, U01 HG007674.
Acute, dose-dependent, blood pressure-lowering effect
of continuous positive airway pressure in autonomic failure
patients with supine hypertension
L.E. Okamoto, J.E. Celedonio, A. Diedrich, C.A. Shibao, A. Gamboa,
B.K. Black, S. Paranjape, D. Robertson, I. Biaggioni
Departments of Medicine, Division of Clinical Pharmacology,
Vanderbilt University Medical Center, Nashville, TN, USA
Primary autonomic failure (AF) is characterized by disabling ortho-
static hypotension but half of these patients also have supine
hypertension. We have previously shown that continuous positive
airway pressure (CPAP 4, 8, 12 and 16 cm H2O, each for 2 min)
applied during autonomic blockade with trimethaphan acutely
decreased systolic blood pressure (SBP) in hypertensive and nor-
motensive subjects (- 17 ± 2 and - 8 ± 2 mmHg at 16 cm H2O)
due to decreases in cardiac output (CO) and stroke volume (SV). In
this study, we hypothesized that CPAP would have an acute, dose-
dependent, blood pressure-lowering effect in patients with autonomic
failure with supine hypertension. Five CPAP levels (0, 4, 8, 12 and
16 cm H2O, each for 2–3 min) were applied sequentially to 15 AF
patients with supine hypertension (12 males, 70 ± 1 year). Hemo-
dynamic parameters were measured at the end of each CPAP level.
We found that CPAP levels of 4, 8, 12 and 16 cm H2O significantly
decreased SBP in a dose-dependent manner. The maximal SBP drop
was - 20 ± 3 mmHg with CPAP 16 (from 154 ± 4 to
134 ± 4 mmHg, P\ 0.01), and was associated with a decrease in CO
(- 12 ± 4%) and SV (- 13 ? 4%). Neither systemic vascular
resistance nor heart rate changed significantly with CPAP. SBP
returned to baseline levels within 5 min after removal of the CPAP
(REC). We conclude that, in AF patients with supine hypertension,
CPAP acutely decreases SBP in a dose-dependent manner, due to
decreases in CO and SV likely reflecting a decrease in venous return.
These results suggest that CPAP could be used as a non-pharmaco-
logic approach to treat the supine hypertension of AF. Future studies
are needed to test the safety and efficacy of this approach.
Funding: NIH Grants U54 NS065736, RO1 HL122847 and UL1
TR002243 (CTSA award).
Norepinephrine transporter inhibition with atomoxetine prevents
tilt-induced vasovagal syncope: a randomized, placebo-controlled
trial
L. Lei, J.C. Guzman, T. Kus, F. Araya-Paredes, J. Angihan, G.
Bennett, C. Maxey, R.S. Sheldon, S.R. Raj
Libin Cardiovascular Institute, University of Calgary, Calgary, AB,
Canada
Background: The norepinephrine transporter (NET) acts as a clearance
mechanism in sympathetic neurons. Pharmacological NET inhibition
increases sympathetic tone and has been shown to decrease tilt-induced
syncope in healthy subjects. There is a paucity of effective therapies for
vasovagal syncope (VVS). The aim of this study was to determine
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whether treatment with atomoxetine (ATOX), a potent NET inhibitor,
reduces the risk of syncope in patients with recurrent VVS.
Methods: The multicenter Prevention of Syncope Trial (POST6) study
was a placebo-controlled, parallel-group, randomized trial of ATOX
(40 mg PO BID; n = 27) vs. matched placebo (PLAC; n = 29). VVS
patients were given two doses of study drug followed by a 60-min
drug-free head-up tilt table test.
Results: VVS patients were 35 ± 14 years (73% female) with a
median of 12 lifetime faints, and 3 faints in the last year. Patients
fainted significantly less with ATOX than PLAC (24% vs. 63%;
P = 0.003), but there was no difference in the rates of presyncope
(76% vs. 78%; P = 0.87). The mean time-to-faint was longer with
ATOX than PLAC (49.9 ± 18.8 min vs. 35.9 ± 21.1 min;
P = 0.012). The logrank hazard ratio for fainting with ATOX:PLAC
was 0.40 (95% CI 0.18–0.87).
Conclusion: NET inhibition with ATOX significantly decreased the
risk of tilt-induced syncope in VVS patients. This is a promising
novel pharmacological strategy for the treatment of VVS.
Funding: Cardiac Arrhythmia Network of Canada (CANet).
Is cerebrovascular autoregulation (CA) impaired during head-up
tilt (HUT)-induced vasovagal syncope (VVS)? Inferences derived
from selective falls in total peripheral resistance (TPR) or cardiac
output (CO)
R. Schondorf, S. Balegh, J. Benoıˆt, B. Ditto
Departments of Neurology and Psychology, McGill University,
Montreal, QC, Canada
During VVS, diastolic and hence mean cerebral blood flow velocity
(CBFV) selectively declines while systolic CBFV remains stable. Some
infer from the increased calculated CBFV pulsatility that cerebrovascular
resistance (CVR) paradoxically increases at syncope because of impaired
CA or increased sympathetic activity. However, CVR measured as [mean
(BP/CBFV)], decreases at VVS indicating preserved CA that is ulti-
mately overwhelmed by the blood pressure (BP) collapse at VVS. We and
others have shown that as much as 75% of HUT-induced VVS is due to a
selective reduction in CO whereas 25% results from a selective decrease
in TPR. These 2 discrepant mechanisms could provide insight regarding
CA at VVS. If CVR increases as a result of a primary decline in CO and
decreases during a primary decline in TPR the profiles of diastolic CBFV
would not superimpose and impaired CA would be inferred. Conversely,
superimposed diastolic CBFV profiles, regardless of VVS mechanism
indicate preserved CA. We studied 48 completely healthy medication-
free VVS patients (age 33.8 ? 12.1 years; 14 men) 12 of whom were
TPR fainters and 36 CO fainters (27 primary decline in heart rate, 9 stroke
volume). Finger BP and middle cerebral artery CBFV were continuously
recorded. CO was derived from Modelflo. Averaged hemodynamic
profiles (2.5 Hz resampling) were created from the last 4 min of HUT.
We found that both mean BP and diastolic CBFV profiles were super-
imposable for CO and TPR fainters. Stepwise linear regression with
partial least squares regression as a control for multicollinearity of CO,
BP and TPR demonstrated that the decline in mean BP was virtually
completely responsible for the decline in diastolic CBFV. These results
indicate that the decline in BP at VVS is uniquely responsible for the
simultaneous decrease in diastolic CBFV regardless of mechanism. This
suggests that CA is preserved at syncope.
MSA Plenary Lecture
Multiple system atrophy: are we ready to tame the beast?
G. Wenning
Division of Clinical Neurobiology, Department of Neurology,
Medical University, MZA, Innsbruck, Austria
MSA is increasingly recognized as a fatal neurodegenerative disorder
associated with autonomic failure, ataxia and parkinsonism. In con-
trast to Parkinson’s disease, MSA is characterized by oligodendroglial
alpha synuclein aggregates that appear to be linked to selective
neurodegeneration in the central autonomic network as well as stri-
atonigral and olivopontocerebellar pathways. In the last decade there
has been considerable progress in our understanding of the key
pathogenic events leading to the discovery of candidate therapeutic
agents primarily targeting alpha synuclein toxicity and its conse-
quences. Although clinical trials have largely been negative so far,
they have provided unique insights into trial methodology and they
firmly established an international network that will facilitate future
trial activities. 50 years after the introduction of the term MSA by
Graham and Oppenheimer we are now ready to tame the beast.
Discovery and validation of MRI morphometry features for early
multiple system atrophy
P. Vemuri, Y. Varatharajah, A.M. Castillo, K.B. Thostenson, C.
Ward, T.L. Gehrking, J.A. Gehrking, A.D. Zeller, C.R. Jack Jr, P.A.
Low, W. Singer
Mayo Clinic, Rochester, MN, USA
Background and Objective: Although characteristic MRI findings are
often seen in later disease stages of multiple system atrophy (MSA),
there is currently a lack of validated imaging biomarkers for early
MSA and imaging markers of disease progression. Our goal with this
study was to identify key morphometric features for early MSA and
examine the utility of these features for cross-sectional diagnosis and
longitudinal tracking of disease progression.
Methods: We prospectively enrolled possible or probable MSA
patients whose disease was still relatively early (UMSARS I: 5–16
and able to walk unaided) to undergo standardized T1 MPRAGE
images on 3 T MRI scanners for morphometric MRI analysis. MRI
morphometric features were computed using Freesurfer v5.3. In a
discovery dataset of 24 MSA patients (19 MSA-C and 5 MSA-P), we
performed unsupervised clustering of 109 MRI volumetric features
that were scaled by the intracranial volume. We identified ‘MSA
regions’ based on inter-cluster and intra-cluster similarity in those 24
patients. We then enrolled an independent validation data set which
consisted of 16 early MSA (8 MSA-C and 8 MSA-P) and 13 normal
subjects with MRI scans at baseline and follow-up scans at 12-months
to examine the utility of ‘MSA regions’ for diagnosis and tracking of
disease progression.
Results: The ‘MSA regions’ identified were brainstem, cerebellar
white matter (WM), and total ventricular volume. In the independent
validation sample, we found that both baseline brainstem and cere-
bellar WM volumes were significantly lower, while the 12 months
decrease in volumes were significantly higher in MSA subjects when
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compared to normal (p\ 0.001). This difference was more pro-
nounced for MSA-C than MSA-P in both regions.
Conclusions: We identified and validated regions of atrophy using
MRI morphometry in early MSA using unbiased methodology.
Morphometric analysis of cerebellar WM and brainstem allows for
separating early MSA patients from control subjects, and detecting
disease progression over 12 months. MRI morphometry of selected
brain regions represents therefore a promising biomarker for the
diagnosis of MSA and a potential surrogate marker of disease pro-
gression for future clinical trials in MSA.
Funding: NIH (P01NS44233, U54NS065736, K23NS075141,
R01NS092625, UL1TR000135), FDA (R01FD004789), Cure MSA
Foundation, and Mayo Clinic.
Cutaneous alpha-synuclein deposition in multiple system atrophy
C.H. Gibbons, N. Wang, S. Rajan, D. Kern, J.A. Palma, H. Kauffman,
R. Freeman
Department of Neurology, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, MA, USA
Background: We recently reported that a-synuclein can be detected
within cutaneous autonomic nerve fibers of patients with Parkinson’s
disease (PD). We now report the deposition of phosphorylated and
total alpha-synuclein in patients with MSA, and compare those
findings to controls and individuals with PD.
Objective: To define the peripheral neural deposition of alpha-synu-
clein in MSA.
Methods: Twenty-nine individuals with MSA, 22 individuals with PD
and 10 healthy control subjects had clinical examinations, autonomic
function testing and skin biopsies taken from multiple proximal and
distal sites. Skin biopsies were stained for PGP9.5, phosphorylated
and total a-synuclein and results compared to autonomic function
tests.
Results: Patients with MSA had evidence of peripheral phosphory-
lated a-synuclein deposits in all subjects (P\ 0.001 vs. controls,
where no a-synuclein was detected) at proximal and distal biopsy
sites. Significant differences in synuclein deposition between MSA
subjects and PD subjects (P\ 0.01) was noted at all biopsy sites.
Discussion: We report the largest study of cutaneous alpha synuclein
in individuals with multiple system atrophy. Contrary to expectations,
peripheral deposition of phosphorylated a-synuclein was present in all
subjects with MSA and PD. These findings may offer insights into the
different patterns of synuclein deposition across a spectrum of neu-
rodegenerative diseases. The results carry significant implications for
disease diagnosis, prognosis and therapeutic interventions that alter
the natural history of the disease.
Funding: Study supported by the MSA Foundation (RF) and NIH U54
NS065736.
Alpha-synuclein deposition in noradrenergically innervated
pilomotor muscles distinguishes Lewy body forms of neurogenic
orthostatic hypotension from multiple system atrophy
D.S. Goldstein1, N. Wang2, C.H. Gibbons2, R. Freeman2
1Clinical Neurocardiology Section, National Institute of Neurological
Disorders and Stroke, National Institutes of Health, Bethesda, MD,
USA; 2Beth Israel Deaconess Medical Center, Harvard Medical
School, Boston, MA, USA
Background: Biomarkers are needed that can distinguish among
forms of neurogenic orthostatic hypotension (nOH)—especially Lewy
body diseases vs. multiple system atrophy (MSA). Both disease types
involve deposition of the protein alpha-synuclein (AS). Measurement
of total alpha-synuclein (AS) alone does not take into account pos-
sible concurrent loss of AS-containing sympathetic noradrenergic
fibers in Lewy body diseases.
Methods: Punch biopsies (3 mm, lateral leg) from 11 patients with
Lewy body nOH and 8 with MSA were analyzed by immunofluo-
rescence microscopy. AS was measured in pilomotor muscles, which
receive pure noradrenergic innervation. AS content was adjusted for
local sympathetic innervation by calculating the ratio of AS to PGP
9.5, a pan-axonal marker. All the subjects had Parkinson’s disease
with orthostatic hypotension, dementia with Lewy bodies, pure
autonomic failure, or MSA based on clinical diagnosis and research
laboratory tests including 18F-dopamine positron emission tomo-
graphic scanning. Three patients had autopsy-proven diagnoses by
neuropathology and catecholamine neurochemistry.
Results: The Lewy body group had a higher mean (± SEM) AS/PGP
9.5 ratio than did the MSA group (0.90 ± 0.02 vs. 0.66 ± 0.04,
p = 0.0001). A receiver operating characteristic curve for the AS/PGP
9.5 ratio showed 100% sensitivity at 86% specificity in separating the
groups. 18F-Dopamine-derived radioactivity in the left ventricular
free wall was lower in the Lewy body group (3247 ± 240 vs.
7924 ± 1095 nCi-kg/cc-mCi p = 0.0002).
Conclusions: Among patients with nOH, the AS/PGP9.5 ratio in
pilomotor muscles in skin biopsies and cardiac sympathetic neu-
roimaging efficiently distinguish Lewy body diseases from MSA.
Funding: Division of Intramural Research, NINDS, NIH.
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Norepinephrine and cognition: revisiting an old friend
D. Claassen
Cognitive and Behavioral Neurology and Movement Disorders,
Department of Neurology, Vanderbilt University, Nashville, TN,
USA
Loss of noradrenergic neurons and reductions in central nore-
pinephrine levels are described in many neurodegenerative disorders,
including Alzheimer’s disease (Kelly et al., 2017), Parkinson’s dis-
ease (Braak, 2003; Zarrow et al., 2003), dementia with Lewy bodies
(Vermeiren et al., 2017; Dickson et al., 2008), and multiple system
atrophy (Benarroch EE, 2012). In PD, a-synuclein accumulation and
cell death in the locus coeruleus precedes that in the substantia nigra
(Braak, 2003; Dickson, 2009), resulting in a measurable nore-
pinephrine deficiency early in the disease (Goldstein, 2012; Hurst,
1985). Given the widespread projections from the locus coeruleus to
areas such as the cortex, basal forebrain, limbic system, thalamus, and
cerebellum, central norepinephrine deficiency may play a major role
in many of the motor and non-motor symptoms in PD, particularly
those that do not respond well to traditional dopaminergic
interventions.
Norepinephrine repletion is a therapeutic target for a wide variety
of PD symptoms including cognitive impairment, apathy, depression,
freezing of gait, and autonomic dysfunction (Espay, 2014). Droxi-
dopa, a norepinephrine precursor, was historically used to treat PD
patients with freezing of gait (Narabayashi et al., 1987; Fukada et al.,
2013). Atomoxetine, a selective norepinephrine reuptake inhibitor,
may improve cognitive function and neuropsychiatric symptoms in
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PD patients. Ultimately, enhanced central norepinephrine appears to
influence fronto-striatal networks, which may be mediated through
improvements in cerebral metabolism and blood flow.
My overarching aim is to review cognitive effects of nore-
pinephrine, with a focus on cognitive neuroscience methods and
assessments of motor control and reward-based learning. Preliminary
work from our group will be presented, and this work emphasizes the
role of norepinephrine therapies in mediating improvements to inhi-
bitory action control, and reward-based learning. I will also describe
novel non-invasive imaging investigations of cerebral norepinephrine
integrity, and review imaging methods that assess cerebral blood flow,
metabolism, and locus coeruleus integrity. This review will hopefully
stimulate further investigations to the cognitive effects of noradren-
ergic modulation.
Cortical morphometric predictors of autonomic dysfunction
in generalized anxiety disorder
L. Carneval, M. Mancini, J. Koenig, E. Makovac, D.R. Watson, F.
Meeten, H.D. Critchley, C. Ottaviani
Department of Psychology, Sapienza University of Rome, Rome,
Italy
Generalized anxiety disorder (GAD) is associated with autonomic
dysfunction, notably decreased vagally-mediated heart rate variability
(vmHRV). Regional differences in brain morphometry correlate with
psychopathology in GAD, and with vmHRV in healthy individuals.
Here, we used both categorical and dimensional models of GAD
pathology to test the hypothesis that specific focal abnormalities in
cortical structure in GAD underpin decreased vmHRV. Adult female
patients with GAD (n = 17) and matched controls (n = 18) underwent
structural magnetic resonance imaging after characterization of
symptoms and quantification of resting vmHRV derived from con-
tinuous pulse oximetry. Cortical reconstruction was performed using
the FreeSurfer image analysis suite. Compared to controls, patients
with GAD showed cortical thinning of the (i) left rostral anterior
cingulate cortex (ii) left medial orbitofrontal cortex, and (iii) right
isthmus cingulate gyrus. Significant negative relationships were
identified between the severity of anxiety symptoms and cortical
thickness of the left medial orbitofrontal cortex and right isthmus
cingulate gyrus. These results extend evidence in GAD for structural
abnormalities within cortical areas implicated in emotion regulation
and cognition. Compared to controls, patients with GAD showed
decreased vmHRV at rest. In controls only, cortical thickness of the
left caudal anterior cingulate cortex correlated positively with resting
vmHRV. Our findings implicate abnormal integrity of anterior cin-
gulate cortex in the psychophysiological expression of GAD. These
insights suggest that interventional targeting of this region to nor-
malize autonomic activity may improve entrenched psychological and
behavioural symptoms of GAD.
Funding: This work was supported by the Italian Ministry of Health
(GR2011-02348232).
Active forelimb exercise mitigates susceptibility to cardiac
arrhythmia compared to passive hindlimb cycling in rats
with high-level spinal cord injury
V.E. Lucci, E.L. Harrison, K.M. DeVeau, K.A. Harmon, J. Liu, J.
Squair, A. Krassioukov, D. Magnuson, C.R. West, V.E. Claydon
Department of Biomedical Physiology and Kinesiology, Simon Fraser
University, Burnaby, BC, Canada
Introduction: High-level spinal cord injury (SCI) is associated with
injury to spinal autonomic (sympathetic) pathways, with abnormal
control of heart rate (HR). Individuals with high-level SCI have
increased susceptibility to cardiac arrhythmia. Active upper-limb and
passive lower-limb exercise interventions are commonly used in SCI
populations to enhance motor function and rehabilitation. It is unclear
whether these exercise modalities influence susceptibility to cardiac
arrhythmia. We aimed to evaluate whether: (i) susceptibility to
arrhythmia is increased in a rodent-model of SCI; (ii) exercise ame-
liorates this arrhythmia risk.
Methods: Experiments were conducted in 29 Wistar rats: controls
(SHAM, n = 7) and second thoracic level contusive SCI in 3 sub-
groups—non-exercisers (T2, n = 7), and exercisers (30 m/day 5 day/
week) completing active forelimb swimming (SWIM, n = 6) or pas-
sive hindlimb cycling (PHLC, n = 7). Electrocardiogram (ECG) data
were evaluated pre-, 1- and 5-weeks post-SCI. Indices of arrhythmia
risk (P-wave duration [PWD] variability, marker of atrial arrhythmia
risk; Tpeak-Tend variability, marker of transmural dispersion of
repolarisation; QT interval corrected for HR (QTc) and the QT
variability index (QTVI), markers of repolarisation) were determined
from ECG. R-R interval (RRI) was determined.
Results: RRI increased over time in both PHLC (p\ 0.001) and
SWIM (p = 0.013), but not SHAM (p = 0.8) or T2 (p = 0.8),
reflecting the effect of exercise training on HR. Tpeak-Tend and PWD
variability increased over time in T2 (p = 0.002, p = 0.009) and
PHLC (p = 0.001, p = 0.002), but not SHAM (p = 0.594, p = 0.98)
and SWIM (p = 0.628, p = 0.816). QTVI tended to increase over
time, in T2 only (p = 0.06). QTc variability increased over time in T2
(p = 0.04), and tended to increase in PHLC (p = 0.08), but not in
SHAM (p = 0.5) or SWIM (p = 0.75).
Conclusion: SCI increases susceptibility to atrial and ventricular
arrhythmia that can be ameliorated by exercise training. However, not
all exercise modalities are equal in mitigating arrhythmia risk pro-
gression post-SCI; active upper-limb exercise was associated with
better outcomes than passive hindlimb exercise.
Autonomic dysreflexia (AD) in individuals with SCI:
the association between elevations in blood pressure
and symptoms of AD over a 30 day observation period
C.G. Katzelnick, T.A. Dyson-Hudson, W.A. Bauman, S. Kirshblum,
N.D. Chiaravalloti, J.M. Wecht
Spinal Cord Injury Research, James J. Peters VA Medical Center,
Bronx, NY, USA
Objective: Although individuals with spinal cord injury (SCI) often
have episodic increases in systolic blood pressure (SBP) that reflect
AD, it has been assumed that many of these individuals remain
asymptomatic (a condition termed, ‘‘silent AD’’). The association
between elevations in SBP that reflect AD and the awareness of
symptoms that suggest AD over a 30-day observation period are
reported.
Participants: Individuals with SCI (n = 69) were categorized as
having AD, which was defined as having at least 1 SBP C 20 mmHg
their average 30-day SBP (AD: n = 58) and those who had no rise in
SBP that met criteria (noAD: n = 11).
Methods: Participants with SCI recorded SBP values 3-times/day for
30 days and were asked to complete an AD symptoms survey at the
end of each week (i.e., 4 surveys/subject).
Results: We observed a total of 6167 SBP recordings over the 30-day
period; 533 (8.6%) reflected AD. Participants in the AD group were older
(46 ± 13 years) and had a longer duration of injury (17 ± 13 years) than
those in the noAD group (30 ± 5 and 4 ± 3 years, respectively;
p\ 0.001). Although the average 30-day SBP did not differ significantly
between the groups, maximum 30-day SBP was increased in the AD
group (156 ± 24) compared to the noAD group (122 ± 15 mmHg;
p\ 0.001); those in the AD group had an average of 9.2 episodes of
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elevated SBP that were identified as being AD. However, there were no
significant group differences in AD symptoms reported and 43% (n = 25)
of participants in the AD group had an absence of symptoms reported over
the 30-day period suggesting silent AD.
Funding: Craig H. Neilsen Foundation (#284196) and VA RR&D
Service (#B2020-C).
Low frequency hemodynamic oscillations distinguish migraineurs
from non-headache controls
M.M. Cortez, J.J. Theriot, N.A. Rea, D. Hunter, F.E. Gowen, K.C.
Brennan
Department of Neurology, University of Utah, Salt Lake City, UT,
USA
Background: Surface imaging is a promising, non-invasive approach
to assess autonomically mediated regional perfusion in craniovascular
disorders such as migraine.
Methods: We used optical imaging to examine differences in facial
blood volume at baseline and in response to ammonia inhalation (a
noxious stimulus), as well as standardized measures of cardiovascular
autonomic function, in normal controls (n = 43) and in inter-ictal
migraine subjects (n = 21).
Results: Resting facial cutaneous oscillation frequency was signifi-
cantly different in migraine compared to healthy, non-headache
controls. Following ammonia inhalation, controls showed a signifi-
cant increase in resting facial cutaneous oscillation frequency,
whereas this response was blunted in the migraine group. Head-up tilt
table testing produced a significant decrease in facial hemodynamic
oscillation frequency in both groups. Standardized autonomic reflex
parameters did not differ significantly between study groups, and
facial cutaneous activity did not correlate with standardized cardio-
vascular autonomic reflex parameters, suggesting a potentially
differing generator for facial hemodynamic responses.
Conclusions: This approach to the assessment of craniofacial hemo-
dynamic function appears to exhibit differing mechanisms from
previously available techniques, and represents a promising new
biomarker for the study of craniofacial vascular function in migraine
and potentially other craniovascular disorders.
Funding: AAS-Lundbeck Research Fellowship (MMC).
WEDNESDAY, OCTOBER 24, 2018
POSTER SESSION I
Poster #1
Non-motor symptoms and gender differences in multiple system
atrophy
S. Eschlbo¨ck1, T. Benke1, S. Bo¨sch1, M. Delazer1, A. Djamshidian-
Tehrani1, A. Fanciulli1, R. Granata1, B. Ho¨gl1, C. Kaindlstorfer1, G.
Kiss2, F. Krismer1, K. Mair1, M. Nocker1, C. Raccagni1, C.
Scherfler1, K. Seppi1, A. Stefani1, W. Poewe1, G. Wenning1
1Department for Neurology, Medical University of Innsbruck,
Innsbruck, Austria; 2Divison of Neurourology, Department of
Urology, Medical University of Innsbruck, Innsbruck, Austria
Objective: To determine the frequency and gender differences of non-
motor symptoms (NMS) in patients with multiple system atrophy
(MSA).
Background: NMS are a core feature in MSA and may precede onset
of motor symptoms. Although NMS are gaining awareness as sig-
nificant cause of morbidity, the frequency of symptoms among MSA
subtypes and gender differences remain to be thoroughly
characterized.
Methods: The clinical features of patients diagnosed clinically as
probable or possible MSA who were treated at the movement disorder
unit of Innsbruck, Austria between 2000 and 2017 were analysed.
NMS were evaluated based on a review of medical records.
Results: Data from 175 MSA patients (51.4% men) were included in
the analysis. Early autonomic dysfunction as defined by occurrence of
at least one symptom within 1 year of motor onset was recorded in
49.1% of the patients. Overall the most frequent NMS reported by
patients at any time throughout the disease course were bladder
symptoms (94.8% of cases), depression (80.7%) and symptoms of
REM sleep behavior disorder (78.8%) followed by postural dizziness/
syncope (77.8%) and constipation (75.2%). Constipation and sudo-
motor symptoms were more prevalent in MSA-P (parkinsonian
variant) patients compared to MSA-C (cerebellar variant) patients (p
men) and early autonomic failure (men[women).
Poster #2
Alpha-synuclein deposition in sympathetic noradrenergic nerves
and cardiac noradrenergic deficiency distinguish Lewy body
from non-Lewy body forms of neurogenic orthostatic hypotension
R. Isonaka, P. Sullivan, A. Corrales, A.Z. Rosenberg, C. Holmes, D.S.
Goldstein
Clinical Neurocardiology Section, National Institute of Neurological
Disorders and Stroke, National Institutes of Health, Bethesda, MD,
USA
Background: Lewy body diseases are characterized by deposition of
the protein alpha-synuclein (AS) in autonomic nerves and a high
frequency of neurogenic orthostatic hypotension (nOH) due to sym-
pathetic neurocirculatory failure. We examined whether measurement
of AS in noradrenergically innervated skin constituents and cardiac
sympathetic neuroimaging by 18F-dopamine positron emission
tomographic scanning distinguish Lewy body from non-Lewy body
forms of nOH.
Methods: Skin biopsies were analyzed from 12 patients with Lewy
body nOH and 12 with non-Lewy body nOH (multiple system atro-
phy, autoimmune autonomic ganglionopathy, autoimmunity-
associated autonomic failure with sympathetic denervation, nOH after
cardiac transplantation, pure autonomic failure without Lewy bodies).
AS was quantified by the AS signal in regions of interest (ROIs)
delineated by smooth muscle actin and by a statistical index of co-
localization of AS with tyrosine hydroxylase (TH), a marker of cat-
echolaminergic neurons.
Results: In the patients with Lewy body forms of nOH the mean
intensities of AS signal in arrector pili muscles, blood vessels, and
sweat glands were 19, 6.5, and 15 times those in patients with non-
Lewy body forms of nOH (p\ 0.0001 each). The mean values for the
AS/TH co-localization index in the Lewy body nOH group averaged
9 times that in the non-Lewy body nOH group (p = 0.0001). Com-
bining myocardial 18F-dopamine-derived radioactivity with AS
deposition by either the ROI or AS/TH co-localization method
completely separated the Lewy body from the non-Lewy groups.
Conclusions: AS quantification in noradrenergically innervated skin
constituents combined with cardiac sympathetic neuroimaging effi-
ciently distinguishes Lewy body from non-Lewy body forms of nOH.
Funding: Division of Intramural Research, NINDS, NIH.
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Poster #3
The impact of supine hypertension on target organ damage
and mortality in patients with neurogenic orthostatic hypotension
J.A. Palma, G. Redel-Traub, A. Porciuncula, D. Samaniego-Toro,
Y.W. Lui, L. Norcliffe-Kaufmann, H. Kaufmann
Department of Neurology, Dysautonomia Center, New York
University School of Medicine, New York, NY, USA
In addition to neurogenic orthostatic hypotension (nOH) patients with
autonomic failure frequently have supine hypertension. The conse-
quences of both problems are difficult to disentangle. We
hypothesized that supine hypertension in patients with nOH increases
the risk of end-target organ damage and negatively impacts survival.
Patients with autonomic failure underwent standardized autonomic
function tests, full neurological examination, and ambulatory 24-h
blood pressure monitoring (ABPM). We assessed end-target organ
damage by measuring cerebral white matter hyperintensities (WMH),
left ventricular hypertrophy (LVH), and renal function. We
prospectively followed these patients for 27 months (range:
12–56 months) and recorded incident cardiovascular events and all-
cause mortality. Fifty-seven patients (35 with multiple system atro-
phy, 14 with Parkinson disease and 8 with pure autonomic failure)
with nOH completed autonomic, cardiovascular, renal, and brain
magnetic resonance imaging evaluations, and had ABPM. Thirty-
eight patients (67%) had supine hypertension (systolic BP[ 140
mmHg). These patients had higher blood urea nitrogen levels
(P = 0.005), lower estimated glomerular filtration rate (P = 0.008),
higher prevalence of LVH (P = 0.040), and higher WMH volume
(P = 0.019) compared to those without hypertension. Within
27.1 ± 14.5 months of follow-up, 25 subjects (6 without, 19 with
supine hypertension) had died (22 patients), had nonfatal myocardial
infarction (1 patient), or had nonfatal stroke (2 patients). Time to
cardiovascular event/death was shorter in patients with supine
hypertension compared to patients without supine hypertension (36
vs. 50 months; HR = 3.28, P = 0.010). Supine hypertension in
patients with autonomic failure is associated with an increased risk for
end-target organ damage, cardiovascular adverse events, and prema-
ture death. Our findings have therapeutic implications.
Funding: NIH, Dysautonomia Foundation.
Poster #4
Relationship between cardiac sympathetic modulation
and inflammation after repetitive automatic mechanical
somatosensory stimulation (AMSS) in Parkinson’s disease
D. Shiffer1, F. Barbic1,7, M. Minonzio1, A.R. Zamuner2, C.P.
Andrade3, B. Bottazzi4, C. Garlanda4,7, R. Leone4, B. Cairo5, A.
Porta5,6, A. Mantovani4,7, R. Furlan1,7
1Department of Internal Medicine, Humanitas Research Hospital,
Rozzano, Italy; 2Departamento de Kinesiologia, Universidad Catolica
del Maule, Chile; 3Departamento de Fisioterapia, Universidade do
Sagrado Corac¸a˜o, Bauru, Brazil; 4Laboratory of Research in
Immunology and Inflammation, Humanitas Research Hospital,
Rozzano, Italy; 5Department of Biomedical Sciences for Health,
University of Milan, Milan, Italy; 6Department of Cardiothoracic,
Vascular Anesthesia and Intensive Care, IRCCS Policlinico San
Donato, San Donato Milanese, Milan, Italy; 7Department of
Biomedical Sciences, Humanitas University, Rozzano, Italy
Introduction: Parasympathetic prevalence is associated with anti-in-
flammatory effects whereas sympathetic over-activity may contribute
to local and systemic inflammation maintenance. Systemic inflam-
mation might promote disease progression in Parkinson’s disease
(PD). We previously showed that single manual mechanical
somatosensory stimulation of both forefeet resulted in a decrease of
spectral indices of cardiac and vascular sympathetic modulation in
PD.
Aim: To assess whether repeated automatic mechanical somatosen-
sory stimulation (AMSS) could induce a reduction of sympathetic
cardiac modulation in PD patients together with a decrease in their
inflammatory profile.
Methods: Sixteen PD patients underwent baseline ECG recording
while supine for 20 min. Blood samples were withdrawn for soluble
interleukin-1 receptor II (sIL1-RII, pg/ml) assessment, a systemic
inflammatory marker. Cardiac autonomic control was evaluated by
RR variability analyses: a. power spectrum analysis provided the
index of cardiac sympatho-vagal relationship (LF/HF). b. Symbolic
analysis provided the percentage of sequences of three heart periods
with no significant change in RR interval (0 V%) and that with two
significant unlike variations (2 UV%), reflecting changes in cardiac
sympathetic and vagal modulatory activity, respectively. AMSS was
delivered to two specific points of both forefeet using the Gondola
device (Ecker-Tech. Switzerland). After the first AMSS, additional
AMSSs were repeated every 72 h. Sixteen days post first AMSS,
cardiac autonomic function and sIL1-RII were re-evaluated.
Results: LF/HF ratio and 0 V% decreased (- 0.95, P = 0.0007; -
12.1, P = 0.049, respectively), 2 UV% slightly increased (n.s.) com-
pared to pre-AMSS. In patients who reduced LF/HF (N = 15) and
0 V % (N = 10) a correlation was seen between LF/HF and 0 V%
reduction and sIL1-RII decrease (r = 0.495, P = 0.030; r = 0.600,
P = 0.037, respectively).
Conclusion: Repeated AMSS reduced resting cardiac sympathetic
modulation in PD. After AMSS, the greater the reduction of sympa-
thetic markers the lower were the systemic indices of inflammation.
This finding might bear a potential favorable influence on the sys-
temic inflammation observed in PD.
Poster #5
Early onset of autonomic failure distinguishes the parkinsonian
variant of multiple system atrophy from Parkinson’s disease
A. Fanciulli1, G. Goebel2, G. Lazzeri3, C. Scherfler1, E.R. Gizewski4,
R. Granata1, G. Kiss5, S. Strano6, C. Colosimo7, F.E. Pontieri8, H.
Kaufmann9, K. Seppi1, W. Poewe1, G.K. Wenning1
1Department of Neurology, Medical University of Innsbruck,
Innsbruck, Austria; 2Department of Medical Statistics, Informatics
and Health Economics, Medical University of Innsbruck – Innsbruck,
Austria; 3Department of Pathophysiology and Transplantation,
IRCCS Foundation Ca’ Grande Ospedale Maggiore Policlinico, Dino
Ferrari Center, Neuroscience Section, University of Milan, Milan,
Italy; 4Department of Neuroradiology, Medical University of
Innsbruck, Innsbruck, Austria; 5Department of Urology, Medical
University of Innsbruck, Innsbruck, Austria; 6Department of Heart
and Great Vessels A. Reale, Sapienza University, Rome, Italy;
7Department of Neurology, Santa Maria Hospital, Terni, Italy;
8Department of Neuroscience, Mental Health and Sensory Organs,
Sapienza University, Rome, Italy; 9Department of Neurology,
Dysautonomia Center, New York University School of Medicine,
New York, NY, USA
Objective: To assess the diagnostic yield of early-onset autonomic
failure in distinguishing the parkinsonian variant of multiple system
atrophy from Parkinson’s disease.
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Methods: Three-hundred and three patients with an MRI-supported
diagnosis of multiple system atrophy—Parkinsonian (n = 71) or
Parkinson’s disease (n = 232)—were retrospectively studied.
According to their disease stage and duration at the time of cardio-
vascular autonomic function testing, patients were divided into early
disease (Hoehn and Yahr stage\ 3 AND/OR disease dura-
tion\ 2 years) or advanced disease (Hoehn and Yahr stage C 3
AND disease duration C 2 years) and features predictive of multiple
system atrophy at last-available visit were investigated. A diagnostic
probability score was generated based on the discriminant variables in
the early disease group.
Results: In patients at early disease, the presence of orthostatic
hypotension (OR 6.50, 1.6–26.7 95% CI, p = 0.009), urinary distur-
bances (OR 22.1, 3.7–150.9 95% CI, p = 0.002) and postural
instability (OR 27.9, 2.9–269.4 95% CI, p = 0.004) predicted multiple
system atrophy at last-available visit. By assigning 1 point per above-
mentioned clinical feature, a cumulative probability score C 2 (score
range 0–3) showed a 74.1% sensitivity and 90.1% specificity for a
final diagnosis of multiple system atrophy—Parkinsonian. At
advanced disease, the presence of urinary disturbances (OR 3.0,
1.0–8.7 95% CI, p = 0.05), but not of orthostatic hypotension, was
distinctive of multiple system atrophy.
Interpretation: Autonomic failure featured both in Parkinson’s dis-
ease and multiple system atrophy, but its early development
anticipated a diagnosis of multiple system atrophy at follow-up.
Parkinsonian patients presenting with 2 or more clinical features out
of urinary disturbances, orthostatic hypotension or postural instability
within the first 2 years of disease, have a high probability of suffering
from the parkinsonian variant of multiple system atrophy.
Funding: Academic study, no external financial support allotted.
Poster #6
Consensus statement on the definition of neurogenic supine
hypertension in cardiovascular autonomic failure
by the American Autonomic Society (AAS) and the European
Federation of Autonomic Societies (EFAS)
A. Fanciulli1, J. Jordan2, I. Biaggioni3, G. Calandra-Buonaura4,5,
W.P. Cheshire6, P. Cortelli4,5, S. Eschlboeck1, G. Grassi7,8, M.J.
Hilz9,10, H. Kaufmann11, H. Lahrmann12, G. Mancia13, G. Mayer14, L.
Norcliffe-Kaufmann11, A. Pavy Le Traon15,16, S.R. Raj17, D.
Robertson3, I. Rocha18, W. Struhal19, R. Thijs20,21, K.P. Tsioufis22,
J.G. Van Dijk21, G.K. Wenning1
1Department of Neurology, Innsbruck Medical University, Innsbruck,
Austria; 2Institute of Aerospace Medicine, German Aerospace Center
and Chair of Aerospace Medicine, University of Cologne, Cologne,
Germany; 3Division of Clinical Pharmacology, Vanderbilt University,
Nashville, TN, USA; 4Department of Biomedical and Neuromotor
Sciences, University of Bologna, Bologna, Italy; 5IRCCS, Institute of
Neurological Sciences of Bologna, Bologna, Italy; 6Department of
Neurology, Mayo Clinic, Jacksonville, FL, USA; 7Clinica Medica,
University of Milano-Bicocca, Milano, Italy; 8Istituto di Ricerca a
Carattere Scientifico IRCCS Multimedica, Sesto San Giovanni,
Milano, Italy; 9Department of Neurology, Universita¨tsklinikum
Erlangen, Erlangen, Germany; 10Department of Neurology, Icahn
School of Medicine at Mount Sinai, New York, NY, USA;
11Department of Neurology, Dysautonomia Center, New York
University School of Medicine, New York, NY, USA; 12Private
Practice, Vienna, Austria; 13Centro di Fisiologia Clinica ed
Ipertensione, Milano, Italy; 14Department of Internal Medicine IV,
Innsbruck Medical University, Innsbruck, Austria; 15French
Reference Centre for Multiple System Atrophy, Department of
Neurology, University Hospital of Toulouse, Toulouse, France;
16UMR INSERM 1048, Toulouse, France; 17Libin Cardiovascular
Institute of Alberta, Department of Cardiac Sciences, University of
Calgary, Calgary, AB, Canada; 18Institute of Physiology, Faculty of
Medicine, University of Lisbon, Lisbon, Portugal; 19Department of
Neurology, Karl Landsteiner University of Health Sciences, Site
Tulln, Tulln, Austria; 20Stichting Epilepsie Instellingen Nederland,
Heemstede, The Netherlands; 21Department of Neurology, Leiden
University Medical Centre, Leiden, The Netherlands; 221st
Department of Cardiology, National and Kapodistrian University of
Athens, Hippokration General Hospital, Athens, Greece
Purpose: Patients suffering from cardiovascular autonomic failure
often develop neurogenic supine hypertension (nSH), which is high
blood pressure (BP) in the supine position, which falls when upright
owing to impaired autonomic regulation. A committee was formed to
reach consensus among experts on the definition and diagnosis of nSH
in the context of cardiovascular autonomic failure.
Methods: A systematic search of PubMed-indexed literature on nSH
up to January 2017 was performed in a preparatory work. Available
evidence was discussed in a consensus panel round table in Innsbruck
on February 16th 2017. Derived statements were further discussed by
representatives of the American Autonomic Society (AAS) and the
European Federation of Autonomic Societies (EFAS) and summa-
rized in the final version of the consensus document, which received
the endorsement of the European Academy of Neurology (EAN) and
the European Society of Hypertension (ESH).
Results: In patients with proven neurogenic orthostatic hypotension,
nSH is defined as systolic BP C 140 mmHg and/or diastolic BP
C 90 mmHg, measured after at least 5 min of rest in the supine
position. Three severity degrees are recommended: mild, moderate
and severe. nSH may be present also during nocturnal sleep, with
reduced-dipping, non-dipping or rising nocturnal BP profiles with
respect to daytime. Home BP monitoring and 24 h-ambulatory BP
monitoring provide relevant information for a customized clinical
management.
Conclusions: The establishment of expert-based criteria to define nSH
should standardize diagnosis and allow better understanding of its
epidemiology, prognosis and ultimately treatment.
Poster #7
Unresponsiveness of baroreflex sympathetic regulation leads
to orthostatic intolerance in a rat model of type 2 diabetes mellitus
K. Kamada, K. Saku, H. Tsutsui, K. Sunagawa
Department of Cardiovascular Medicine, Graduate School of Medical
Sciences, Kyushu University, Fukuoka, Japan
Introduction: Patients with diabetes mellitus often present autonomic
neuropathy and manifest arterial pressure (AP) dysregulation such as
orthostatic hypotension. Since arterial baroreflex is the central
mechanism to stabilize AP via regulating sympathetic nerve activity
(SNA), we investigated how diabetes mellitus impairs baroreflex
function by using a baroreflex open-loop analysis.
Methods: We used ZDF-Lean rats as control (CNTL) and ZDF-Fatty
rats (DM) as type-2 DM. Under general anesthesia, we vagotomized
and isolated carotid sinuses from the systemic circulation. We
changed intra-carotid sinus pressure (CSP) stepwise from 60 to
180 mmHg every 30 s, and recorded SNA, AP, and HR. We com-
pared the CSP-SNA (neural arc), SNA-AP (peripheral arc), CSP-AP
(total arc), and CSP-HR relationships between CNTL (n = 9) and DM
(n = 6).
Results: Although the total arc gain (DAP/DCSP) at the operating
point did not differ between the two, the gain in the low CSP range
(60–120 mmHg) markedly decreased (\ 1/30) in DM (0.95 ± 0.10
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vs. 0.03 ± 0.01 mmHg/mmHg, P\ 0.01). The neural arc showed the
exaggerated trend as the total arc. In DM, increases in CSP below the
threshold pressure (140.5 ± 0.8 mmHg) did not suppress SNA at all
while markedly suppressed SNA above the threshold. The peripheral
arc did not differ between the two. In the CSP-HR relationship, the
gain in the low CSP range significantly reduced (\ 1/10) in DM than
in CNTL (0.43 ± 0.08 vs. 0.04 ± 0.04 bpm/mmHg, P\ 0.01). In the
simulation study, estimated pressure fall against a hypotensive stress
(- 20 mmHg) increased in DM by nearly 80% (9.6 ± 1.0 vs.
16.9 ± 2.5 mmHg, P\ 0.05) reflecting exacerbating orthostatic
intolerance in DM.
Conclusions: DM virtually nullifies the baroreflex-mediated SNA
response in the low CSP range and markedly reduces the gain of
baroreflex total arc. The baroreflex dysfunction may play a significant
role in the pathogenesis of orthostatic intolerance in DM.
Funding: Omron Healthcare.
Poster #8
Human deep brain stimulation as a tool to study the neural
control of blood pressure and heart rate
P. Kumar, J.A. Palma, A. Mogilner, H. Kaufmann, M. Pourfar
Department of Neurology, Dysautonomia Center, New York
University School of Medicine, New York, NY, USA
Introduction: Deep brain stimulation (DBS) of the subthalamic
nucleus (STN) is a well-established and effective therapy to improve
motor dysfunction in selected patients with Parkinson’s disease.
Stereotactic neurosurgical implantation of the DBS electrode allows
for intraoperative registration/stimulation of neuronal areas, useful to
identify cerebral structures. We aimed to identify deep brain control
sites for human blood pressure regulation.
Methods: Patients with Parkinson’s disease undergoing STN DBS
surgery at New York University School of Medicine were potential
candidates for this study. During the DBS electrode implantation
surgery, we recorded changes in continuous, noninvasive, beat-by-
beat blood pressure parameter responses from the deep brain areas in
the trajectory of the implantation electrode, through the thalamus,
zona incerta, STN and substantia nigra. Electrocardiogram and arte-
rial oxygen saturation were monitored as well.
Results: Two men (aged 60 and 74 years old; disease duration 4 and
8 years, respectively) were studied. Patient 1 underwent DBS
implantation into the right STN and Patient 2 underwent implantation
into the left STN. Baseline blood pressure and heart rate were
89/64 mmHg 68 bpm in Patient 1 and 81/74 mmHg 90 bpm in
Patient 2. In both cases there was a striking, sudden increase in blood
pressure of ? 30 mmHg and heart rate when the registering elec-
trodes had just left the terminal end of the thalamus, before entering
the STN. Blood pressure and heart rate increased to 123/93 mmHg
99 bpm in Patient 1 and to 127/105 mmHg 128 bpm in Patient 2. In
both cases, the blood pressure and heart rate returned to baseline
numbers as the electrodes were further inserted into the STN. No
other stimulated structure produced significant blood pressure or heart
rate changes.
Conclusion: These findings suggest that the area between the thala-
mus and the STN, traditionally referred to as zona incerta, could have
a role in increasing blood pressure and heart rate in humans. Further
studies are warranted.
Funding: Dysautonomia Foundation, Inc.
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Susceptibility to cardiac arrhythmia increases with sympathetic
stimulation in rodents with high-thoracic spinal cord injury
V.E. Lucci, E.L. Harrison, K.M. DeVeau, K.A. Harmon, J. Liu, J.
Squair, A. Krassioukov, D. Magnuson, C.R. West, V.E. Claydon
Department of Biomedical Physiology and Kinesiology, Simon Fraser
University, Burnaby, BC, Canada
Introduction: Autonomic dysfunction (due to injury to descending
sympathetic pathways) is common in individuals with high-level
spinal cord injury (SCI) and associated with abnormal control of
blood pressure and heart rate. Periods of sympathetic stimulation are
thought to be proarrhythmogenic and this has important implications
for individuals with high-level SCI who experience paroxysmal
increases in sympathetic tone during episodes of autonomic dysre-
flexia (profound hypertension provoked by sensory stimuli below the
injury level). Dobutamine (DOB) is a cardiac inotrope that mimics
cardiac sympathetic stimulation. We aimed to evaluate whether:
(i) susceptibility to arrhythmia increases in a rodent-model of SCI; (ii)
the impact of cardiac sympathetic stimulation (DOB) on arrhythmia
risk.
Methods: Experiments were conducted in 14 Wistar rats: sham-in-
jured controls (SHAM, n = 7); and second thoracic level contusive
SCI (T2, n = 7). Electrocardiogram (ECG) data were evaluated
before (PRE), 1-week (POST) and 5-weeks post-SCI (TERM). At
each time point, animals were infused with 30 lg/min/kg of DOB.
ECG indices of atrial (P-wave duration [PWD] variability) and ven-
tricular (Tpeak-Tend variability, QT interval corrected for heart rate
[QTc], and QT variability index [QTVI]) arrhythmia risk were
determined at baseline and during DOB. R-R interval (RRI) was
determined.
Results: At PRE, RRI decreased in both groups (both p 0.05). Tpeak-
Tend and PWD variabilities increased in T2 compared to SHAM at
POST (p = 0.033, p = 0.058) and TERM (p\ 0.001, p = 0.004). On
average, QTVI worsened with DOB infusion (p\ 0.001). In the
presence of sympathetic stimulation (DOB) Tpeak-Tend, PWD and
QTc variabilities, and QTVI all increased over time in T2 (p\ 0.001,
p = 0.044, p\ 0.001, p = 0.026) but not in SHAM (p = 0.115,
p = 0.929, p = 0.21, p = 0.115).
Conclusion: Susceptibility to cardiac arrhythmia is increased in a
rodent-model of high-level SCI. Cardiac sympathetic stimulation
further increases susceptibility to arrhythmia in high-level SCI. These
data explain the high susceptibility to arrhythmia in individuals with
SCI, particularly during sympathetic stimulation associated with
autonomic dysreflexia.
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Heart rate variability and gastric myoelectric activity in women
with chronic pelvic pain: a pilot study
D.P. Williams1, E.R. Muth2, C. Ustine4, P. Simpson3, T. Chelimsky4,
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Research has shown that factors that impact parasympathetic (PSNS)
activity systematically impact gastric myoelectrical activity. We
recently showed poorer PSNS function in individuals with chronic
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pelvic pain (CPP) disorders from a supine to upright position. The
following pilot study sought to examine if poorer autonomic function,
marked by maladaptive patterns in PSNS activity, is accompanied by
maladaptive gastric myoelectric activity in those with CPP. A sample
of 111 women (36 health controls (HC); 75 CPP) were placed in
supine (10 min), upright (tilted 70 head up; 30 min), and back to
supine (10 min) positions. High-frequency heart rate variability (HF-
HRV; 0.15–0.4 Hz) was measured at each time point as an index of
PSNS activity. Electrogastrography (EGG) was used to assess gastric
myoelectric activity pre- and post-upright tilt. EGG measures from 47
women (16 healthy; 31 CPP patients) were available for analysis and
included relative percentage of gastric activity within the normal
(2–4 cpm) and tachygastria (4–10 cpm) ranges, in addition to a ratio
between the two (normal/tachy). HF-HRV was lower in CPP indi-
viduals at all time points (each p\ 0.05). CPP individuals also
showed a lesser decrease in HF-HRV from supine to upright, and
poorer HF-HRV recovery from upright back to supine, as compared
to HC (F (1,106) = 4.62, p = 0.034). The CPP group showed no
change in tachygastria activity from pre-upright to post-upright
(t(30) = - 0.62, p = 0.537), whereas HC showed an increase in
tachygastria activity (t(15) = - 2.09, p = 0.054). No pre-post dif-
ferences were found for either group in normal gastria or the
normal/tachy ratio. Overall, as tachygastria should increase along
with decrements in HRV from supine to upright, our results suggest
poorer physiological activity in CPP individuals from both a cardio-
vascular and gastric standpoint. Implications, limitations, and future
directions will be discussed.
Funding: The ICEPAC Study is funded by the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK;
5R01DK083538, ClinicalTrials.gov Identifier: NCT01616992).
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D.P. Williams1, E.R. Muth2, C. Ustine4, P. Simpson3, T. Chelimsky4,
J.F. Thayer1, G.Chelimsky3
1Department of Psychology, The Ohio State University, Columbus,
OH, USA; 2Institute of Medical Psychology, Center for Psychosocial
Medicine, University Hospital Heidelberg, Heidelberg, Germany;
3Mannheim Institute of Public Health, Social and Preventive
Medicine, Mannheim Medical Faculty, Heidelberg University,
Mannheim, Germany; 4Section for Translational Psychobiology in
Child and Adolescent Psychiatry, Department of Child and
Adolescent Psychiatry, Centre for Psychosocial Medicine, University
of Heidelberg, Heidelberg, Germany; 5BioTekna Biomedical
Technologies, London, UK; 6Open Academy of Medicine, London,
UK; 7Department of Experimental Medicine, ‘‘Sapeinza’’ University,
Rome, Italy
Body mass index (BMI) serves as a modest predictor of cardiovas-
cular disease (CVD). In contrast, the lipid accumulation product
(LAP), calculated using both waist circumference (WC) and triglyc-
eride (TG) fasting concentration, better predicts CVD risk compared
to BMI. Interestingly, lower vagally mediated heart rate variability
(vmHRV), an index of parasympathetic activity and overall health, is
associated with both higher BMI and greater CVD risk. Yet, research
has not shown a relationship between vmHRV and LAP; the fol-
lowing study investigated this in a sample of 641 individuals (70
females, mean age of 42 years, standard deviation of 12 years).
Continuous heart rate data was recorded for a typical work day. The
root mean square of successive differences was used as the measure
of vmHRV for the full day (total vmHRV). LAP was calculated as:
LAP (men) = (WC [cm] - (65) 9 (TG concentration [mmol/L]);
LAP (women) = (WC [cm] - 58) 9 (TG concentration [mmol/L]).
Zero-order correlations results showed total vmHRV to be signifi-
cantly negatively associated with BMI (r = - 0.134, p = 0.001), WC
(r = - 0.160, p\ 0.001), TG concentration (r = - 0.108, p = 0.006),
and LAP (r = - 0.205, p 0.05). These data are the first to show a
significant association between vmHRV and LAP, but not BMI,
independent of age and sex. Overall, these data highlight the strong
influence of autonomic activity—particularly PSNS activity—in
regulating deleterious excess-weight.
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Introduction: Cardiovascular disease (CVD) is the leading cause of
morbidity and mortality in individuals with spinal cord injury (SCI).
Anthropometric markers of obesity provide convenient CVD risk
prediction, but proposed cut-offs for able-bodied individuals under-
estimate CVD risk in individuals with SCI. We aimed to evaluate use
of waist circumference (WC) as a proxy for CVD risk and determine
sex-specific cut-off values for individuals with SCI.
Methods: We performed a multicentre cross-sectional study of indi-
viduals with traumatic SCI (n = 257, 61 females, aged 47 ± 9 years,
duration of injury 23 ± 9 years). Three anthropometric measures
were compared: body mass index (BMI); WC; and waist-to-height
ratio (WHtR). CVD risk was determined from the 10 and 30 years
Framingham risk score (FRS). Cut-off criteria were determined using
receiver operator characteristic curves (Euclidean Index).
Results: WC, WHtR, and BMI were significantly correlated (all
p\ 0.00001) with 10 and 30 years FRS in all participants (r
0.34–0.48) and males (r 0.32–0.46); in females only WC and WHtR
were significantly correlated with 10 and 30 years risk (all p\ 0.05; r
0.29–0.38). The optimal cut-off for WC (the most highly correlated
anthropometric variable) was 96 cm for 10 and 30 years FRS for all
participants. Sex specific cut-offs were 96 cm for 10 years and 95 cm
for 30 years FRS for males, and 93 cm for 10 years and 84 cm for
30 yearss FRS for females.
Conclusion: WC is a practical measure of obesity and CVD risk for
individuals with SCI. The WC cut-off for an adverse CVD risk profile
is lower for individuals with SCI compared to established able-bodied
criteria. Use of WC with sex and SCI-specific cut-offs should guide
risk management decisions, and provide target criteria for individuals
with SCI to maintain a healthy body composition.
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Introduction: African American women (AAW) are at greater risk for
cardiovascular disease (CVD) versus Caucasian women (CW).
Decreased spontaneous baroreflex sensitivity (sBRS) is associated
with negative cardiovascular outcomes and AAW have been found to
have significantly lower sBRS versus CW. Increased arterial stiffness
(AS) is associated with reduced sBRS particularly in older individ-
uals, while increased cardiorespiratory fitness (CRF) is associated
with increased sBRS and improved cardiovascular health. Although
AAW have lower baroreflex sensitivity and are at greater risk for
CVD, there is a paucity of research examining how much of the
variation in sBRS is explained by AS and CRF in young, healthy,
normotensive AAW and CW. Therefore, the aim of this study was to
determine how much of the variation in sBRS is explained by AS and
CRF in young, healthy, normotensive AAW and CW.
Methods: Thirty-seven (AAW-13; CW-24) healthy, age, height, and
weight-matched college-aged women were examined for AS, CRF,
and sBRS. AS was determined by pulse wave velocity (PWV), and
CRF by maximal oxygen consumption (VO2 max), while sBRS was
determined by the alpha-index.
Results: Multiple regression analysis with sBRS as the dependent
variable and AS and CRF as predictors indicated that in AAM, AS
and CRF explained 11% of the variation in sBRS and 10% in CW.
ANOVA demonstrated that neither model was significant: AAW
(P = 0.55) and CW (P = 0.31).
Conclusion: Preliminary data suggest that AS and CRF are not sig-
nificant predictors of sBRS in young, healthy, normotensive AAW or
CW.
Funding: This study was partially supported by a grant from the
Connecticut State University System.
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Introduction: Arterial hypertension (AH) is the most important factor
of cardiovascular mortality but its impact is varying for different
patients.
Objective: To estimate the influence of blood-circulation autonomic
regulation on the course disease in patients with AH.
Methods: We studied 56 patients with AH (59 ± 12 years) with target
organ damage, among them 28 patients were with associated clinical
conditions. Autonomic regulation was assessed by applying sequence
of tests including tilt test, Valsalva maneuver, handgrip test, cold
stress vasoconstriction test (CVC). In addition, arterial baroreflex and
power spectrum of variability of both the heart rate and blood pres-
sure (BPV) were calculated. Hemodynamic parameters were
measured by using noninvasive continuous blood pressure (BP)
monitor, electrocardiogram, and air-cuff occlusion plethysmograph.
Repeated clinical and laboratory examinations were performed after a
lapse of 5.5 to 7.9 years.
Results: Valsalva index (VI) and CVC in the group of deceased
patients (n = 5) were smaller than in the group of survivors:
1.4 ± 0.2 vs. 1.6 ± 0.4 a.u., p\ 0.05 and 0.20 ± 0.02 vs.
0.39 ± 0.16%, p\ 0.05, respectively, whereas total peripheral
resistance and BPV in the respiratory range were larger: 1.4 ± 0.2 vs.
0.9 ± 0.3 a.u., p\ 0.001 and 18 ± 14 vs. 6 ± 4 mmHg2, p\ 0.001,
respectively. Patients, who suffered a stroke (n = 5) had higher total
BPV 114 ± 49 vs. 66 ± 40 mmHg2, p\ 0.05, and a tendency to
increase of systolic BP in orthostasis: 4 ± 15 vs. - 8 ± 13 mmHg,
p = 0.06. Patients who underwent revascularization (n = 7) showed
orthostatic hypotension: - 15.8 ± 8.8 vs. 3.6 ± 12.9 mmHg,
p\ 0.05 and tendency of decreased VI: 1.5 ± 0.1 vs. 1.8 ± 0.5,
p = 0.07. Patients with newly developed associated clinical condi-
tions showed orthostatic hypertension: 15 ± 6 vs. - 10 ± 13 mmHg,
p\ 0.005 but decreased VI: 1.41 ± 0.08 vs. 1.99 ± 0.55 a.u.,
p\ 0.05.
Conclusion: The parameters of cardiac and vasomotor reactivity, such
as Valsalva index, cold-stress vasoconstriction, inadequate BP
dynamics in orthostasis, and beat-to-beat BP variability are important
markers for prognosis of the disease progression in patients with
arterial hypertension.
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Introduction: Baroreflexes and peripheral chemoreflexes have a
powerful effect on efferent autonomic activity making them prime
suspects in the pathogenesis of cardiovascular disease and attractive
treatment targets. However, the literature on their interaction is con-
troversial, likely through inter- and intraindividual variability in
cardiovascular reflex regulation. Therefore, we applied an n-of-1 trial
design to elucidate individual baroreflex-chemoreflex interactions.
Methods: We studied 10 healthy men (18–40 years, BMI 18–28 kg/
m2) breathing either normal air or an air-nitrogen-carbon dioxide
mixture for 90 min each in randomized order. We applied 20
phenylephrine boli per subject and condition to raise blood pressure
(one every 4 min). To limit variability, we utilized an automated
injector providing standardized boli. We determined the pressor
response to phenylephrine as estimate of baroreflex blood pressure
buffering capacity and baroreflex sensitivity (BRS).
Results: Hypoxia reduced arterial oxygen saturation from 98.0 ± 1.0
to 80.8 ± 1.3% (p\ 0.0001), raised heart rate from 63.6 ± 6.5 to
75.6 ± 10.2 bpm (p = 0.004), but did not change systolic blood
pressure (132.1 ± 10 vs. 133.8 ± 8.9 mmHg; p = 0.404). 5 out of 10
subjects had significantly lower BRS with hypoxia (p\ 0.05). 5 out
of 9 subjects showed a significantly increased pressor response to
phenylephrine during hypoxia likely through impaired baroreflex
buffering (p\ 0.05). One subject presented a reverse response,
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namely significant increases in BRS and baroreflex buffering function
under hypoxic conditions. On average, hypoxia decreased BRS by
5.6 ± 6.3 ms/mmHg (20.1 ± 6.4 vs 14.6 ± 6.9 ms/mmHg,
p = 0.021) but did not change the phenylephrine pressor response
(p = 0.769).
Conclusion: An n-of-1 trial design can be applied to assess individual
baroreflex-chemoreflex interactions in human subjects. Indeed, we
identified a subgroup of persons exhibiting significant impairments in
baroreflex blood pressure buffering and BRS with peripheral
chemoreflex activation. The approach may have utility in elucidating
individual pathophysiology and in targeting treatments modulating
baroreflex or chemoreflex function.
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Introduction: Takotsubo cardiomyopathy (TCM) is a disease typically
characterized by transient left ventricular dysfunction with apical
ballooning. The clinical presentation is often similar to those of an
acute myocardial infarction. Although the cause of TCM remains
unknown, the emotional and physical stress and exaggerated sym-
pathetic nerve activity plays a key role.
Methods: We studied psychological stress response of plasma cate-
cholamine in 8 TCM patients (72 years old, 11 female) and 3 healthy
subjects (39 years old, 3 female). The mean onset age to develop
TCM was 70. All the subjects were asked to finish 3 min mental
calculation (MC) task and 3 min public presentation (PP) task (stress
test). The order of MC and PP task were randomly assigned. Plasma
epinephrine, norepinephrine, dopamine, renin, and aldosterone were
measured before and after the series of two procedures. Autonomic
function tests were performed to assess cardiovascular sympathetic
indices and cardio-vagal indices.
Results: TCM patients had reduced sinus arrhythmia ratio (1.2 vs. 1.6,
p = 0.004) and Valsalva ratio than the healthy subjects (1.2 vs. 1.8,
p = 0.02). The incremental change of systolic blood pressure during
cold pressor, hand grip, and hyperventilation test were comparable to
those of the healthy subjects. Plasma norepinephrine (74.7 pg/ml vs.
167.2 pg/ml, p = 0.004) and epinephrine (16.3 pg/ml vs. 13.2 pg/ml,
p = 0.03) were significantly increased in TCM patients than the
healthy subjects after the series of stress tests. However, incremental
change of plasma aldosterone was lower in TCM patients (25.6 pg/ml
vs. 40.2 pg/ml).
Conclusion: Gene polymorphisms of alpha-adrenergic receptors, beta-
adrenergic receptors, and dopamine receptors were evaluated.
ADRA1A, ADRA2B, ADRB1, DRD2, DRD4 gene variants were
found in TCM patients. Further evaluation of the genotypes combined
with clinical presentation is currently proceeding.
Funding: This work was supported by JSPS Grant-in-Aid for Scien-
tific Research 26461092.
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Objective: Cognitive deficits in persons with spinal cord injury (SCI)
are often attributed to concomitant traumatic brain injury (TBI);
however, emerging evidence supports potential association with car-
diovascular autonomic (CardioAuto) dysfunction. Analysis of heart
rate variability (HRV) in the mid-frequency range (MF:
0.07–0.14 Hz) during cognitive testing may provide insight regarding
the contribution of both sympathetic and vagal influences to
performance.
Participants: Subjects included 30 controls and 60 individuals with
chronic (10 ± 7 years) SCI (C3-T12). The participants were age-
matched and none had a documented history of TBI.
Methods: The Paced Auditory Serial Addition Task (PASAT) eval-
uates information processing and sustained and divided attention.
Participants were presented with a number every 1.2 to 2.4 s, in 4
sets, at an accelerated rate of presentation, and were asked to add the
preceding number to each new number. Beat-to-beat HR was assessed
at rest and continuously during the PASAT. Frequency analysis was
used to determine change in power spectral density (ms/Hz) from rest
to during the PASAT within the MF bandwidth of HRV as an indi-
cator of CardioAuto function.
Results: Scores on the PASAT were significantly lower in participants
with SCI (102.6 ± 47.2) compared to the controls (130.2 ± 38.1;
p\ 0.01). MF amplitude during the PASAT was significantly lower
in participants with SCI compared to the controls (1012.2 ± 1132.2
vs. 1759.5 ± 1938.3, respectively; p\ 0.05). Change in MF was
significantly correlated with PASAT scores in the controls
(r2 = 0.468; p\ 0.01) but not in the SCI group.
Conclusion: Diminished performance on the PASAT in the SCI
group, in the absence of documented TBI, suggests an alternative
etiology may be responsible for the reported cognitive dysfunction in
the SCI population. Furthermore, lower MF amplitudes and the lack
of an association between changes in MF and PASAT scores in
persons with SCI suggests that CardioAuto impairment may con-
tribute to the observed cognitive dysfunction.
Funding: New Jersey Commission on Spinal Cord Injury Research
(CSCR13IRG018) and VA RR&D Service (#B2020-C).
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Sudomotor dysfunction in diabetic autonomic neuropathy is
not a frequent finding
A. Barboi, S. Pocica, V. Patel
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Introduction: Timely diagnosis of diabetic autonomic neuropathy
(DAN) should allow for an early intervention so as to prevent com-
plications. Literature review reveals that the most common pattern of
involvement is cardiac vagal and distal sudomotor dysfunction
occurring in equal frequency. We performed a retrospective review of
a cohort of patients with DAN of various severity who had autonomic
reflex testing in our laboratory. As part of quality improvement, we
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wanted to see if published autonomic reflex screen abnormalities can
be reproduced in our population
Methods: All consecutive patients, men, and women regardless of
age, diagnosed as DAN after autonomic reflex screen testing in the
NorthShore autonomic laboratory between 2014 and 2018 were
included. The patients had DM and had no other identified etiology
for their autonomic symptoms. All patients underwent autonomic
reflex screen testing and some also had quantitative pupillometry.
Potential pharmacological interfering agents, including eye drops,
were stopped before testing as per laboratory protocol. Age appro-
priate cardiovagal and sex-appropriate sudomotor normative data
were used.
Results: 100 patients were studied. 38 of subjects had CV dysfunction
in isolation. 62 subjects had combined CV and SD: 29 length
dependent SD, 14 non-length dependent SD ([ 2 sites), 16 with single
site sweat abnormality (6 at the foot and 10 at various other sites).
Only 3 subjects had normal CV function but had SD dysfunction (1
length dependent and one patchy).
Conclusions: Most common autonomic reflex testing abnormality in
DAN is CV dysfunction: 97%. Little over 50% of subjects with
abnormal CV also have SD: roughly half-length dependent and half
patchy or single site SD pattern. We believe that pseudo normaliza-
tion or even excessive sweat volumes may also be a manifestation of
DAN, suggestive of denervation hypersensitivity.
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Background: Fingolimod, an oral medication for relapsing–remitting
multiple sclerosis (RRMS), alters cardiovascular-autonomic modula-
tion due to its vagomimetic effects on S1P1-receptors of
cardiomyocytes. S1P1-receptors occur ubiquitously and might present
within the bladder wall and sphincters. We hypothesize that Fin-
golimod affects these receptors and alters autonomic bladder-function
due to direct parasympathomimetic or secondary autonomic
influences.
Objective: To determine whether Fingolimod alters bladder-function
in RRMS-patients without clinically evident bladder dysfunction prior
to Fingolimod-treatment.
Methods: In 24 RRMS-patients (mean age 39 ± 11 years, 17
women), we performed uroflowmetry to determine voided-urine-
volume, maximum-flow-rate, average-flow-rate, flow-time, time-to-
maximum flow, and bladder ultrasonography (Solar-UroflowTM,
ScanmasterTM, MMS, Germany) to assess pre-voiding urine-volume
and post-voiding residual urine-volume. Measurements were taken
upon Fingolimod-initiation and after one year of Fingolimod-therapy
(0.5 mg/day), and were compared to values assessed in 25 age- and
sex-matched healthy controls (mean age 32 ± 10 years, 13 women).
Parameters measured in patients at the two time-points and in controls
were compared by ANOVA and post hoc analysis, using t-tests for
normally distributed data and Mann–Whitney-U-tests or Wilcoxon-
tests for non-normally distributed data. Significance was assumed for
p\ 0.05.
Results: Voided-urine-volume, maximum-flow-rate, average-flow-
rate, flow-time, and time-to-maximum flow, as well as pre-voiding
urine-volume did not differ between controls and patients at the two
measurement dates. Only post-voiding residual urine-volume was
higher in patients than controls, but again did not differ within the
patient-group at the two measurement dates.
Conclusion: Our findings showed slightly elevated post-voiding
residual urine-volume which is common among RRMS patients. The
results otherwise confirmed that the assessed parameters of bladder-
function were similar between controls and patients at Fingolimod-
initiation, a requirement to assure that possible changes in bladder-
function are most likely not related to the RRMS but to Fingolimod.
Yet, parameters remained unchanged in the RRMS-patients after
1 year of Fingolimod-treatment, suggesting that Fingolimod itself
does not have any clinically relevant effects on bladder-function.
Funding: The authors received a travel grant from Novartis Pharma
Germany.
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Uroflowmetry and bladder ultrasonography non-invasively
quantify slightly impaired autonomic bladder function in patients
with relapsing–remitting multiple sclerosis
R. Wang1, S. Roy1, M. Liu1, K.M. Ho¨sl2, K. Winder1, R. Linker1, D.-
H. Lee1, M.J. Hilz1,3
1Department of Neurology, University of Erlangen-Nuremberg,
Erlangen, Germany; 2Department of Psychiatry and Psychotherapy,
Paracelsus Medical University, Nuremberg, Germany; 3Icahn School
of Medicine at Mount Sinai, New York, NY, USA
Background: Although lower-urinary-tract symptoms are common in
relapsing–remitting multiple sclerosis (RRMS), correlation between
voiding parameters and disease-severity or -duration has not yet been
assessed. In this study, we evaluated voiding parameters of RRMS-
patients using non-invasive uroflowmetry and bladder-sonography to
correlate these parameters with disease-duration and -severity, and to
compare parameters between RRMS-patients and healthy persons.
Methods: 50 RRMS-patients (mean age 35.1 ± 8.7 years, 31 women)
and 25 age- and gender-matched healthy participants participated in
uroflowmetry (Solar-UroflowTM, MMS, Germany) to determine voi-
ded-urine-volume, maximum-flow-rate, average-flow-rate, flow-time,
time-to-maximum flow. Bladder ultrasonography (ScanmasterTM,
MMS, Germany) was used to assess pre-voiding urine-volume and
post-voiding residual urine-volume. Parameters were compared
between patients and controls using Student’s-t-tests for normally
distributed data and Mann–Whitney-U-tests for non-normally dis-
tributed data. Uroflowmetry and ultrasound values were correlated
with MS-duration and MS-severity, assessed as Expanded-Disability-
Status-Scale (EDSS) scores and Multiple-Sclerosis-Functional-Com-
posite (MSFC) scores, using Spearman’s rank-correlation-tests for
non-normally distributed data and Pearson-tests for normally dis-
tributed data. Significance was assumed for p\ 0.05.
Results: In the patients, EDSS-scores ranged from 1.0 to 7.5 (median
2.0; interquartile range (IQR) 1.5–3.0, MSFC was - 0.07 ± 0.96,
disease duration was 88.7 ± 84.5 months. Average-flow-rate tended
to be lower in patients than controls (11.2 ± 4.2 ml/s vs.
13.9 ± 5.7 ml/s, p = 0.052). Flow-time was longer in patients than
controls (31.9 ± 15.9 s vs. 24.2 ± 12.9 s, p = 0.012). Post-voiding
residual urine-volume was higher in patients than controls
(56.0 ± 61.5 ml vs. 28.2 ± 14.4 ml, p = 0.003). Other uroflow-pa-
rameters were similar in both groups. In the RRMS-patients, average-
flow-rate correlated negatively with disease-duration (Spearman’s
rho = - 0.331, p = 0.019) and EDSS-scores (Spearman’s rho = -
Clin Auton Res (2018) 28:453–505 479
123
0.360, p = 0.010). Voided-urine-volume correlated positively with
MSFC-scores (Spearman’s rho = 0.314, p = 0.026).
Conclusion: In our RRMS-patients, non-invasive uroflowmetry and
bladder ultrasonography non-invasively unveiled mild autonomic
bladder dysfunction which is associated with longer disease-duration
and higher disease-severity.
Funding: The authors received a travel grant from Novartis Pharma
Germany.
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Persistent baroreflex dysfunction in patients with a history
of moderate or severe traumatic brain injury
S. Roy1, M. Liu1, R. Wang1, F. Ammon1, K.M. Ho¨sl2, J. Markus1, D.
Murasenu3, M.J. Hilz1,4
1Department of Neurology, University of Erlangen-Nuremberg,
Erlangen, Germany; 2Department of Psychiatry and Psychotherapy,
Paracelsus Medical University, Nuremberg, Germany; 3Department
of Clinical Neurosciences, ‘‘Iuliu Hatieganu’’ University of Medicine
and Pharmacy, Cluj-Napoca, Romania; ‘‘RoNeuro’’ Institute for
Neurological Research and Diagnostic, Cluj-Napoca, Romania;
4Icahn School of Medicine at Mount Sinai, New York, NY, USA
Background: In a previous study of patients with a history of mild
traumatic brain injury (post-mTBI patients), we found a delay in
blood pressure (BP) decrease upon Valsalva maneuver (VM)-induced
baroreceptor-loading, indicating a compromised baroreflex-mediated
sympathetic withdrawal. Given the more severe cerebral lesions in
patients with a history of moderate or severe TBI, we hypothesize that
these patients also have persistent baroreflex-mediated autonomic
dysfunction.
Methods: In 17 patients with a history of moderate or severe TBI,
defined by Glasgow Coma Scale (GCS) scores below 13 (aged
32.2 ± 10.5 years; 9 women, GCS of 6.4 ± 2.5, interval since TBI
43.1 ± 33.4 months), and 29 healthy controls (aged
31.3 ± 12.2 years; 9 women), we performed 3 VMs from which we
calculated Valsalva ratios (VRs) and intervals from the highest sys-
tolic BP (BPsys)-value after strain-release to the time when BPsys
had fallen by 90% of the difference between peak-phase-IV-BPsys
and baseline-BPsys (90%-BPsys-normalization-times), and velocities
of BPsys-normalization, defined as change in BPsys related to the
90%-BPsys-normalization-time (90%-BP-normalization-velocities)
as indices of sympathetic withdrawal. We used the Kolmogorov–
Smirnov-test to evaluate normal distribution of data. To compare
patient and control data, we used independent t-tests for normally
distributed data and Mann–Whitney-U-tests for non-normally dis-
tributed data. (significance: p\ 0.05).
Results: VR did not differ significantly between patients (1.85 ± 0.4)
and controls (2.0 ± 0.6; p = 0.3). 90%-BP-normalization-times were
longer in patients than controls (22.2 ± 14.5 ms vs. 12.6 ± 4.8 ms;
p = 0.02), 90%-BP-normalization-velocities were lower in patients
than controls (2.3 ± 2.4 mmHg/s vs. 3.7 ± 1.1 mmHg/s; p = 0.003).
Conclusion: While autonomic dysfunction is known to be common
after acute TBI, our data show that baroreflex-mediated sympathetic
withdrawal after VM remains compromised for extended periods of
time after moderate or severe TBI, and thus confirm our previous
findings in post-mTBI patients.
Poster #22
Psychological and physiological effects of 12 weeks of slow
breathing exercise on healthy subjects
A. Gamboa, S. Paranjape, A. Diedrich, K. Nelson, A. Coppola, R.
Abraham, H. Nian, K. Wallston, G. Birdee
Department of Medicine, Vanderbilt University, Nashville, TN, USA
Introduction: Slow breathing exercises (less than 10 breaths/min) are
an integral part of different mind–body practices, and they might
reduce both psychological and physiological stress. Yoga practition-
ers modify the ratio of inhalation and exhalation to enhance
relaxation. It is unknown, if extended exhalation technique (Exhale
longer than Inhale, E[ I) applied over longer time will have different
effects than common slow breathing (Exhale equal to Inhale, E = I).
Purpose: We hypothesize that E[ I will enhance of vagal autonomic
function and reduce of stress more than E = I.
Methods: We studied 94 healthy subjects (41 years old, 79%
females), randomly assigned to either E[ I (n = 48) or E = I
(n = 46) daily exercise guided by Yoga teachers over 12 weeks. We
measured autonomic modulation by spectral analysis of heart rate and
blood pressure variability, cardio-vagal baroreflex sensitivity by
spontaneous sequence technique (BRS), and recorded self-reported
stress scales (PROMIS Anxiety).
Results: We found that both groups decreased anxiety from baseline
to 12 weeks significantly (E[ I: - 5.365 ± 0.93, pI: -
3.5 ± 0.9 mmHg, E = I: - 2.3 ± 1.0 mmHg, p(time) = 0.028). BRS
changed differently by time and group with increase in E[ I (E[ I:
3.07 ± 1.2 ms/mmHg, E = I: - 0.24 ± 0.8 ms/mmHg, p(-
time) = 0.013, p(timeXgroup) = 0.019 (rmANOVA).
Conclusion: 12 weeks of slow breathing exercises resulted in reduc-
tion of self-reported anxiety and blood pressure in both groups.
Additionally, E[ I increases cardio-vagal BRS.
Poster #23
Prediction of systolic blood pressure responses to orthostasis
in persons with spinal cord injury
M.F. La Fountaine1,2, J.P. Weir3, C.G. Katzelnick1,2, A.T. Lombard1,
M.T. Maher1, J.M. Levine1, J.M. Wecht1
1VA RR&D National Center for the Medical Consequences of SCI,
James J. Peters VA Medical Center, Bronx, NY, USA; 2School of
Health and Medical Sciences, Seton Hall University, South Orange,
NJ, USA; 3Department of Health, Sport and Exercise, University of
Kansas, Lawrence, KS, USA
Persons with spinal cord injury (SCI) often have exaggerated systolic
blood pressure (SBP) responses to orthostasis that may present as
hypotension (HYPO: SBP declines C 20 mmHg) or hypertension
(HYPER: SBP increases C 20 mmHg). However, there remains
uncertainty as to the specific mechanisms that contribute to the
observed orthostatic BP responses in persons with SCI, which may
relate to autonomic nervous system impairment and diminished
sympathetic vasomotor tone. One hundred fifty-seven persons with
SCI [age (years): 45 ± 14] performed a sit-up test (e.g., 5-min of
supine followed by 4-mins in seated upright position) while contin-
uous 3-lead electrocardiogram and beat-to-beat SBP was performed.
Fast-fourier transform algorithms were used to calculate the high
(HF), low (LF), and very low frequency (vLF) components of the SBP
and heart rate (HR) signals; each variable was log10 transformed. A
change score between supine and seated positions was calculated and
stepwise regression analyses were performed to identify independent
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variables with significant contribution to the observed changes in SBP
(delta_SBP) during the sit-up test. Age, supine SBP, delta_vLF and
grouping based on orthostatic response [e.g., HYPO, HYPER, or
normal (NORM: SBP - 19 B 19 mmHg)] were identified as signif-
icant contributors to delta_SBP. This combination created a
significant prediction equation (p\ 0.0001) that accounted for 93%
of the variance delta_SBP (r2: 0.925); delta_vLF contributing 64% (r2
change: 0.639). Follow-up analyses on delta_vLF identified a sig-
nificant group main effect (P\ 0.0001) between the HYPO, HYPER
and NORM groups, such that delta_vLF was significantly different for
each group in response to orthostasis: HYPER: 0.28 ± 0.12; NORM:
0.00 ± 0.09; and HYPO: - 0.30 ± 0.16. (p\ 0.0001). The vLF
component, which has been demonstrated to reflect myogenic vas-
cular mechanisms that are influenced by circulating catecholamines
and angiotensin II, is a robust contributor to the prediction of ortho-
static SBP responses and may be a sensitive marker for determination
of orthostatic tolerance in persons with SCI.
Funding: Veterans Affairs Rehabilitation Research and Development
Service (#B2020-C).
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Optimization of heart rate variability testing
S. Rajan, M. Campagnalo, V. Galvis, C.H. Gibbons
Department of Neurology, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, MA, USA
Background: Heart variability is assessed clinically by a variety of
methods, but it is often difficult to determine if abnormal results
reflect a pathologic process, or suboptimal effort. This may be par-
ticularly problematic in older or frail individuals where sustained
respiratory effort may be compromised.
Objective: To modify aspects of clinical heart rate variability testing
in an effort to increase sensitivity and specificity.
Methods: We altered our autonomic testing protocol by including a
single supra-maximal breathing cycle over 10 s after a baseline period
of rest. Subjects also underwent standard heart rate variability testing,
a Valsalva maneuver, 45 min tilt table testing and a 5 min active
stand. Continuous heart rate and beat-to-beat blood pressures were
recorded throughout. We tested 50 subjects (mean age 53, range
17–85) with a range of autonomic dysfunction from healthy to severe
dysautonomia undergoing clinical autonomic testing and compared
the results of the single supra-maximal breath to other measures of
heart rate variability.
Results: There was a strong correlation between heart rate variability
measured by single supramaximal breath compared to 10 cycles of
breathing by E:I ratio (R2 = 0.72, P\ 0.001), or maximum-to-mini-
mum heart rate variability (R2 = 0.70, P\ 0.001). However, in a
significant number of cases the single supramaximal breath suggested
routine HRV testing could be improved by better effort, and in some
cases identified ‘abnormal’ results that were simply due to poor effort.
Discussion: The single supra-maximal breath provides a valuable
insight into effort related variation in parasympathetic function, and
may improve the ability to interpret clinical testing results. The use of
a single supramaximal breath in large clinical trials where 10 s
electrocardiogram tracings are routinely utilized could offer a pow-
erful insight into parasympathetic function that might not otherwise
be obtained. We plan to evaluate this technique in a large number of
subjects across a range of age, gender and disease severity.
Poster #25
Reproducibility of Valsalva maneuver–derived baroreflex
parameters
C. Ustine, J. De Los Santos, P. Simpson, G. Chelimsky, T. Chelimsky
Department of Neurology, Medical College of Wisconsin,
Milwaukee, WI, USA
Background: The Valsalva maneuver (VM) can provide estimates of
both vagal and sympathetic baroreflex sensitivity (BRS).
Objective: To determine the intra-subject variability of VM-derived
baroreflex parameters.
Methods: Subjects in the IRB-approved ICECAN trial return 5 times
in 6 months for a series of 4 Valsalva maneuvers, using 1500 and
40 mmHg supine and at 30 until good recordings were obtained. As
per Singer et al., the vagal baroreflex component (BRS_v) constitutes
the RR interval response to a preceding change in BP, either during
vagal excitation (BRS_vup, from Phase IV), or vagal inhibition
(BRS_vdown, from Phase II early) while Pressure Recovery Time
(PRT) to baseline during phase IV reflects adrenergic baroreflex. A
custom MATLAB script selected the BP and RR interval correlation
with the best R2 among 0, 1 and 2 beat delays, and calculated BRS_v
as the linear regression slope. We examined 4 VMs collected from 4
subjects over 2 visits and selected the highest quality VM for analysis
based on the best R2 and absence of artifact. The spread of BRS
values was also assessed in 3 subjects using all 4 VMs in each visit.
Results: The BRS_vdown and the BRS_vup were highly reproducible
with Pearson correlations of 0.99 and 0.69, respectively. BRS_vdown
did not correlate with BRS_vup. Except for 2 trials, the R2 for
selected trials ranged from 0.88 to 0.96. Values for BRS_vup: S1:
0.002 ± 0.001, S2: 0.002 ± 0.0009, S3: 0.005 ± 0.006; for
BRS_vdown S1: 0.005 ± 0.003, S2: 0.002 ± 0.0008, S3:
0.009 ± 0.008. The PRT clustered nicely for each subject across the 2
trials, S1: 5.7 ± 2.91 s, S2: 2.67 ± 0.92 s, S3: 1.13 ± 0.33 s, S4:
2.44 ± 0.75 s.
Discussion: The VM baroreflex parameters show robust intra-subject
reproducibility in this small sample, including BRS_vup,
BRS_vdown, and PRT. There was little correlation between any of
these paramenters.
Funding: NIH Diabetes, Digestive and Kidney Diseases, RO1-
DK083538.
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Ventilatory and cerebrovascular response to metaboreflex
activation while supine or upright in men and women
H. Joshi, H. Edgell
Kinesiology and Health Sciences, York University, Toronto, ON,
Canada
Men have an enhanced metaboreflex compared to women [as mea-
sured by blood pressure and sympathetic nerve activity (Jarvis et al.,
2011)]; however, sex differences in the ventilatory and cerebrovas-
cular response to metaboreflex activation have never been
determined. Since it has been previously shown in men that the
chemoreflex is activated subsequent to metaboreflex activation
(Edgell et al., 2014), we hypothesized that there would be reduced
ventilation in women leading to higher end-tidal CO2 and greater
cerebrovascular conductance. Men (n = 14; age: 21 ± 1) and women
(n = 11; age: 19 ± 1) performed 40% maximal voluntary contraction
handgrip exercise (HG) for 2 min followed by 3 min of post-exercise
circulatory occlusion (PECO) in supine and 70 head-up tilted
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postures. Supine: 1) During HG and PECO men increased ventilation,
but women did not (Men: Baseline: 12.5 ± 0.5 L/min, HG:
18.6 ± 1.5 L/min, PECO: 17.7 ± 2.8 L/min; Women: Baseline:
12.0 ± 0.4 L/min, HG: 12.4 ± 0.4 L/min, PECO: 11.5 ± 0.4 L/min;
Sex 9 Time interaction P = 0.037), 2) During PECO both sexes had a
similar reduction of end-tidal CO2 (Men: Baseline:
38.6 ± 0.9 mmHg, PECO: 35.3 ± 1.6 mmHg; Women: Baseline:
33.5 ± 0.9 mmHg, PECO: 32.2 ± 1.0 mmHg; Main effect of Time
P\ 0.001), and 3) During HG and PECO men and women decreased
cerebrovascular conductance equally (Men: Baseline:
0.79 ± 0.04 cm/s/mmHg, HG: 0.68 ± 0.05 cm/s/mmHg, PECO:
0.61 ± 0.05 cm/s/mmHg; Women: Baseline: 0.87 ± 0.04 cm/s/
mmHg, HG: 0.83 ± 0.04 cm/s/mmHg, PECO: 0.75 ± 0.05 cm/s/
mmHg; Main effect of Time P\ 0.015). Upright: The increase of
mean arterial pressure due to PECO was significantly smaller in the
upright position compared to the response while supine in both men
and women (Supine posture: Men: ? 23.3 ± 4.0 mmHg, Women: ?
12.0 ± 7.7 mmHg; Upright posture: Men: ? 15.7 ± 3.9 mmHg,
Women: ? 7.7 ± 2.0 mmHg; Main effect of sex P = 0.042, Main
effect of posture P\ 0.001). Our results indicate that women do not
increase ventilation during metaboreflex activation which may be due
to an absence of chemoreflex activation. However, the reduction of
cerebrovascular conductance was similar between the sexes likely due
to similar reductions of end-tidal CO2.
Funding: Funded by a Discovery Grant from the Natural Sciences and
Engineering Research Council of Canada (RGPIN 2016-05289) and
Infrastructure Operating Funds from the Canadian Foundation for
Innovation (#34485).
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The effect of habitual physical activity on sympathetic vascular
transduction
A.T. Robinson, M.C. Babcock, J.C. Watso, K.U. Migdal, W.B.
Farquhar
Department of Kinesiology and Applied Physiology, University of
Delaware, Newark, DE, USA
Purpose: Physical activity (PA) positively influences cardiovascular
(CV) health. Increasing PA reduces muscle sympathetic nerve activity
(MSNA) in elevated CV risk populations, but not in healthy adults.
Sympathetic vascular transduction represents SNA-induced changes
in beat-to-beat blood pressure (BP) and vascular conductance (flow7
mean BP). Importantly, groups with heightened CV risk exhibit
augmented transduction, however, the influence of PA on transduc-
tion is unknown. Therefore, the purpose of this investigation was to
determine the influence of PA on sympathetic vascular transduction.
Methods: Seventeen healthy adults (7F/10M; age: 24 ± 1 years; BMI:
25 ± 1 kg/m2; BP: 114 ± 3/65 ± 2 mmHg, mean ± SEM) under-
went MSNA (microneurography), beat-by-beat BP (finger
photoplethysmography), and femoral artery blood flow (ultrasound)
measurements throughout 10 min of rest. Femoral blood flow was
used to derive leg vascular conductance (LVC). Each cardiac cycle
containing burst(s) of MSNA was identified and the absolute change
in mean BP and %DLVC were determined over 10 subsequent cardiac
cycles. Changes after each burst were averaged to quantify trans-
duction. Habitual PA was assessed via 7 days of accelerometry. A
median split was performed to divide participants into less- and more-
active groups based on their average daily steps and moderate to
vigorous PA (MVPA).
Results: Data are presented as less active (n = 8) vs. more active
(n = 9). There was a significant difference between groups for daily
step count (6788 ± 693 vs. 12,233 ± 929, p\ 0.01) and MVPA
(74 ± 7 vs. 124 ± 7 min/day, p\ 0.01). MSNA was similar between
groups (Burst freq: 14 ± 3 vs. 14 ± 2 burst/min, p = 0.96). There
was an interaction (time 9 group) on %DLVC transduction for step
count (p 0.05, for both step count and MVPA). There was a significant
unexpected correlation between negative peak %DLVC and MVPA
(r = - 0.59, p = 0.02).
Conclusion: These preliminary data suggest habitual physical activity
may influence sympathetic vascular transduction in young healthy
adults.
Funding: NIH Grant 1R01HL128388 (William B. Farquhar, senior
author), ACSM Research Endowment Award #16-00213 (Austin T.
Robinson, principal author), AHA 18POST34060020 (Austin T.
Robinson, principal author).
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Stimulation of the dorsal root ganglion (DRG) for medicine
refractory chronic neuropathic pain: Is there sympathetic
involvement?
Y.B. Sverrisdottir1, J. Fitzgerald1, A. Kent2, J. Kramer2, A.L. Green1
1Nuffield Department of Surgical Sciences, Department of Functional
Neurosurgery, John Radcliffe Hospital, University of Oxford, UK;
2St. Jude Medical, Sunnyvale, CA, USA
Background: The cell bodies of afferent nerves that pass from the
periphery to the spinal cord are housed in the dorsal root ganglion
(DRG), a swelling in the nerve just before it enters the spine. In pain
processing, the DRG is hypothesized to be an important site in the
induction of neuropathic pain, with alterations in neurotransmitters,
genetic markers, and neurophysiological characteristics having been
demonstrated. However, the role of the DRG in sympathetic regula-
tion is yet to be elucidated and there have been no human
neurophysiological studies due to the inaccessibility of the DRG to
manipulation. Lesion to a peripheral nerve may result in chronic pain
syndromes, hypothesized to be relieved only by inhibiting the effect
of efferent sympathetic impulses on primary afferent neurons. The
dorsal root ganglion (DRG), which is a robust target for neuromod-
ulation therapies, has been shown to be a site for such a coupling.
Stimulation of the DRG may affect certain painful conditions by
modulating sympathetic outflow, as well as being a useful target for
other non-painful conditions that also involve the sympathetic ner-
vous system. In order to elucidate whether stimulation of the DRG for
pain relief alters sympathetic nerve traffic, this study evaluated
sympathetic nerve activity in humans with DRG electrodes at spinal
levels known to have sympathetic supply during periods of ON and
OFF stimulation.
Methods: Muscle sympathetic nerve activity (MSNA) was recorded
during DRG stimulation ON and OFF in patients with chronic neu-
ropathic pain due to peripheral nerve injury (n = 15). Arterial blood
pressure (ABP), heart rate, respiration and pain perception (VAS)
were monitored during the recording session.
Results: Stimulation of right sided L1–L5 and C6–C7 DRG elec-
trodes, while giving adequate pain relief, showed no changes in
MSNA burst frequency, heart rate and ABP, but resulted in a shift in
burst amplitude distribution towards larger amplitudes which was
related to pain perception (VAS). Stimulation of left sided L1–L3
DRG electrodes resulted in decreased MSNA burst frequency and
ABP, which was related to pain perception and unchanged burst
amplitude distribution. Stimulation of left sided L4–L5 DRG elec-
trodes, resulted in an increase in heart rate and ABP, no changes in
MSNA burst frequency, but a shift in burst amplitude distribution
towards larger amplitudes.
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Conclusion: We have previously shown that electric deep brain
stimulation (DBS) in midbrain nuclei in humans alters cardiovascular
parameters by modulating baroreflex control of efferent sympathetic
nerve traffic. Here we show that stimulation of the DRG for pain relief
in humans can modulate sympathetic nerve traffic in a differential
manner depending on electrode location. Our results may have
implications in understanding abnormal sympathetic discharge in
painful as well as non-painful conditions and provide an opportunity
for therapeutic targeting.
Funding: British Heart Foundation, Saint Jude Medical.
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Heightened sympathetic neural and blood pressure responses
to cold pressor test in women with post-traumatic stress disorder
J.-K. Yoo1,2, M.B. Badrov1,2, R.S. Parker2, E.H. Anderson1,3, A.M.
Suris1,3, Q. Fu1,2
1University of Texas Southwestern Medical Center, Dallas, TX, USA;
2Institute for Exercise and Environmental Medicine, Dallas, TX,
USA; 3Mental Health, VA North Texas Healthcare System, Dallas,
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Post-traumatic stress disorder (PTSD) is a psychiatric illness that is
more common in women compared to men, and there is growing
evidence suggesting a close link between PTSD and future develop-
ment of hypertension and cardiovascular disease. The underlying
mechanisms are unclear, but increased sympathetic reactivity to
stressors may be involved. We hypothesized that women with PTSD
would have an augmented sympathetic neural response to the cold
pressor test (CPT). Heart rate (HR, ECG), blood pressure (BP, Sun-
Tech) and muscle sympathetic nerve activity (MSNA,
microneurography) were measured in 16 women with PTSD and 9
healthy female controls [age: 43 ± 3 (SE) vs. 41 ± 3 years] during
supine baseline, 2-min CPT, and 3-min recovery. Data were averaged
for every 30 s. At the baseline, mean arterial pressure (MAP) and HR
were not different between groups; however, MSNA burst frequency
(BF) was greater in women with PTSD (30 ± 3 vs. 13 ± 3 bursts/
min; P = 0.002). MAP and MSNA increased during CPT in both
groups. The CPT-evoked MSNA BF response was greater in women
with PTSD compared with healthy controls (Group 9 time interac-
tion P = 0.039, Group P = 0.001, Time P = 0.0001). Similarly, the
CPT-induced BP (pressor) response was also greater in women with
PTSD (MAP; Group 9 time interaction P = 0.001, Group P = 0.04,
Time P = 0.0001). The changes in MSNA BF and MAP during CPT
were strongly correlated in the PTSD group (1 min CPT: P = 0.01
r = 0.63; 2 min CPT: P = 0.02, r = 0.61). We found women with
PTSD have augmented sympathetic neural and pressor responses to
cold (painful) stimuli which may, in part, explain the propensity
toward developing hypertension and cardiovascular disease in this
population.
Funding: Supported by the Harry S. Moss Heart Trust Medical
Research Grant.
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Resting state fMRI functional connectivity of the PAG in healthy
adolescents and adolescents with functional gastrointestinal
disorder
C. Ustine, L. Conant, S. Rausch, D. Bierer, K. Yan, P. Simpson, T.
Chelimsky, G. Chelimsky
Department of Pediatric Gastroenterology, Children’s Hospital of
Wisconsin and the Medical College of Wisconsin, Milwaukee, WI,
USA
Background: The midbrain periaqueductal gray region (PAG) mod-
ulates both pain and cardiac vagal outflow. Few neuroimaging studies
have investigated the PAG’s functional connectivity with the rest of
the brain or its role in pain, anxiety, stress or autonomic regulation in
patients with functional gastrointestinal disorders (FGID).
Methods: High resolution anatomical and resting-state fMRI images
were acquired from 11 healthy controls (HC) and 9 FGID patients on
a GE 3T scanner. 1 HC excluded from fMRI analyses due to exces-
sive motion. The PAG boundary was hand traced and the structural
image was segmented into CSF, white matter and grey matter using
FSL. The tissue volumes were compared across groups. We collected
two 6-min runs of resting-state fMRI data (TR = 2000 ms; TE = 24
ms; FOV = 240 mm, matrix size = 64 9 64; slice thick-
ness = 3.5 mm). Time-series data were extracted from the PAG mask
and correlated with the data from 14 target ROIs in the subject space.
Statistical analysis was performed on the Fisher z transformed cor-
relation scores.
Results: There were no significant age (p = 0.341) or gender differ-
ences (p = 0.094) between groups (HC: 7 females, age range
12–17 years, mean 14.72 ± 1.35; FGID: 9 females, age range
14–17 years, mean 15.33 ± 1.41). Volumetric analyses showed no
group differences. Significant group connectivity differences of the
PAG occurred with the L insula (HC mean - 0.11 ± 0.25; FGID
mean 0.28 ± 0.27; p = 0.017), with trends for the R insula (HC mean
- 0.009 ± 0.26; FGID 0.22 ± 0.27; p = 0.070) and R hypothalamus
(HC mean 0.21 ± 0.33; FGID 0.51 ± 0.41; p = 0.096).
Discussion: The PAG in adolescents with FGID demonstrates
increased connectivity with the insular cortex. This may reflect an
attempt by the insula to restore impaired autonomic and pain modu-
lation at the level of the PAG, or greater afferent information flow
from the PAG to the insular cortex, leading to conscious perception of
the subject’s symptom experience.
Funding: Advancing a Healthier Wisconsin Grant #5520298.
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Distinguishing multiple system atrophy and Parkinson’s disease
using resting state functional MRI: a pilot study
M. Sklerov1, N. Browner1, E. Dayan2
1Department of Neurology, University of North Carolina;
2Biomedical Research Imaging Center, Department of Radiology,
University of North Carolina, Chapel Hill, NC, USA
Background: Multiple system atrophy parkinsonian subtype (MSA-P)
and Parkinson’s disease (PD) can be difficult to distinguish clinically.
A common feature among PD patients misdiagnosed with MSA-P is
autonomic dysfunction. Though the central nervous system (CNS)
contributions to autonomic dysfunction in MSA and PD are incom-
pletely understood, several brain regions are strongly implicated.
Particularly, there is evidence of involvement of the hypothalamus
(HTH) in both diseases. We collected pilot data to investigate the role
of intrinsic interactions within large scale brain systems, as measured
using resting state functional magnetic resonance imaging (rs-fMRI),
in distinguishing MSA-P from PD, focusing on CNS autonomic
structures, specifically the HTH given its role in both diseases.
Methods: We enrolled 5 subjects with MSA-P from among patients at
the UNC Neurology clinic. rs-fMRI data for 10 age and disease
duration matched PD subjects were obtained from the Parkinson’s
Progression Markers Initiative (PPMI) database, an open-access
database for PD patients. We used seed-to-voxel analysis, placing
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seeds in the left and right HTH, to investigate patterns of functional
connectivity between the HTH and cortical and subcortical structures,
with correction for multiple comparisons.
Results: Mean age of MSA and PD subjects was 65.2 and 63.4 years,
respectively. Mean disease duration for MSA and PD subjects was 5.4
and 5.9 years, respectively. PD subjects had significant differences in
functional connectivity between the HTH and cortical and subcortical
structures (p\ 0.001) compared to MSA subjects.
Discussion: Preliminary analysis of functional connectivity of the
HTH from the first 5 MSA subjects recruited to this study demon-
strates robust differences distinguishing them from 10 age and disease
duration matched PD subjects. Using autonomic central nervous
system structures as a candidate system, rs-fMRI may prove to be an
important clinical and research tool for PD and MSA. Further
investigation is warranted, and our data collection continues.
Funding: UNC Department of Neurology - Soo Neuroimaging
Research Fund, Parkinson Foundation travel awards.
Poster #32
Evidence of cortical autonomic impairment
in the pathophysiology of neurogenic orthostatic hypotension
associated with peripheral autonomic dysfunction
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Background: Neurogenic orthostatic hypotension (NOH), defined as a
drop in systolic blood pressure (SBP) C 30 mmHg on standing or
head-up tilt, is associated with autonomic dysfunction. The cortical
autonomic network (CAN) is a network of brain regions associated
with autonomic function. Our aim was to investigate CAN activation
patterns in NOH patients during autonomic testing.
Methods: Fifteen controls (63 ± 13 years) and fifteen NOH patients
(67 ± 6 years; p = 0.2) with peripheral autonomic dysfunction
completed: (1) deep breathing (DB), (2) Valsalva maneuver (VM) and
(3) lower-body negative pressure (LBNP) during a functional MRI.
Blood-oxygen level dependent contrasts were obtained and
contrasted.
Results: Hemodynamics: Compared to controls, patients had signifi-
cantly smaller heart rate responses to DB (C: 15.23 ± 9.6 vs. NOH:
5.7 ± 2.1) and Valsalva ratios (C: 2.1 ± 0.47 vs. NOH: 1.2 ± 0.1;
p\ 0.001). NOH patients had absent adrenergic phases (late phase II
and phase IV) during VM as per a qualitative analysis. Patients had
significantly larger BP drops during LBNP (p\ 0.001). Function
Imaging: During VM, controls had greater activation in the right
hippocampus (TR-value: 8.03), left posterior cingulate (TL: 7.6) and
bilateral thalamus (TR: 7.41, TL: 8.45; p\ 0.05). During phase IV,
controls had greater activation in the right hippocampus (TR: 5.78;
p\ 0.05). Following subtraction analysis, no significant differences
were evident during DB. Compared to controls, NOH patients had
significantly less activation within the cerebellum during both LBNP
and VM.
Conclusion: NOH patients have significantly less CAN activation
during tests of sympathetic, but not parasympathetic, activation.
Furthermore, the cerebellum, which plays an important role in
orthostatic reflexes such as the vestibulo-sympathetic reflex, may be
impaired in NOH patients. Overall, impaired cortical autonomic
networks appear involved in the pathophysiology of NOH.
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The Orthostatic Discriminate and Severity Scale (ODSS): a tool
to discriminate orthostatic from non-orthostatic symptomatology
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Objective: In the present prospective study, we aimed to assess the
ability of Orthostatic Discriminate and Severity Scale (ODSS) to
distinguish symptoms of orthostatic intolerance from non-orthostatic
symptoms.
Methods: Clinical evaluations and questionnaire responses were col-
lected in 73 healthy controls and 132 patients referred to the
Autonomic Disorders Clinic for queries surrounding autonomic dys-
function. A receiver operating characteristic (ROC) curve analysis
was used to interpret sensitivity and specificity and to determine cut-
off scores for symptom assessment. Inter-item reliability was assessed
using Cronbach’s alpha. To calculate positive and negative predictive
powers, patient data was collected in a single-blinded fashion where
the researcher collecting questionnaire data was blinded to the clinical
evaluation and diagnosis. Predictive powers were calculated using a
Chi square cross-tabulation.
Results: The orthostatic and non-orthostatic symptoms scores pro-
duced ROC curves with an area under the curve of 0.89 and 0.79,
respectively. The orthostatic scores yielded a positive and negative
predictive power value of 73% and 81%, respectively. Combined, the
ODSS identified patients with and without orthostatic symptoms with
an overall accuracy of 76%. The reliability of the ODSS was sig-
nificant with a Cronbach’s alpha of 0.88 and all dichotomous items
were deemed worthy of retention following an inter-item reliability
assessment.
Conclusion: The ODSS demonstrates a strong ability to distinguish
patients with and without orthostatic intolerance and demonstrates a
sensitivity and specificity equivalent to that of other standardized
measures. Overall, the ODSS produces symptom scores that are both
reliable and useful for both research and clinical practice.
Poster #34
Can head-up tilt (HUT) be used to distinguish between clinical
sub-groups of vasovagal syncope (VVS): the Heisenberg principle
at play
S. Balegh, J. Benoit, B. Ditto, R. Schondorf
Department of Neurophysiology, McGill University, Montreal, QC,
Canada
VVS is triggered by emotive, orthostatic or both (mixed) stressors.
The initial blood pressure (BP) collapse during HUT-induced VVS in
VVS patients is unique and due either to a decrease in heart rate,
stroke volume or total peripheral resistance. These hemodynamic
patterns are largely exclusive of age, gender or clinical subtype of
VVS. Many patients with identical clinical patterns of VVS, however,
do not faint during HUT. To determine whether HUT, an ‘‘orthostatic
stressor’’, selectively uncovers ‘‘orthostatic’’ phenotypes of VVS we
evaluated the response of 144 healthy [age 17–62 (31.5 ± 1 year, 43
men)] VVS patients. 76 had HUT-induced VVS (Reactors) 68 did not
(HUT duration (38.4 ? 4.0 min). Strict inclusion criteria eliminated
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patients who took medications or had any medical condition. Finger
BP and EKG were continuously recorded. We averaged the first six
20 s data segments of the cardiovascular responses to HUT. The time
to HUT-induced VVS was not significantly different for the 3 groups
of VVS patients (overall 13.8 ? 9.0 min). The distribution of clinical
VVS groups was identical between Reactors vs. Non-Reactors
(Orthostatic 33 vs. 37; Emotive 13 vs. 11; Mixed 30 vs. 20; X2
(2) = 2.0, p = 0.38.). Any of the 3 groups were equally likely to have
or not have HUT-induced VVS. Group (Reactor/Non-reactor) X 6
Time averages of the initial cardiovascular responses of Reactors to
HUT were indistinguishable from Non-Reactors. Although HUT
testing is considered an ‘‘orthostatic stress test’’, it is just as likely to
lead to a presyncopal reaction in those with a purely emotive (24/144)
or mixed orthostatic-emotive (50/144) history of VVS. The very act
of laboratory testing imposes measurement error and unanticipated
stressors. Further research is needed to help elucidate the potentially
psychological components of HUT testing, or other factors con-
tributing to VVS during HUT.
Funding: Fonds de Recherche Sante Quebec (FRSQ) - Programme de
bourses de formation de doctorat (FF11-24D).
Poster #35
Effects of droxidopa treatment for neurogenic orthostatic
hypotension in patients concomitantly on dopa decarboxylase
inhibitors
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Objective: To assess the long-term efficacy of droxidopa for treatment
of neurogenic orthostatic hypotension (nOH) in patients concomi-
tantly on dopa decarboxylase (DDC) inhibitors (DDCIs).
Background: nOH is a non-motor symptom of Parkinson’s disease
(PD). Treatment of PD frequently includes DDCIs. Droxidopa, a
treatment for symptomatic nOH, is converted to norepinephrine by
DDC.
Methods: Patients were enrolled in a prospective cohort study com-
paring outcomes before initiation of droxidopa and after 1, 3, and
6 months of treatment. Patients recorded monthly number of falls
using a questionnaire and dizziness/lightheadedness using the
Orthostatic Hypotension Symptom Assessment, Item 1 (OHSA-1). A
post hoc analysis compared outcomes in patients on DDCIs vs.
without DDCIs. ‘‘DDCI treatment’’ was defined as receiving car-
bidopa/levodopa, with or without entacapone. The influence of
DDCIs was compared across time points using generalized linear
mixed models adjusting for repeated measures within individuals.
Results: 168 patients were included (PD: 32.1%, autonomic failure:
66.1%, other: 1.8%). 61.8% of patients on DDCIs (n = 55) repor-
ted C 1 fall at baseline vs. 46.9% of patients not on DDCIs (n = 113).
Patients on DDCIs experienced a significant reduction in fall rate
(30.1%, 36.4 point reduction) and improvement in OHSA-1 scores (-
1.8) from baseline to 6 months (P\ 0.05 for both). Patients not on
DDCIs also experienced significant improvement in OHSA-1 scores
(- 1.9, P\ 0.05), but the reduction in fall rate was not significant
(39.8%, 6.2 point reduction, P = 0.49). The differences in change
from baseline to 6 months for fall risk and OHSA-1 score were not
significant between groups (P = 0.15, P = 0.96, respectively).
Conclusions: These post hoc analyses suggest that both DDCI users
and nonusers experienced reductions in fall rate and dizziness/light-
headedness with droxidopa treatment. Additional studies are needed
to examine the impact of DDCIs on droxidopa because the current
study was not powered for subgroup analyses and data were self-
reported by patients.
Funding: This work was supported by Lundbeck.
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Diagnosis of orthostatic hypotension: contribution of diastolic
blood pressure
S. Galvis, M. Campagnalo, S. Rajan, C.H. Gibbons
Department of Neurology, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, MA, USA
Background: Orthostatic hypotension (OH) is defined as a drop in
systolic blood pressure (SBP) of C 20 mmHg or diastolic blood
pressure (DBP) of C 10 mmHg within 3 min of upright tilt
table testing or active standing.
Objective: To determine the role of DBP on the diagnosis of OH.
Methods: We tested 50 subjects (mean age 53, range 17–85 years)
ranging from healthy to severe dysautonomia. Subjects underwent
heart rate variability to paced breathing, Valsalva maneuver, a 45 min
tilt table test and a 5 min active stand. Automated sphygmo-
manometer recordings each minute of testing and continuous heart
rate and beat-to-beat blood pressures were monitored. SBP and DBP
results were compared to overall diagnosis and correlated with other
autonomic function testing.
Results: There was poor agreement between orthostatic drops in SBP
and DBP that met criteria for OH across any disease state with the
exception of severe OH (where it was consistent) (P\ 0.01, X2).
Intermittent (non-sustained) drops in DBP were more than twice as
common as non-stained drops in SBP (P\ 0.01). When the diagnosis
of OH was made by SBP criteria, the mean drop was 32 ± 18 mmHg,
the corresponding DBP fall was 12 ± 12 mmHg. When the diagnosis
of OH was made by diastolic blood pressure, the mean diastolic drop
was 17 ± 7 mmHg and the corresponding drop in SBP was
10 ± 18 mmHg.
Discussion: Although a diagnosis of OH can be made with both SBP
and DBP criteria, we found little agreement between the two methods
in the routine analysis of blood pressures across a range of disease
states. DBP was frequently abnormal without a corresponding change
in SBP. In contrast, abnormal drops in SBP were frequently accom-
panied by corresponding drops in DBP. Our findings suggest that a
diagnosis of OH using only DBP criteria should only be made with
caution.
Poster #37
Can the Valsalva maneuver serve as a biomarker for syncope
diagnoses?
B.C.D Hockin, C. Johnston, E. Williams, M.G. Lloyd, V.E. Claydon
Department of Biomedical Physiology and Kinesiology, Simon Fraser
University, Burnaby, BC, Canada; International Collaboration on
Repair Discoveries (ICORD), University of British Columbia,
Vancouver, BC, Canada
Introduction: Syncope or fainting is ultimately caused by a reduction
in cerebral blood flow. Previous research identified that impaired
cerebral autoregulation contributes to increased fainting
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susceptibility. The Valsalva maneuver (VM) challenges cerebral
autoregulation and may reveal impairments in individuals who are
susceptible to syncope. Seated VM elicit exaggerated blood pressure
responses, and may further unmask cerebrovascular impairments, and
better identify syncope disorders, in susceptible individuals. We
hypothesized that both cardiovascular and cerebrovascular responses
to the VM would be exaggerated in the seated position and would
serve as a biomarker for syncope susceptibility.
Methods: In a randomized order, healthy participants (N = 15; 8
males; 26.5 ± 1.2 years) performed a standard 40 mmHg, 20 s VM
in both a supine and seated position. This was followed by a graded
608 head-up-tilt test with combined lower body negative pressure
continued to pre-syncope, to determine orthostatic tolerance (OT) in
minutes. Beat-to-beat cardiovascular responses were determined
using finger plethysmography and transcranial Dopper ultrasound was
used to measure cerebral blood flow velocity (CBFv).
Results: Mean arterial pressure (MAP) responses were greater in the
seated position in phases 2A (p = 0.023), 2B (p\ 0.001) and 4
(p = 0.031) compared to supine. Similarly, the magnitude of the
phase 2B CBFv recovery (p = 0.026) and phase 4 overshoot
(p = 0.065) were greater in the seated position, compared to supine.
The area under the curve from the phase 4 peak, until CBFv returned
to baseline values was used as a measure of autoregulatory integrity,
and in seated VM this measure was predictive of OT (seated: R = -
0.637, p = 0.048). Interestingly, the max systolic arterial pressure
achieved during phase 4 of a seated VM was strongly related to OT
(R = - 0.785; p = 0.0025), this relationship was not seen in supine
VM.
Conclusion: Cardiovascular and cerebrovascular responses to seated
VM may provide attractive biomarkers for susceptibility to syncope.
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The relationship between changes in orthostatic blood pressure
and symptoms in patients with orthostatic hypotension
B.M.W. Illigens, R. Lapusca, M. Campagnolo, A. Abuzinadah, D.I.
Sinn, L. Walsh, J. White, C.H. Gibbons, R. Freeman
Department of Neurology, Beth Israel Deaconess Medical Center,
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Background: Orthostatic hypotension (OH) is a common feature of
many neurological disorders. Patients with OH can present with a
wide range of symptoms. The relationship of symptoms to blood
pressure (BP) is not known.
Objective: To define the relationship between changes in orthostatic
BP and symptoms in patients with OH.
Methods: In this retrospective study, 1037 charts of patients referred
for autonomic testing from January 2016 to March 2018 were
reviewed. Systolic, diastolic and mean BPs were recorded continu-
ously and every minute of testing using an automated, oscillometric,
cuff sphygmomanometer. Orthostatic BP falls were compared to
baseline supine values. Symptoms were acquired at baseline and
during the first 3 min of upright tilt using a 0 to 10 scale.
Results: Eighty-nine patients (57% male, mean age 69 years) with OH
were included in the final analysis. The majority (78/89) had OH
related to neurodegenerative disease or a peripheral neuropathy.
Lightheadedness and dizziness were the most common symptoms.
Thirty-two (36%) patients had orthostatic systolic BPs of\ 90
mmHg. Of those, 16% were asymptomatic and only 47% rated
symptoms as 4/10 or more. Thirty-eight (43%) patients had systolic
BP falls of C 50 mmHg. Of these 39% were asymptomatic and only
39% rated symptoms as 4/10 or more. There was no relationship
between magnitude of BP fall and individual orthostatic symptoms
(R2 = 0.0, P = NS) or total symptom score (R2 = 0.04, P = NS).
There was no relationship between absolute lowest BP and maximum
symptoms (R2 = 0.02, P = NS) or total symptom score (R2 = 0.05,
P = NS).
Conclusions: These results suggest a poor relationship between the
magnitude of the orthostatic BP fall, the absolute orthostatic BP and
symptoms. Many patients are asymptomatic or mildly symptomatic
despite substantial BP falls and low orthostatic BPs. These findings
have implications for clinical care of patients with OH and clinical
trials to treat patients with OH.
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Validation of finger blood pressure monitoring in children
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Continuous beat-to-beat blood pressure monitoring permits the rapid
detection of blood pressure fluctuations for cardiovascular reflex
testing and clinical hemodynamic monitoring. In adults, this can be
achieved non-invasively with high accuracy, using finger blood
pressure monitoring with volume clamp photoplethysmography.
However, data are lacking on the validity of finger blood pressure
monitoring in children compared to the gold standard—invasive intra-
arterial blood pressure monitoring. We aimed to evaluate the accuracy
of novel non-invasive index and middle finger arterial pressure
measurements in children. Using prototype pediatric finger cuffs, we
compared: mean differences, bias and limits of agreement (Bland–
Altman analyses); cumulative percentage differences [clinical grade
A–D (based on the percentage of heart beats in agreement with the
standard)]; and waveform morphology (regression analysis and
smoothing) between both raw finger arterial pressure (FinAP;
Finapres NOVA) and reconstructed finger-brachial arterial pressure
(reBAP) compared to intra-arterial blood pressure measurements. We
tested 18 children [aged 7 ± 3 standard deviation (SD) years (range
3–13 years); 12 male]. The bias for all conditions of reBAP fell
within 3 ± 9 mmHg, while accuracy of systolic, diastolic and mean
arterial pressure met clinical grades of C, B and A, respectively.
reBAP improved numerical accuracy, but reduced waveform mor-
phological agreement. Finger arterial measurements are an
acceptable surrogate for invasive intra-arterial recording in children,
with accuracy at, or close to (within 0.5 mmHg) clinical guidelines.
Finger arterial pressure monitoring is a novel, comfortable, conve-
nient, and accurate alternative approach for non-invasive beat-to-beat
blood pressure monitoring in children.
Funding: Heart and Stroke Foundation of Canada.
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Postural orthostatic tachycardia syndrome (POTS) is a chronic con-
dition involving orthostatic intolerance and tachycardia upon standing
in the absence of hypotension. While multiple comorbid disorders
have been documented and studied, a relationship between menstrual
disorders and adolescent POTS has not been well described. To better
educate patients on their syndrome and to better guide providers on
how to counsel their patients, a retrospective cohort study of pediatric
patients seen at the Mayo Clinic explored this relationship. This study
aimed to explore menstrual disorders and dysfunction among pedi-
atric patients with postural orthostatic tachycardia syndrome, as well
as characterize the pharmaceutical contraceptive agents used by this
population. The results were analyzed with the Fisher exact test. 149
POTS patients (age 12–18, mean 15.4) and 226 healthy controls (age
12–18, mean 14.6) were reviewed. In the POTS patients, 67%
reported at least one menstrual irregularity as compared to 42% in the
control group (p\ 0.0001). Of POTS patients reporting menstrual
irregularities, 80% reported cramping, 47% reported irregular periods,
36% reported abnormal flow, and 17% reported vaginal discharge. 8%
of POTS patients reported POTS symptoms worsening with men-
struation. Significantly more POTS patients were on hormonal birth
control than their healthy peers (36% versus 14%, p\ 0.0001). In
patients with POTS, combined oral contraceptive pills were the most
prevalent birth control used (72%), followed by the mini pill (7%) and
Depo-Provera shot (7%), IUD (6%), patch (2%), and implant (2%).
Adolescent patients with POTS are more likely to report menstrual
irregularities than their healthy peers and are also more likely to be
prescribed a hormonal birth control agent. Providers caring for ado-
lescent patients with POTS should consider taking a thorough
menstrual history to identify menstrual irregularities and address the
concerns of this patient population.
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Silicone breast implant rupture as a cause of postural orthostatic
tachycardia syndrome (POTS)
W. Almardini, S.B. Alam, M.A. Nasri, H. Mistry, N. Noor, S. Alam,
Z. Rehman, M. Rajumon, L.B. Gaied, B. Sheikh, A. Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Introduction: Postural orthostatic tachycardia syndrome (POTS) is a
heterogenous group of disorders that has been associated with mul-
tiple etiologies. We hereby present a case of POTS most probably
caused by rupture of breast implants.
History: A 41-year-old female presented with an acute onset of
symptoms of dizziness, lightheadedness, and syncope after her
colonoscopy. A detailed workup revealed joint hypermobility, evi-
dence of exaggerated heart rate response to tilt test that was consistent
with postural tachycardia, normal heart rate with deep breathing,
normal Valsalva maneuver and no evidence of small fiber neuropathy
in Q-SWEAT. A complete diagnostic workup including abdominal
ultrasound and referral to an immunologist was done. No definite
cause of her symptoms was established and she was stabilized on
Florinef and IV fluids. The patient was barely able to get back to
work. During one of her incidental self-exams, she found an asym-
metric breast. She consulted the plastic surgeon who had performed
her breast implant surgery, and was told follow up after an MRI was
done. An MRI scan of the breasts showed rupture of the right breast
implant. The area on the right side was found to have gross ecchy-
mosis with inflammation of the right breast. Surgical removal of both
breast implants was done and resulted in almost immediate
improvement in the patient’s symptoms of orthostatic intolerance. A
repeat tilt that was done post breast implant removal showed
exaggerated heart rate response to tilt that was less than the original
tilt table test.
Conclusion: We conclude that in this particular case for a patient with
joint hypermobility, breast implant rupture was associated with acute
onset of orthostatic symptoms that coincided with a colonoscopy.
There was a strong relationship with resolution of the patient’s
symptoms and removal of the breast implants. It has resulted in sig-
nificant improvement in the quality of life and the patient is able to
return back to work and back to her baseline. We still suspect that
because of her joint hypermobility, she may still be prone to devel-
oping postural tachycardia from another cause. The patient has been
taken off her medications. We recommend that in appropriate sub-
jects, breast implant rupture should be considered as a potential cause
of postural orthostatic tachycardia syndrome, especially in the group
of patients with joint hypermobility. MRI of the breast or self-ex-
aminations may aid in the diagnosis.
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Postural tachycardia syndrome and pregnancy: insights
from a cross-sectional community based survey
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Background: Postural tachycardia syndrome (POTS) is a common
form of orthostatic intolerance. Despite the primarily female demo-
graphic, there is little research investigating the impact of pregnancy
in POTS. This study sought to investigate the impact of pregnancy on
POTS symptoms using large cohort data.
Methods: The ‘‘Diagnosis and Impact of POTS’’ is a structured
patient-community based online survey approved by the Vanderbilt
University IRB. Between July 2015 and February 2018, 5811 patients
(or their parents) with a physician-diagnosis of POTS completed the
survey. This analysis was restricted to females who have been preg-
nant at least once (n = 2151).
Results: During the first trimester of pregnancy, 62% of POTS
patients reported that their POTS symptoms worsened compared to
baseline (p\ 0.001 vs. improved or no change). During the second
trimester, 47% reported their symptoms worsened (p\ 0.001), but
36% reported improved symptoms. In the third trimester, 58%
reported worsened symptoms (P\ 0.001), with improved symptoms
in 27%. After delivery, 61% reported worsened symptoms
(p\ 0.001), while 23% reported improvement compared to baseline.
Patients who had worsening POTS symptoms in their first trimester
were more likely to have worsening symptoms than better symptoms
or no change in the second (38% vs. 24%, p\ 0.001) and third tri-
mesters (43% vs. 19%, p\ 0.001). Cesarean sections occurred in
29% of patients. Miscarriages occurred in 29% of total pregnancies,
and 45% of POTS patients experienced at least one miscarriage. A
pregnancy complication was reported in 65% of patients, although the
details are not known. Patients with Ehlers-Danlos syndrome (EDS)
were more likely to experience a pregnancy complication (74% vs.
61%, p\ 0.001) than patients without EDS.
Conclusions: In this large cross-sectional study, individuals with
POTS experience a worsening of baseline symptoms during and after
pregnancy. Worsening symptoms in the first trimester may be pre-
dictive of POTS symptoms in later stages of pregnancy.
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Small fiber neuropathies and related autoimmunity in postural
orthostatic tachycardia syndrome
G.A. Cook
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Objective: Describe rates of small fiber neuropathy findings and
autoimmune disorders associated with postural orthostatic tachycardia
syndrome (POTS) in a Military Health System autonomic disorders
referral clinic.
Background: The Military Health System (MHS) provides medical
care to active duty military personnel, their family members, and
retirees and their spouses. POTS comprises a significant portion of
patients seen in the MHS Autonomic Disorders Clinic.
Methods: Clinical and diagnostic information was obtained both ret-
rospectively (through May 31, 2017) and prospectively (beginning
June 1, 2017) on patients diagnosed with POTS seen in the Clinic.
Results of sudomotor testing, epidermal nerve fiber density (ENFD),
sensory abnormalities, and associated autoimmune disorders (in-
cluding post-infectious onset) were analyzed.
Results: Of 215 patients, 68 (32%) were diagnosed with POTS. Of the
POTS patients, 53 (78%) were female. Thirty-seven (54%) of POTS
patients were classified as having neuropathic POTS. Of those clas-
sified as neuropathic POTS, 4 had abnormal sudomotor testing and
abnormal ENFD, 2 had abnormal sudomotor testing and normal
ENFD, 13 had abnormal sudomotor testing with no skin biopsy
performed, and 11 had abnormal ENFD with normal sudomotor
testing. Six patients were diagnosed as having neuropathic POTS
based on small fiber sensory abnormalities. Of these, four had normal
sudomotor testing without skin biopsy and one had normal sudomotor
testing and normal ENFD. Of the neuropathic POTS, 11 (30%) were
classified as having a possible or probable autoimmune cause (in-
cluding post-infectious onset). Only 2 of the non-neuropathic POTS
patients were designated as having possible or probable autoimmune
cause to their POTS.
Conclusions: Based on abnormal sudomotor testing or abnormal
ENFD on skin biopsy, neuropathic POTS is quite common. The
possibility of false positive results on both these tests limits the
widespread applicability of this finding. Possible or probable
autoimmune disorders may be more common in neuropathic POTS as
opposed to non-neuropathic POTS subtypes.
Funding: The views expressed are those of the author and do not
necessarily reflect the policy or position of the Department of the
Navy, Department of Defense, or the United States Government. I am
a military service member. This work was prepared as part of my
official duties. Title 17 U.S.C. 105 provides that ‘Copyright protection
under this title is not available for any work of the United States
Government.’ Title 17 U.S.C. 101 defines a United States Govern-
ment work as a work prepared by a military service member or
employee of the United States Government as part of that person’s
official duties. The study protocols were approved by the Naval
Medical Center Portsmouth Institutional Review Board in compliance
with all applicable Federal regulations governing the protection of
human subjects. Research data derived from Naval Medical Center
Portsmouth, Virginia, IRB protocol numbers NMCP.2016.0035 and
NMCP.2017.0054.
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POTS patients vs. healthy controls: similar postural tachycardia,
different symptom burden
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Background: Postural orthostatic tachycardia syndrome (POTS) is a
condition of orthostatic intolerance diagnosed in symptomatic indi-
viduals with an excessive rise in orthostatic heart rate (HR) without
orthostatic hypotension. Patients complain not only of orthostatic
symptoms such as dizziness, palpitations, and tremulousness, but also
of pervasive symptoms including fatigue, sleep disturbance, head-
ache, and gastrointestinal dysfunction. Previous studies of POTS
patients have described both improvement in symptoms with persis-
tent postural tachycardia, and persistent symptoms despite
improvement in postural tachycardia.
Objective: To describe orthostatic vital signs in a cohort of POTS
patients and healthy controls, and to compare these to symptom
profiles (both acute orthostatic symptoms and pervasive symptoms).
Methods: POTS patients and healthy controls (both by self-report)
participated in 10-min stand testing and symptom surveys as part of
the 2016 Dysautonomia International conference research project.
Results: 142 POTS patients and 14 healthy controls participated.
Mean orthostatic HR increments were similar between the two
groups: 21.7 beats per minute (bpm) for POTS patients and 19 bpm
for healthy controls. 26.8% of POTS patients and 28.6% of healthy
controls had orthostatic HR increase C 30 bpm. After accounting for
age and presence of orthostatic hypotension, 18.3% of POTS patients
and 21.4% of healthy controls met formal hemodynamic criteria for
POTS (2011 consensus definition). Despite the similarity in ortho-
static tachycardia, POTS patients reported higher symptom burden
during the stand test (Vanderbilt Orthostatic Symptom Scale average
24.8 in POTS vs. 4.2 in healthy controls), worse orthostatic symptoms
over the past year (COMPASS-31 orthostatic intolerance score
average 23.3 vs. 3.3), and more general autonomic symptoms
(COMPASS-31 total score average 45.3 vs. 11.7).
Conclusions: In a sample of self-reported healthy controls and POTS
patients, orthostatic HR increment was similar between the two
groups, despite significantly higher orthostatic and general autonomic
symptom burden in the POTS group.
Funding: Dysautonomia International.
Poster #45
Is pseudobulbar affect unique to PoTS? Emotional lability
in orthostatic intolerance
R.K. Khurana
Department of Internal Medicine, MedStar Union Memorial Hospital,
Baltimore, MD, USA
Background: Our previous report identified pseudobulbar affect
(PBA) and emotional lability (EL) as distinctive features of postural
tachycardia syndrome (PoTS). Crying predominance suggested
depression as a possible co-factor.
Objectives: To compare 1. EL symptoms between controls and three
forms of OI: PoTS, neurally mediated hypotension (NMH), and
symptomatic nonspecific (SN) type. 2. Overt occurrence of PBA
during head-up tilt (HUT) among OI groups. 3. Depression between
controls and OI groups.
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Methods: Institutional review board approved the study. Participants
were 90 OI patients (symptoms[ 6 months): PoTS 47, NMH 16, SN
27; normal controls 12. OI types were documented with HUT, heart
rate response to deep breathing, and Valsalva maneuver. Center for
Neurologic Study-Lability Scale (CNS-LS) assessed EL symptom
severity; score C 13 predicts EL in amyotrophic lateral sclerosis
patients. Patients Health Questionnaire 9 (PHQ-9) score of C 10
indicated depression. Questionnaires were completed before the
author performed HUT. ANOVA and Fisher exact test were
employed.
Results: Subclinical EL was found in 43% PoTS, 31% NMH, 41%
SN, and 0% controls (P = 0.03). CNS-LS score was higher in PoTS
compared with controls (12.2 ± 4.2 versus 8.4 ± 1.7; P = 0.04) but
not between other OI groups and controls (P[ 0.05). Overt PBA was
observed in 19% PoTS, 0% NMH, 4% SN, and 0% controls
(P = 0.02). PHQ-9 score was higher in all OI groups versus controls
(PoTS 10.6 ± 5.1, NMH 9.5 ± 5.5, SN 10.0 ± 6.1, controls
1.8 ± 1.8; P = 0.001). Depression scores did not differ among the OI
groups (P = 1.00) or between PoTS patients with CNS-LS score C 13
versus\ 13 (12.1 ± 3.7 versus 9.7 ± 5.7; P = 0.16).
Conclusions: Subclinical emotional lability afflicts all OI types.
Despite EL predisposition in all OI types, HUT precipitated overt
PBA mostly in PoTS. Orthostatic stress mediated central cate-
cholaminergic dysregulation may predispose PoTS patients to overt
occurrence of reversible PBA. Depression, although co-morbid, does
not contribute to emotional lability.
Poster #46
Antimuscarinic autoimmunity in postural tachycardia syndrome
H. Li, X. Yu, G. Zhang, D.C. Kem
Department of Medicine, University of Oklahoma Health Sciences
Center and VAMC, Oklahoma City, OK, USA
Background: Postural tachycardia syndrome (POTS) is characterized
by an exaggerated heart rate increase during orthostasis and a wide
spectrum of adrenergic-related symptoms. Activating autoantibodies
to the alpha1- adrenergic and beta1/2- adrenergic receptors have
previously been found in sera from patients with POTS. We
hypothesized that patients with POTS might also harbor activating
autoantibodies to M2 muscarinic receptor (M2R). This study exami-
nes a possible pathophysiological role for M2R autoantibodies in
POTS.
Methods and Results: Serum from 11 patients with POTS and 5
healthy controls was analyzed for the ability to activate M2R and alter
M2R orthosteric ligand responsiveness in M2R-transfected cells using
the GPCR assay kit (DiscoveRx). Of the 11 subjects with POTS, 6
demonstrated significant M2R-activating antibody activity from their
serum. No significant M2R antibody activity was found in the healthy
subjects. IgG from 3 of the POTS subjects was tested at 4 different
concentrations. There was a significant dose effect of IgG on M2R
activation, and the maximal effect appeared to occur at 0.2 mg/mL of
IgG. M2R activation by POTS IgG was blocked by the muscarinic
blocker atropine (1 mM). Moreover, POTS IgG significantly shifted
the selective M2R agonist oxotremorine dosage response curve to the
right, indicating an inhibitory allosteric effect of M2R antibodies.
This would exaggerate the effect of vagal withdrawal on the heart rate
during upright posture in POTS.
Conclusions: Over half of the subjects with POTS harbor M2R
autoantibody activity. This supports the concept that a negative
allosteric effect of these M2R autoantibodies may exert a significant
impact on the cardiovascular pathophysiological characteristics in
POTS.
Funding: NIH HL128393.
Poster #47
Impaired glucose homeostasis in lean women with postural
tachycardia syndrome
S.E. Mehr, S.Y. Paranjape, S. Scudder, S. Lonce, J. Celedonio, B.
Preheim, B. Plunkett, C.A. Shibao
Autonomic Dysfunction Center, Department of Medicine, Division of
Clinical Pharmacology, Vanderbilt University Medical Center,
Nashville, TN, USA
The autonomic nervous system is a key regulator of metabolic
function. The sympathetic nervous system (SNS) promotes hyper-
glycemia by inhibiting insulin secretion, stimulating hepatic glucose
production and lipolysis and by decreasing whole-body insulin sen-
sitivity. The parasympathetic nervous system (PSNS) opposes these
actions and maintains glucose homeostasis. We previously reported
an abnormal increase in SNS activity in obese subjects, which reduces
insulin sensitivity. Similarly, patients with postural tachycardia syn-
drome (POTS) are characterized by increased SNS activity; however,
the metabolic effects of this hyperadrenergic state are unknown. We
hypothesized that similar to the obese subjects, the increased SNS
activity in POTS patients results in impaired glucose homeostasis. We
recruited 14 women with POTS (37 ± 11 years, BMI 25 ± 5 kg/m2)
and 12 obese women (37 ± 9 years, BMI 35 ± 5 kg/m2) as positive
controls. All subjects received 75 grams oral glucose tolerance,
plasma samples were obtained at baseline, 30, 60, 90 and 120 min
post-administration. Our results showed that fasting glucose levels
were significantly elevated in obese subjects when compared to POTS
women (93 ± 8.7 vs. 84 ± 7.6 mg/dL, p = 0.018). However, 50% of
POTS women had impaired glucose tolerance defined as glucose level
above 140 mg/dL between 90 and 120 min post-ingestion. The blood
glucose at 120 min was similar between POTS and obese subjects
(126 ± 8.4 vs. 126 ± 8.7, P = 0.96). We concluded that despite
normal BMI, POTS patients have impaired glucose tolerance, which
dramatically increases their risk to develop type 2 diabetes mellitus.
Further studies are needed to evaluate differences in insulin sensi-
tivity or beta cell function in this population.
Funding: Dysautonomia International.
Poster #48
Prevalence and treatment of small intestinal bacterial overgrowth
(SIBO) in patients with postural orthostatic tachycardia
syndrome (POTS)
Z. Rehman, M. Rajumon, S.B. Alam, W. Almardini, H. Mistry, A.
Khan, N. Noor, L.B. Gaied, S. Alam, B. Sheikh, M.A. Nasri, A.
Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Background: POTS is a form of orthostatic intolerance characterized
by a myriad of symptoms including syncope, dizziness, poor con-
centration, exaggerated heart rate response (palpitations) upon
postural changes, fatigue, and nausea. Patients with autonomic dys-
function, such as POTS, often present with GI motility issues. SIBO
refers to a condition in which large amounts of bacteria are present in
the small intestine. The two processes that most commonly predispose
to bacterial overgrowth are diminished gastric acid secretion and
small intestine dysmotility.
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Objective: We aim to study the prevalence of small intestinal bacterial
overgrowth in POTS patients. We also aim to analyze the improve-
ment of POTS symptoms by treating SIBO in POTS patients.
Method: We did a retrospective study of 876 patients randomly
selected from our pool of POTS patients. Their electronic medical
records were reviewed and the SIBO tests were evaluated to deter-
mine their diagnosis.
Results: 67 (7.65%) out of 876 POTS patients (age = 32.94 ± 12.21)
had SIBO testing for clinically unexplained or unresolved nausea,
vomiting, and bloating. 39 of 67 patients (58.21%) tested positive
whereas 28 of 67 patients (41.79%) tested negative for SIBO. Out of
the 39 patients that tested positive for SIBO, 6 (15.38%) were male
(age 28 ± 9.34) whereas 33 (84.62%) were female (ages
26.69 ± 10.08). 14 of 39 SIBO (?) patients were prescribed antibi-
otics (rifaximin or metronidazole) to alleviate associated symptoms
out of which 4 patients were available for follow-up results. 2 patients
treated with rifaximin (200 mg BID) reported improvement in
abdominal pain, sleep, dizziness and chest pain. The other 2 patients
treated with metronidazole denied improvement in GI symptoms and/
or had no change in symptoms.
Conclusion: Our study reports show that out of 67 POTS patients that
had SIBO testing, approximately 58.21% tested positive and those
that were treated with rifaximin reported an improvement in their
POTS and GI symptoms. It has been clinically observed that POTS
patients respond to lower doses of medication than the general pop-
ulation. Our study shows that SIBO is a pathology that can be
associated with POTS and must be acknowledged for more compre-
hensive treatment. Further studies must be conducted in order to
better understand this relationship.
Poster #49
Postural hyperventilation as a cause of POTS
J.M. Stewart1,2, P. Pianosi3, M.A. Shaban1, C. Terilli1, M.
Svistunova1, P. Visintainer4, M.S. Medow1,2
Departments of 1Pediatrics and 2Physiology, New York Medical
College, Valhalla, NY, USA; 3Paediatric Respiratory Medicine,
King’s College Hospital NHS Foundation Trust, London, UK;
4Epidemiology and Biostatistics, Baystate Medical Center, University
of Massachusetts School of Medicine, Worcester, MA, USA
Background: Postural tachycardia syndrome (POTS) is a heteroge-
neous condition. We stratified patients previously evaluated for POTS
on the basis of supine resting cardiac output (CO) or with the com-
plaint of platypnea or ‘‘shortness of breath’’ during orthostasis. We
hypothesize that postural hyperventilation is one cause of POTS, and
that hyperventilation-associated POTS occurs when initial reduction
in CO is sufficiently large. We also propose that circulatory abnor-
malities normalize with restoration of CO2.
Methods and Results: Fifty-eight POTS enrollees were compared to
16 healthy volunteer controls. Low CO in POTS was defined by a
resting supine CO\ 4 L/min. Patients with shortness of breath had
hyperventilation (designated HV) with end tidal CO2 (ETCO2)\ 30
Torr during head-up tilt table testing (HUT). There were no differ-
ences in height or weight between control and POTS patients or
differences between the POTS groups. Beat-to-beat blood pressure
(BP) was measured by photoplethysmography and CO by Model-
Flow. Systemic vascular resistance (SVR) was defined as mean
arterial blood pressure (MAP)/CO. ETCO2 and cerebral blood flow
velocity of the middle cerebral artery were only reduced during HUT
in the HV group, while BP was increased compared to control. We
corrected the reduced ETCO2 in HV by addition of exogenous CO2
into a re-breathing apparatus. With added CO2, HR, BP, CO and SVR
in HV became similar to control.
Conclusions: We conclude that all POTS is related to decreased CO,
decreased central blood volume, and increased SVR and that a variant
of POTS is consequent to postural hyperventilation.
Funding: Funding for this project was provided by Grants R01 HL
134674 and R01 HL 112736 from the National Heart Lung and Blood
Institute.
Poster #50
A rabbit model of autoimmune postural tachycardia syndrome
X. Yu, H. Li, G. Zhang, L. Zhou, D.C. Kem
Department of Medicine, University of Oklahoma Health Sciences
Center and VAMC, Oklahoma City, OK, USA
Background: Previous studies have demonstrated that functional
autoantibodies to adrenergic receptors may be involved in the
pathogenesis of postural tachycardia syndrome (POTS). The objective
of this study was to develop an animal model to examine the impact
of these autoantibodies on cardiovascular responses to postural
changes and adrenergic orthosteric ligand infusions.
Methods: Eight New Zealand white rabbits were coimmunized with
peptides from the first and second extracellular loops of alpha1-
adrenergic receptor (alpha1AR) and the second extracellular loop of
beta1-adrenergic receptor (beta1AR) to produce sympathomimetic
antibodies. Tilt test using a custom-made device and separate agonist-
infusion studies in the ventral recumbent position were performed on
conscious animals before and after immunization and subsequent
treatment with epitope-mimetic peptide inhibitors.
Results: All immunized animals produced high alpha1AR and
beta1AR antibody titers. At 6 weeks after immunization, there was a
greater percent increase in heart rate upon tilting compared to
preimmune baseline (28 ± 8% vs. 18 ± 4%, P = 0.02). No signifi-
cant difference in blood pressure response to tilting was observed
between preimmune and postimmune animals. The heart rate
response to infusion of the beta1AR agonist isoproterenol (0.1–2 lg/
kg) was significantly enhanced in immunized animals, suggesting a
hyperadrenergic state and/or a positive allosteric effect of beta1AR
antibodies. In contrast, the blood pressure response to infusion of the
alpha1AR agonist phenylephrine (5–30 lg/kg) was attenuated in
immunized animals, indicating a negative allosteric effect of
alpha1AR antibodies. A single intravenous injection of the antibody-
neutralizing peptides (1 mg/kg) into immunized animals suppressed
the postural tachycardia and reversed the altered heart rate and blood
pressure responses to orthosteric ligand infusions.
Conclusions: The differential allosteric effect of alpha1AR and
beta1AR autoantibodies would lead to compensatory increase in
norepinephrine and overstimulation of cardiac beta1AR. These data
support evidence for an autoimmune basis for increased upright
plasma norepinephrine and tachycardia that characterize POTS.
Funding: NIH HL128393.
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Inter-rater agreement of thermoregulatory sweat testing (TST)
A. Arvantaj, J. Robinson, C. Geiger, B. Katirji
Neurological Institute, University Hospitals Case Medical Center,
Case Western Reserve University, Cleveland, OH, USA
Introduction: TST is a clinical test for evaluating sudomotor function
in central or peripheral disorders of autonomic nervous system such
as multiple system atrophy and small fiber neuropathy. The TST
evaluates the distribution of sweating by a change in color of an
indicator powder, Alizarin Red.
Design: Retrospective.
Methods: TST was done at 50 C heat and 50% humidity and multiple
photos was taken at the end of 30 min cycle. Each subject’s digital
photographic pictures were reviewed by two reviewers (neuromus-
cular specialist with experience on reporting TST) separately and
rated four body locations—dorsum of hand, forearm, proximal leg
(neck of fibula) and dorsum of foot (on extensor digitorum brevis) on
two ordinal scales: 1-normal/reduced/absent, 2-present/absent.
Reviewers were blind to other clinical data of the patient including
quantitative sweat collection by Q-sweat machine. Cohen’s kappa
was used for measuring inter rater agreement.
Results: 81 subjects (female 57%) with mean age of 41 years (SD: 20,
range 14–85) were included. Three level ordinal rating showed
moderate agreement for all the testing locations (kappa for foot,
proximal leg, hand and forearm: 0.57, 0.57, 0.50, 0.51). However, two
level ordinal rating of sweat present/sweat absent showed strong inter-
rater agreements (kappa for foot, proximal leg, hand and forearm:
0.80, 0.77, 0.78, 0.72). The agreement between reviewers was higher
in male subjects (highest agreement: 0.87 for proximal leg of male
subjects).
Conclusion: Photographic review of TST by two reviewers showed
strong agreement between reviewers on a two level scale (sweat
present/sweat absent) for detecting local anhidrosis. The reviewers’
agreement on a three level scale (normal, reduced, absent) was
modest.
Poster #52
Quantification of thermoregulatory sweat testing (TST)
A. Arvantaj, J. Robinson, C. Geiger, B. Katirji
Neurological Institute, University Hospitals Case Medical Center,
Case Western Reserve University, Cleveland, OH, USA
Introduction: TST evaluates the distribution of sweating by a change
in color of an indicator powder (Alizarin Red) from orange to purple.
Uniform Spreading of the powder over different body parts is tech-
nically challenging and may cause false readings. The amount of
sweat volume required per cm2 to change the color of powder to
purple has not been studied.
Objective: To quantify minimum amount of sweat volume required
for changing the Alizaren red mix to purple.
Design: Retrospective.
Methods: TST was done at 50 C heat and 50% humidity and multiple
photos was taken at the end of 30-min cycle. A Q-Sweat device was
used to collect sweat from foot, proximal leg, hand and forearm with
0.79 cm2 capsules. Digital photographic pictures were reviewed by
two reviewers who were blind to clinical situation and quantitative
sweat collection on two level scale (sweat present/sweat absent) for
the areas around the Q-Sweat capsules.
Results: 80 patients (44 females) were included. Mean and 95%
confidence interval of sweat outputs (ll/0.79 cm2 square) in patients
who were rated as ‘‘Anhidrosis’’ were: foot 15.1 (11.2–20.3), proxi-
mal leg 25.2 (17.1–2.71), hand 32.3 (13.9–50.7) forearm 18.3
(12.1–24.5). In the group rated as ‘‘Sweat present’’ by reviewers,
mean and 95% confidence interval were: foot 45.7 (23.8–67.6), calf
62.5 (50.3–84.8), hand 75.2 (61–89.5) and forearm (52.4–71.2).
Conclusion: Visually-rated anhidrosis is sometimes misjudged with
values as high as 50 ll per 0.79 cm2 while sweat output as low as 24
were considered normal in other subjects. Uneven spreading of the
indicator powder on different body parts may be one of the con-
tributing factors. Simultaneous collection of sweat output by Q-Sweat
device may reduce misinterpretation of TST.
Poster #53
Neurogenic orthostatic hypotension unawareness in multiple
system atrophy compared to peripheral autonomic neuropathy
W.P. Cheshire
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
Objective: To assess whether multiple system atrophy (MSA)
patients’ inability to recognize symptoms of orthostatic hypotension
(OH) is specific to the disease or a phenomenon of cerebral
hypoperfusion.
Background: Despite OH being one of the most disabling manifes-
tations of MSA, patients frequently do not express symptoms during
even large falls in blood pressure (BP). Unawareness of OH might be
explained by degeneration of central afferent systems, such as cortical
processing units that attend to changing stimuli and are subject to
noradrenergic influence by the locus ceruleus, or it might be a general
phenomenon caused by global cerebral hypoperfusion.
Methods: Orthostatic symptoms and beat-to-beat BP responses to the
Valsalva maneuver and tilt table testing were undertaken in 50
patients (64.4 ± 10.6 years M/F 1.9) clinically diagnosed with MSA
(35 MSA-C, 15 MSA-P) who, therefore, had central autonomic fail-
ure. Findings were compared to those in a cohort of 50 patients
(67.0 ± 12.2 years, M/F 1.8) with neurogenic OH caused by
peripheral autonomic neuropathy (PN) due to diabetes (N = 43),
amyloidosis (N = 6), or autoimmune autonomic ganglionopathy
(N = 1).
Results: 20.0% of MSA patients (14.3% of MSA-C and 33.3% of
MSA-P) and 32.0% of PN patients reported symptoms during head-up
tilt. The difference did not reach statistical significance (p = 0.17).
Presence of symptoms correlated with lowest systolic BP (p = 0.016)
but not with lowest diastolic BP, magnitude of BP drop, heart rate,
pressure recovery time, adrenergic score, age, or duration of disease.
Conclusions: Failure of recognition of symptoms of OH in MSA did
not differ significantly in comparison to PN causing comparable OH
severity. Therefore, OH symptom unawareness is most likely
explained by cerebral ischemia rather than by degeneration of central
afferent systems. Measuring standing BP rather than relying on
symptoms alone is indispensable to the evaluation of the patient with
MSA.
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Symptom burden within 1 year differentiates rapidly progressive
multiple system atrophy
E.A. Coon, D.M. Sletten, J.N. Mandrekar, M. Suarez, J.E. Ahlskog,
J.H. Bower, P. Sandroni, E.E. Benarroch, P.A. Low, W. Singer
Department of Neurology, Mayo Clinic, Rochester, MN, USA
Objective: To evaluate demographic and clinical features which may
differentiate multiple system atrophy (MSA) patients who have a
rapidly progressive disease course.
Background: Median survival time in multiple system atrophy (MSA)
is around 7.5 years; however, some patients have a rapidly progres-
sive course. Demographic and clinical features differentiating rapidly
progressive MSA are uncertain.
Methods: We performed a retrospective review of all patients diag-
nosed with MSA between 1998 and 2012 with autonomic function
testing. Living patients were called to assess development of symp-
toms. Survival data was obtained from the clinical record and social
security data base. Short duration MSA patients were defined as those
less than the 5th percentile of overall disease duration in the entire
cohort. Patients lost to follow-up or with unknown death date were
excluded.
Results: Of 669 MSA patients included in the survival analysis, 33
patients were short duration of disease patients with survival ranging
from 1.13 to 3.21 years. When comparing short duration patients to
the main cohort, there were no significant demographic or clinical
differences at the time of assessment, when adjusting for multiple
comparisons. However, when focusing on the first year of symptom
onset, short duration patients were more likely to have motor symp-
toms (p = 0.0002), falls (p = 0.0007), orthostatic intolerance
(p = 0.0001) and bladder symptoms (p\ 0.0001). Odds ratios for
short duration of MSA with development of specific symptoms within
1 year of onset were: bladder symptoms 5.41, orthostatic intolerance
4.04 and falls 3.42. Those clinical features were often coexistent with
most short duration MSA patients having 3 factors.
Conclusions: Our data suggests that demographic and baseline clin-
ical features do not readily differentiate MSA patients with short
duration of disease; however, symptom burden within 1 year from the
onset of symptoms may be indicative of rapid progression to death.
Poster #55
Pure autonomic failure with sick sinus syndrome of reduced
striatal DAT binding
M. Sugiura, K. Sato, Y. Nishimura, Y. Kubo, T. Nakaoka, K. Shibata,
H. Sakura
Department of Internal Medicine, Tokyo Women’s Medical
University Medical Center East, Tokyo, Japan
Pure autonomic failure (PAF) is a rare neurodegenerative disorder of
the autonomic nervous system which is caused by pathological
accumulation of misfolded alpha-synuclein. We experienced two
cases of PAF with sick sinus syndrome (SSS) who had frequent
episodes of syncope. Neither of them had any neurological abnormal
findings including tremor, bradykinesia nor rigidity. However, the
Odor Stick Identification Test for Japanese score was low in both
patients. One of them also had REM sleep behavior disorder in the
past. Moreover, dopamine transporter (DAT) single photon emission
computed tomography imaging revealed that striatal DAT binding
was reduced. Kaufmann et al. reported that olfactory dysfunction is
one of the prognostic predictors of these patients. A recent study
showed that the cumulative incidence of phenoconversion from PAF
to synucleinopathy of the central nervous system was 34% during the
4-year follow-up. We have anticipated the high risk of phenocon-
version in these patients from these findings. Their
electrophysiological evaluation showed prolonged sinoatrial node
recovery time but had no evidence of the atrioventricular node con-
duction time and His-Purkinje conduction time prolongation in both
patients. Based on these results, we confirmed their diagnosis as SSS.
After their pacemaker implantations, they have not experienced any
syncope episodes. SSS is caused by the sinoatrial node dysfunction
which is possibly caused by the degeneration of the SA node cells.
However, its pathophysiology is not well elucidated. Alpha-synuclein
is abundant in the brain while smaller amounts are found in the heart,
muscles, and other tissues. On the other hand, cardiac sympathetic
denervation is well known in PAF. Taken together, the alpha synu-
cleinopathy may have some role of the etiology, severity, and
prognosis of our patients. This is the first report of PAF patients with
severely affected sinoatrial node function and reduced striatal DAT
binding without any apparent neurological findings.
Poster #56
Neuroimaging evidence for decreased cardiac sympathetic
innervation and a vesicular storage defect in residual nerves
in Lewy body forms of neurogenic orthostatic hypotension
D.S. Goldstein, C. Holmes, Y.-S. Ding, Y. Sharabi
Clinical Neurocardiology Section, National Institute of Neurological
Disorders and Stroke, National Institutes of Health, Bethesda, MD
USA
Background: Pure autonomic failure (PAF) and Parkinson’s disease
with orthostatic hypotension (PD ? OH) are Lewy body diseases
characterized by neurogenic orthostatic hypotension (nOH) and
myocardial norepinephrine depletion. Since norepinephrine is syn-
thesized in vesicles, decreased vesicular uptake might contribute to
sympathetic neurocirculatory failure in these disorders. To explore
this we conducted positron emission tomographic scanning after
administration of 18F-dopamine (18F-DA) and on a separate day
11C-methylreboxetine (11C-MRB). Both are radioligands for the cell
membrane norepinephrine transporter (NET), but after neuronal
uptake 18F-DA is stored in vesicles, whereas 11C-MRB does not
enter neurons. A vesicular storage defect would produce a greater fall
in 18F-DA-derived than in 11C-MRB-derived radioactivity.
Methods: Nine patients with nOH from PAF or PD ? OH and 6
control subjects without evidence of central neurodegeneration or
nOH underwent 18F-DA- and 11C-MRB scanning. Two other sub-
jects with cardiac transplants were studied, to adjust for non-specific
binding of 11C-MRB.
Results: In the Lewy body group the mean values for 18F-DA- and
11C-MRB-derived radioactivity (4200 ± (SEM) 23 and 4075 ± 22
nCi-kg/cc-mCi) were lower than those in the controls (10,820 ± 1046
and 6012 ± 426 nCi-kg/cc-mCi; p = 0.0002, 0.0122). After adjust-
ment for non-specific binding the mean 18F-DA/11C -MRB ratio was
also lower in the Lewy body group (1.88 ± 0.43 vs. 3.30 ± 0.31,
p = 0.0005).
Conclusions: Lewy body forms of nOH are associated with neu-
roimaging evidence for both decreased cardiac sympathetic
innervation and a vesicular storage defect in the residual nerves,
indicating populations of catecholaminergic neurons are ‘‘sick but not
dead’’ in these diseases.
Funding: Division of Intramural Research, NINDS, NIH.
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Effects of different classroom temperatures on cardiac autonomic
control and cognitive performance in students
M. Minonzio:1, F. Barbic1, B. Cairo2, D. Shiffer1, A. Dipasquale1, L.
Cerina3, A. Vatteroni1, P. Verzeletti4, F. Badilini5, M. Vaglio5, R.
Iatrino1, A. Porta2,6, M. Santambrogio3, R. Gatti7,8, R. Furlan1,8
1Department of Internal Medicine, Humanitas Research Hospital,
Rozzano, Italy; 2Department of Biomedical Sciences for Health,
University of Milan, Milan, Italy; 3Dipartimento di Informazione,
Elettronica e Bioingegneria, Politecnico di Milano, Milan, Italy;
4Cardio Calm srl, Montichiari, Brescia, Italy; 5AMPS-LLC, New
York, NY, USA; 6Department of Cardiothoracic, Vascular Anesthesia
and Intensive Care, IRCCS Policlinico San Donato, San Donato
Milanese, Milan, Italy; 7Service of Physiotheraphy, Department of
Biomedical Sciences, Humanitas University, Rozzano, Italy;
8Department of Biomedical Sciences, Humanitas University,
Rozzano, Italy
Background: Indoor microclimate may affect students’ wellbeing,
cardiac autonomic control and cognitive performance with potential
impact on learning capabilities.
Aim: To assess the effects of classroom temperature variations on the
autonomic profile and student’s learning capabilities.
Methods: Thirty-four students attending Humanitas University School
of Physiotherapy (15 F, age 20 ± 1 yrs) underwent a single lead ECG
continuous recording by a portable device (MR&D Pulse, Italy)
during a 2-h lecture both when classroom temperature was set
‘‘neutral’’ (22 C, Day 1) and in a different day (Day 2), when
classroom temperature was increased up to 26 C. Data were sent by
telemetry (HP Mobile H&S) to a server for off-line analysis. Sym-
bolic analysis of heart rate (HR) variability provided the percentage of
sequences of three heart periods with no significant change in RR
interval (0 V%) and with two significant unlike variations (2 UV%)
reflecting cardiac sympathetic and vagal modulation, respectively.
Students’ cognitive performance (memory, verbal comprehension and
reasoning) was assessed at the end of the lecture using the online
Cambridge Brain Science cognitive evaluation tool, developed by
Cambridge University (https://www.cambridgebrainsciences.com/
science/tests). Classroom temperature was remotely assessed every
5 min.
Results: Classroom actual temperatures were 22.4 ± 0.1 C (Day 1)
and 26.2 ± 0.1 C (Day 2). HR and 0 V % were greater (p\ 0.04)
during Day 2 (80 ± 13 bpm and 74.6 ± 6.5%, respectively) than
during Day 1 (73 ± 12 bpm and 69.9 ± 6.2%, respectively). Con-
versely, 2 UV% was lower (p = 0.009) during Day 2 (7.9 ± 3.9%)
than during Day 1 (10.9 ± 5.4%). Memory and verbal comprehension
scores were lower (p = 0.03) during Day 2 (10.3 ± 0.3 and
8.2 ± 0.4, respectively) compared to Day 1 (11.3 ± 0.5 and
10.6 ± 0.3, respectively). Reasoning score was unchanged. In Day 2
the overall cognitive c-score (10.7 ± 0.4) was lower (p = 0.001)
compared to Day 1 (12.2 ± 0.4).
Conclusions: During Day 2, the greater HR and 0 V% index are likely
to indicate a cardiac sympathetic over-activity counteracting the
potential vasodilation due to enhanced environmental temperature.
This autonomic response was, however, associated with a global
reduced student’s cognitive performance.
Funding: Funded by Fondazione Humanitas per la Ricerca.
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Central acetylcholinesterase inhibitor, galantamine, prevents
lipid-induced oxidative stress in African Americans
J.E. Celedonio, S.E. Mehr, S.Y. Paranjape, A. Diedrich, C.A. Shibao
Department of Medicine, Vanderbilt University Medical Center,
Nashville, TN, USA
African American women (AAW) have one of the highest prevalence
of hypertension in the US. Obese AAW have decreased parasympa-
thetic (PSNS) activity compared to whites. Continuous lipid infusion
that causes cardiovascular autonomic imbalance (decrease in PNS and
increase in sympathetic activity) induces a greater increase in
oxidative stress in AA compared to whites. Considering that PSNS
protects against oxidation and that central acetylcholinesterase inhi-
bitors have been shown to suppress oxidative stress in animal models.
We tested the hypothesis that the central acetylcholinesterase inhi-
bitor, galantamine attenuates oxidation in response to lipid infusion in
obese AAW compared to white women. We randomized 14 healthy
obese AA (39.5 ± 10.7 yo, BMI 38.8 ± 3.4) and 10 (35.9 ± 8.3 yo,
BMI 36.3 ± 2.1) white women. All subjects underwent 4-h infusions
of Intralipids and heparin. On separate days subjects received either
16 mg galantamine or placebo in a crossover fashion. Lipid-induced
oxidative stress and inflammation were assessed with plasma F2-
isoprostanes and cytokines at baseline, 2 and 4-h post-intralipid
infusion. In AA, 16 mg of galantamine significantly suppressed the
increase in lipid-induced oxidative stress (10 ± 18 vs. -
3.0 ± 12 pg/mL with galantamine, P = 0.014). No effect was noted
in whites. Galantamine tended to increase IL10 (4.8 ± 7.58 vs.
17.3 ± 20.7 pg/mL with galantamine, P = 0.06). We did not observe
any effect on blood pressure or heart rate. In conclusion, increased
parasympathetic tone with central acetylcholinesterase inhibitor,
galantamine, suppressed lipid-induced oxidative stress in African
American women.
Funding: Doris Duke Foundation Career Development Award.
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Comparison of cerebral oxygen saturation patterns in adolescents
with autonomic dysfunction who experience syncope
versus convulsive syncope during head up tilt testing
E.M. Smith, S.S. Hashmi, A. Gourishankar, M.T. Numan, I.J. Butler,
J.E. Lankford
Department of Pediatrics, McGovern Medical School, The University
of Texas at Houston, Houston, TX, USA
Introduction: The autonomic nervous system is composed of the
parasympathetic and sympathetic nervous systems which are typically
in balance and achieve normal vascular flow throughout the body.
Autonomic dysfunction implies an imbalance of these systems and
symptoms may be revealed during times of stress. One symptom is
syncope defined as a transient loss of consciousness resulting from
reduced cerebral blood flow precipitated by standing. Convulsive
syncope, syncope that is accompanied by seizure-like activity, may
have a more severe cerebral blood flow disruption leading to a more
severe clinical symptomatology. At our institution, we sought to
further understand the differences in cerebral blood flow changes
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between patients with syncope and convulsive syncope during head-
up tilt testing (HUTT) utilizing near-infrared spectroscopy.
Methods: Near-infrared spectroscopy was used to estimate bilateral
cerebral perfusion patterns during HUTT in 23 adolescents with a
diagnosis of autonomic dysfunction. The resulting waveforms of
cerebral regional oxygen saturation (rSO2) were analyzed visually and
a Stata algorithm for data point identification was generated and
compared to the visual analysis for more objective and efficient
analysis of the waveforms. Parameters of absolute changes and rates
of change in rSO2 during HUTT were calculated and compared for
adolescents who experienced syncope versus convulsive syncope.
Results: The Stata program identified key data points in the rSO2
waveforms that were similar to those identified by visual analysis.
Absolute changes and rates of change in the rSO2 waveforms during
three phases of HUTT were described numerically for patients who
experienced syncope and convulsive syncope. No significant differ-
ence was identified in the cerebral oxygen patterns between the two
groups.
Conclusion: These results suggest that cerebral oxygenation patterns
may not differ significantly between patients who experience syncope
versus convulsive syncope. However, the Stata program for analyzing
NIRS data contour changes may enable further analysis for a larger
patient population.
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Hypocapnic cerebral hypoperfusion: a biomarker of orthostatic
intolerance
P. Novak
Department of Neurology, Brigham and Women’s Hospital, Boston,
MA, USA
The objective of the study was to assess the presence of hypocapnic
cerebral hypoperfusion (HYCH) in patients with orthostatic intoler-
ance (OI) without tachycardia and without orthostatic hypotension.
This single center, retrospective study included OI patients referred
for autonomic evaluation which included the 10 min tilt test. Heart
rate, end-tidal CO2 (ET-CO2), blood pressure, and cerebral blood flow
velocity (CBFv) from middle cerebral artery were monitored. HYCH
was defined by: (1) symptoms of OI; (2) orthostatic hypocapnia (low
ET-CO2); (3) abnormal decline in orthostatic CBFv due to
hypocapnia; (4) absence of tachycardia, orthostatic hypotension, or
other causes of low CBFv or hypocapnia. Sixteen subjects met HYCH
criteria (15/1 women/men, age 38.5 ± 8.0 years) and were matched
by age and gender to postural tachycardia patients (POTS, n = 16)
and healthy controls (n = 16). During the tilt, CBFv decreased more
in HYCH (- 22.4 ± 7.7%, p\ 0.0001) and POTS (- 19.0 ± 10.3%,
p\ 0.0001) compared to controls (- 3.0 ± 5.0%). Orthostatic ET-
CO2 was lower in HYCH [26.4 ± 4.2 (mmHg), p\ 0.0001] and
POTS (28.6 ± 4.3, p\ 0.0001) compared to controls
(36.9 ± 2.1 mmHg). Orthostatic heart rate was normal in HYCH
(89.0 ± 10.9 (BPM), p\ 0.08) and controls (80.8 ± 11.2), but was
higher in POTS (123.7 ± 11.2, p\ 0.0001). Blood pressure was
normal and similar in all groups. In conclusion, both HYCH and
POTS patients have comparable decrease in CBFv which is due to
vasoconstrictive effect of hypocapnia. CBFv monitoring can serve as
an objective biomarker for HYCH in OI patients without tachycardia.
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Prevalence of convulsions in the pediatric population
with orthostatic intolerance and neuro-cardiogenic syncope
M.T. Numan1, H. Varner2,3, J.E. Lankford4, I.J. Butler4
Departments of 1Pediatric Cardiology, 2Neurology, 3Internal
Medicine, and 4Pediatric Neurology, McGovern Medical School, UT
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Introduction: Neurocardiogenic syncope (NCS) results from decom-
pensated vascular mechanisms that maintain postural brain perfusion,
usually preceded by prodromal symptoms. Convulsive disorders have
been considered in the differential diagnosis of such patients that
necessitate electroencephalograms (EEG) and brain imaging in most
of these patients. The mechanism of convulsions in the two clinical
entities is different. The presence of generalized tonic movements
during NCS adds to such diagnostic confusion. Our aim of this study
is to evaluate the prevalence of convulsions in pediatric patients with
NCS during head up tilt table test (HUTT), determine their physio-
logical parameters and evaluate their brain imaging and EEG.
Methods: This is a retrospective cohort study of pediatric and young
adult population who underwent HUTT evaluation for their ortho-
static intolerance (OI) symptoms (such as dizziness, blurry vision,
nausea, palpitations and syncope) between 2013 until December
2017. HUTT consisted of 10 min of supine baseline phase, 30 min of
head up tilt at 70 followed by 10 min of recovery supine phase.
Physiological parameters collected included continuous heart rate and
blood pressure, cardiac stroke volume, bilateral cerebral near infra-
red spectroscopy (NIRS) and sympathetic/parasympathetic tone. All
HUTT procedures were performed by an attending physician. Sub-
jects who developed NCS during HUTT were further categorized as
to the presence of tonic–clonic movements of one or more extremities
during their unconscious state. Physiological parameters were eval-
uated for differences in those specific groups.
Results: During the study period, 616 patients underwent HUTT
evaluation for their OI symptoms (492 subjects were female) with
median age of 16 years (range 8–24 years). Of those subjects 240
developed NCS during HUTT (* 39% of the study group). Females
comprised 178 of the 240 NCS group (74%). Upon further evaluation
of the NCS group, there were 68 subjects who developed convulsions
during HUTT with 55 being females (81%). There was a significant
gender difference between the NCS-none convulsion group and the
convulsion group with a predominance of females in the convulsion
group (p = 0.04). The degree of decrement in blood pressure was not
significantly different between the two groups whereas the cerebral
perfusion pattern was unique in that there was a sharp sudden
decrease in NCS non-convulsion and convulsion groups compared to
the OI group. Among the 68 subjects who developed convulsions,
EEGs and/or MRIs were performed in 59 patients and both were
reportedly normal per the neurologist. Cardiac asystole for C 3 s was
present in 42/68 in the convulsion group compared to 24/172 the NCS
non-convulsion group (p\ 0.01).
Conclusion: Convulsions in NCS are not uncommon with a preva-
lence of 28% in our study group. Female gender carries a higher risk
of developing convulsions during NCS. Cardiac asystole is signifi-
cantly more common in the convulsion group. Cerebral NIRS add a
significant diagnostic value in evaluating this specific population.
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What chronic disorders overlap with the migraine complex?
D. Bierer, E. Awe, A. Mueller, A. Husain, G. Chelimsky*, T.
Chelimsky*
Department of Pediatric Gastroenterology, Children’s Hospital of
Wisconsin and Department of Neurology, the Medical College of
Wisconsin, Milwaukee, WI, USA, *Co-senior authors
Introduction: Pediatric migraine headache frequently clusters with
other chronic overlapping pain disorders such as, chronic nausea,
irritable bowel syndrome and fibromyalgia. We reasoned that if a
condition responded to dihydroergotamine (DHE), it may arise from
migraine neural generators.
Methods: This prospective IRB-approved study included 18 patients
receiving the 4-day inpatient DHE (10 mg total) Raskin protocol for
chronic migraine headache. The ‘‘improvers’’ group was defined as
C 20/100 headache amelioration at 4 weeks after discharge. Pre-
hospitalization, daily inpatient, and weekly post-hospitalization
100-point symptom severity scores included: headache, nausea,
vomiting, abdominal pain, sound sensitivity, light sensitivity and
restedness. Group differences were tested using non-parametric
Mann–Whitney and Kruskal–Wallis tests. Pearson correlations among
symptom groups were calculated.
Results: 18 female patients aged 12–21, did not differ in age between
the 8 improvers and 10 non-improvers (p = 0.46). Improvers had
significantly worse headache (p = 0.027) and sound sensitivity
(p = 0.015) at baseline. At four-week follow up, improver headaches
dropped from 61.754.85 to 14.255.98 (p = 0.001) compared to
25.609.60 to 29.909.78 (p = 0.676) in non-improvers. Abdominal
pain in improvers dropped from 42.569.72 to 29.6310.71 (p = 0.344)
and in non improvers 28.309.87 to 25.8010.88 (p = 0.815). Between
baseline and 2-week follow up, nausea correlated strongly with
abdominal pain (R = 0.84, p\ 0.01), as did headache with photo-
phobia (R = 0.75, p\ 0.01).
Discussion: Baseline predictors of DHE responsiveness included
higher headache scores, and light and sound sensitivity, typical fea-
tures of ‘‘true’’ migraine headache. No other symptom was as clearly
responsive to DHE, and these may therefore not share the same neural
generators. Nausea and abdominal pain correlate with one another and
could reflect a different symptom mechanism.
Funding: Advancing a Healthier Wisconsin Grant #5520298.
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Quality improvement and practice-based research in autonomic
neuropathy using the electronic medical record
A. Barboi, V. Patel, O. Kincaid, D. Randall, S. Pocica, L. Gardun, M.
Szela, S. Tideman, L. Hillman, D. Macapinlac, R. Frigerio, K. Simon,
D. Maraganore
Department of Neurology, NorthShore University HealthSystem,
Evanston, IL, USA
Objectives: (1) To develop a structured clinical documentation sup-
port (SCDS) toolkit within the electronic medical record (EMR) that
navigates care, writes notes, and captures data at office visits; (2) to
share the toolkit with neuromuscular and autonomic specialists using
the Epic EMR platform, as part of a Neurology Practice-Based
Research Network (NPBRN).
Background: We developed a seven-stage process for quality
improvement and practice-based research in Neurology using the
EMR: (1) SCDS toolkits (custom navigators, electronic forms, smart
data elements); (2) enrollment reports; (3) data quality reports; (4)
descriptive cohort reports; (5) quality improvement dashboards; (6)
clinical decision support; (7) sharing of toolkits and data (NPBRN).
Methods: We met every 2 weeks for 3 months to develop content:
define the cohort, select outcome measures, and delineate factors
known to modify disease progression. We assigned tasks to the care
team and mapped data elements to the progress note. We then met
every 2 weeks for 3 more months with programmer analysts to build
and test the SCDS toolkit. Auto scored and interpreted tests included
the Center for Epidemiological Studies-Depression (CES-D) scale,
Fatigue Severity Scale (FSS), Survey of Autonomic Symptoms
(SAS), Insomnia Severity Index (ISI), modified Rankin scale
(mRankin), timed 25 foot walk (T25-W) and newly created North
Shore Neuropathy Impairment Score (NS-NIS).
Results: Our toolkit captures 745 fields of data per office visit. We
have used the toolkits 1087 times to assess patients at initial visits for
possible neuropathy, finding autonomic polyneuropathy in 280 of
those patients. We present screenshots of our SCDS toolkit and
descriptive data, pairwise correlations principal component analyses
of score test measures at initial visit from 280 patients in our auto-
nomic neuropathy cohort.
Conclusions: The EMR can be effectively structured to standardize
autonomic neuropathy office visits, capture data, and support multi-
center quality improvement and practice-based research initiatives
Funding: Agency for Healthcare Research and Quality Grant
5R01HS024057-03 ‘Quality Improvement and Practice-Based
Research in Neurology Using the EMR’.
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Autoimmune component of diabetic autonomic gastroparesis
M.C. Yu, H. Li, S. Li, D.C. Kem
Department of Medicine, University of Oklahoma Health Sciences
Center and VAMC, Oklahoma City, OK, USA
Background: Diabetic gastroparesis is characterized by stomach pump
failure. Although its etiology is still unknown, its association with
other manifestations of autonomic neuropathy has led to the pre-
sumption that autonomic nerve dysfunction is a primary issue. There
is indirect evidence that autoantibodies directed toward the autonomic
receptors may alter nerve function.
Methods and Results: Sera from 25 DG subjects and 20 healthy
controls were screened by ELISA for autoantibodies to the second
extracellular loops of the M2 and M3 muscarinic cholinergic recep-
tors (M2R and M3R). Out of the 25 DG subjects, 12 and 10 were
positive for autoantibodies to M2R and M3R, respectively, while only
1 of the 20 controls was antibody positive for M2R and M3R. Nine
DG subjects and 1 control subject harbored both autoantibodies (9/25
vs. 1/20, P\ 0.05). Sera from 4 DG subjects and 2 controls were
tested to examine the impact of these autoantibodies on gastric motor
activity using rat gastric fundus strips. The DG sera significantly
reduced the contractile responses to the cholinergic agonist acetyl-
choline (0.1–10 lM) compared to control sera (fold over baseline at
maximal concentration of acetylcholine: 0.5 ± 0.2 vs. 2.0 ± 0.5,
P\ 0.01). The control sera did not show any significant effect on the
contractile responses to acetylcholine. These data are similar to those
obtained with purified serum IgG.
Conclusions: M2R and M3R are both involved in gastric motility. Our
study demonstrates that circulating autoantibodies to these receptors
alter gastric contractility in vitro. These data support the hypothesis
that autoantibody-mediated changes in gastric motility may contribute
to abnormal gastric emptying. If these data are confirmed, future
diagnostic and specific therapeutic interventions may provide relief.
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A new approach in assessing vasomotor reactivity in response
to cold stress using non-contact optical technology
O.V. Mamontov1,3, V.V. Zaytsev2, E.V. Shlyakhto1,3, A.A.
Kamshilin2
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3Department of Neurology and Neurosurgery, Pavlov First Saint
Petersburg State Medical University, St. Petersburg, Russia
Introduction: Cold stress vasoconstriction reflects general sympa-
thetic reactivity, and it is an important indicator of autonomic
regulation wellness. Vasomotor components are typically measured
by contact plethysmographs, the use of which is inconvenient and
limited in areas of application.
Aim: To compare the blood flow reactivity in response to the cold
stress estimated by the classical Dohn occlusion plethysmography and
novel imaging photoplethysmography (iPPG) systems during venous
occlusion.
Methods: The group of seven volunteers with age of 41 ± 15 years
participated in the experiment for assessing the forearm blood flow by
two methods. Musculocutaneous blood flow was measured by Dohn
occlusion plethysmography simultaneously with the cutaneous blood
flow estimations by green-light iPPG system. Reaction of blood flow
on three sequential venous occlusion was compared at rest and during
the cold stress that was induced by placing an ice package on the
chest.
Results: After venous occlusion, the linear increase of the forearm
volume accompanied by the linear decrease of the PPG signal was
observed, registered by air-plethysmography and iPPG system,
respectively. Cold stress resulted in decrease of the slope in both
curves. The relative changes of the curve inclination measured by air-
plethysmography optical system were comparable: 40 ± 17 vs.
36 ± 12%, p = 0.60 (Wilcoxon test). Moreover, individual values of
the relative change in the angle of inclination obtained by different
methods correlated with each other: r = 0.82, p = 0.023 (Spearman
rank correlation).
Conclusion: The classical and novel optical methods of occlusion
plethysmography gave a similar assessment of blood flow changes in
response to the cold stress. Therefore, the use of iPPG system sim-
plifies and expands the research capabilities allowing study of
vasomotor reactivity in different regions of the body.
Funding: Russian Science Foundation Grant 15-15-20012.
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Impaired sensorimotor control of the hand in congenital absence
of functional muscle spindles
L.J. Smith1, J.A. Palma2, L. Norcliffe-Kaufmann2, H. Kaufmann2,
V.G. Macefield3
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Patients with hereditary sensory and autonomic neuropathy type III
(HSAN III) exhibit marked gait disturbances. The cause of the gait
ataxia is not known, but we recently showed that functional muscle
spindle afferents in the leg, recorded via intraneural microelectrodes
inserted into the peroneal nerve, are absent in HSAN III, although
large-diameter cutaneous afferents are intact. Moreover, there is a
tight correlation between loss of proprioceptive acuity at the knee and
the severity of gait impairment. Here we tested the hypothesis that
manual motor performance is also compromised in HSAN III,
attributed to the predicted absence of muscle spindles in the intrinsic
muscles of the hand. Manual performance in the Purdue pegboard
task was assessed in 12 individuals with HSAN III and 12 age-mat-
ched healthy controls. The mean (± SD) pegboard score (number of
pins inserted in 30 s) was 8.1 ± 1.9 and 8.6 ± 1.8 for the left and
right hand respectively, significantly lower than the scores for the
controls (14.3 ± 2.9 and 15.5 ± 2.0; p\ 0.0001). In five patients we
inserted a tungsten microelectrode into the ulnar nerve at the wrist.
No spontaneous or stretch-evoked muscle afferent activity could be
identified in any of the 11 fascicles supplying intrinsic muscles of the
hand, whereas rich tactile afferent activity could be recorded from 4
cutaneous fascicles. We conclude that functional muscle spindles are
absent in the hand, and likely absent in the long finger flexors and
extensors, and that this largely accounts for the poor manual motor
performance in HSAN III.
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Disturbed proprioception at the knee but not the elbow
in hereditary sensory and autonomic neuropathy type III
V.G. Macefield, L.J. Smith, J.A. Palma, L. Norcliffe-Kaufmann, H.
Kaufmann
Dysautonomia Center, Department of Neurology, New York
University School of Medicine, New York, NY, USA
Hereditary sensory and autonomic neuropathy type III (HSAN III)
features a marked ataxic gait that progressively worsens over time.
We recently assessed whether proprioceptive disturbances can explain
the ataxia. Proprioception at the knee joint was assessed using passive
joint angle matching in 18 patients and 14 age-matched controls; five
patients with cerebellar ataxia were also studied. Ataxia was quanti-
fied using the Brief Ataxia Rating Score, which ranged from 7 to
26/30. Patients with HSAN III performed poorly in judging joint
position at the knee: mean (± SE) absolute error was 8.7 ± 1.0 and
the range was very wide (2.8–18.1); conversely, absolute error was
only 2.7 ± 0.3 (1.6–5.5) in the controls and 3.0 ± 0.2 (2.1–
3.4) in the cerebellar patients. This error was positively correlated to
the degree of ataxia in patients with HSAN III but not in patients with
cerebellar ataxia. However, using the same approach at the elbow
revealed no significant differences in mean error in 12 patients with
HSAN III (4.8 ± 1.2; 3.0–7.2) and 12 age-matched controls
(4.1 ± 1.1; 2.1–5.5). Interestingly, microelectrode recordings
from the peroneal nerve showed a complete absence of spontaneous
or stretch-evoked muscle afferent activity, confirmed in the ulnar
nerve. Clearly, the lack of muscle spindles compromised proprio-
ception at the knee but not at the elbow, and we suggest that patients
with HSAN III have learned to rely more on proprioceptive signals
from the skin around the elbow. Indeed, applying longitudinal strips
of elastic tape around the joint to increase tensile strain in the skin
improved proprioception at the knee but not the elbow.
Funding: Dysautonomia Foundation.
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Transdermal vagal stimulation in postural tachycardia syndrome
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Postural tachycardia syndrome (POTS) is a clinical syndrome char-
acterized by an excessive increase in heart rate (C 30 bpm) on
standing in the absence of orthostatic hypotension, and frequent
orthostatic symptoms for more than 6 months. While most research-
ers focus on the hyperadrenergic features of POTS, these patients also
have significant cardio-vagal (parasympathetic) impairment. We tes-
ted the hypothesis that transdermal electrical stimulation of the
auricular branch of the vagus nerve will enhance cardio-vagal mod-
ulation, reduce heart rate, upright symptoms, and improve orthostatic
tolerance. We studied 14 patients with POTS (31.5 ± 11.7 years, BMI
22.6 ± 3.9 kg/m2). Sham or transdermal electrical vagal stimulation
below perception threshold was applied in random order to the
auricular branch in the right ear in supine and during graded tilt
maneuver. Patients with low vagal modulation (low high frequency
HF\ 200 ms2) responded to vagal stimulation (Kruskal–Wallis
p = 0.01, n = 7) with significant increase in HF power (e.g., @50 Hz:
? 51 ± 10 ms2, p = 0.0032). Vagal stimulation during upright tilt
tended to reduce orthostatic tachycardia and overall orthostatic
symptom score. It improved significantly tilt time (? 5.3 ± 2.6 min,
p = 0.0156). Patients with higher baseline vagal modulation (HF C
200 ms2) did not response to vagal stimulation (interaction p = 0.41).
This proof of concept study indicates that auricular transdermal vagal
stimulation improves supine cardio-vagal function in POTS patients
with low vagal modulation. Further research will determine if this
approach can be used therapeutically, alone or in combination with
other therapies.
Funding: NIH 2P01HL056693-19, UL1TR000445, NS65736-08.
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Non-invasive intervention for trigeminal neuropathy pain
through mechanical modulation of pterygopalatine ganglia
and trigeminal afferents
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Chronic trigeminal neuropathic pain is frequently inadequately
managed by classic pain medications. We used mechanical vibratory
neuro-modulation techniques to affect trigeminal nerve branches to
relieve chronic pain and accompanying autonomic symptoms from
oral, intranasal, and facial regions. One device consisted of a small
magnetized vibratory motor latched to an opposite-polarity disc
magnet fused to adhesive tape. A second device used a customized
silicon impression for one nasal cavity with an embedded magnet for
attachment of a magnetized vibratory motor. Device 1 was placed on
the skin overlying trigeminal nerve branch exits. Device 2 was
inserted into one nasal cavity to modulate branches of the second
trigeminal division (V2; internal nasal; lateral nasal; nasopalatine),
some of which connect to the pterygopalatine ganglion. The vibra-
tions also affected branches of the first trigeminal division (V1,
medial and lateral internal nasal; anterior ethmoidal, supplying pos-
terior orbit contents). Parasympathetic fibers arising from the
pterygopalatine ganglion were also affected, as were sympathetic
fibers accompanying nasal blood vessels. The intervention reduced
concurrent autonomic deficits, e.g., xerostomia, accompanying pain.
Fifteen subjects with varying symptoms, including burning mouth
syndrome, localized facial pain, and retroorbital pain were recorded
during a 10-min baseline, 25-min stimulation, and 10-min post-
stimulation period; pain levels were obtained at onset and offset of
sessions, and declined by 3.25 ± 2.54 sd perceived units (p\ 0.01,
ANOVA). The mechanical vibration provides a rapid-acting (within
minutes), drug-free, low-cost, non-invasive means to reduce chronic
trigeminal pain without electrical stimulation to the skin or nasal
mucosa, and with few side effects. The mechanisms of action are
likely multi-fold, and presumably include massive disruption of
existing neural circuitry for pain in the descending nucleus of V, as
well as interruption of mechanoreception and pain circuitry in the
thalamus, basal ganglia, insula, and cingulate cortices.
Funding: The Fidelity Charitable Nancy Adams and Scott Schoen
Fund and the Kraig and Linda Kupiec Family Trust.
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Background: Diagnosing patients with transient loss of consciousness
(T-LOC) is a challenge, as patients are often asymptomatic upon
presentation. The hospital-wide diagnostic yield ranges from 31 to
64%. The diagnostic yield of a tertiary Syncope Unit (SU), with
complex patients and often thorough testing prior to the consult, has
never been assessed.
Methods: Consecutive patients C 18 y with T-LOC were eligible for
inclusion. Patients underwent the Initial Syncope Evaluation com-
bined with autonomic testing according to the ESC guidelines. The
physician also reported if the diagnosis was certain, highly likely,
likely, or unknown. Critical follow-up was applied after 1–1.5 years
by an expert committee who established the definitive diagnosis. We
identified the yield, accuracy, and safety (adverse events or unex-
pected diagnosis of epilepsy or cardiac syncope).
Results: 264 patients were included [median age 51, IQR: (34–64)]. A
tilt-table test was performed in 59%. A certain diagnosis was made in
42% and a highly likely diagnosis in 39.8% patients, resulting in a
diagnostic yield of 81.8%. A likely diagnosis was made in 15.2%.
T-LOC remained unexplained in 3%. The diagnostic accuracy was
99% for certain diagnoses, 92% for highly likely diagnoses and 64%
for likely diagnoses. Some patients with a likely or no diagnosis were
referred to a neurologist specialized in epilepsy for a third opinion
initiated by the SU. Three patients died. In one patient the expert
committee deemed the cause of T-LOC as the suspected cause of
death, although they made no diagnosis.
Discussion and Conclusion: The diagnostic yield of a tertiary SU was
high, at 81.8%, with a high accuracy. The SU was safe, as no dan-
gerous diagnoses were missed. The use of a tertiary Syncope Unit ran
by a syncope expert provides a huge benefit in safely diagnosing and
treating patients with unexplained T-LOC.
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Patient-reported falls and fear of falling in a prospective study
of droxidopa for treatment of neurogenic orthostatic hypotension
S. Kymes1, C. Franc¸ois1, K. McLeod2, A. Duhig2, A. Ogbonnaya2, A.
Quillen2, J. Cannon1, C.A. Shibao3, B. Yue2, R.A. Hauser4, I.
Biaggioni3
1Lundbeck, Deerfield, IL, USA; 2Xcenda, LLC, Palm Harbor, FL,
USA; 3Vanderbilt University Medical Center, Nashville, TN, USA;
4Parkinson’s Disease and Movement Disorders Center, University of
South Florida Health, Byrd Institute, Tampa, FL, USA
Objective: To assess the long-term effectiveness of droxidopa in
reducing the risk of falling and fear of falling (FoF) in patients with
neurogenic orthostatic hypotension (nOH).
Background: nOH, a sustained blood pressure drop upon standing
may increase fall incidence, which can trigger FoF and future fall risk.
Droxidopa is approved to treat nOH symptoms; fall benefits were
suggested in pivotal trials.
Methods: Patients newly initiating droxidopa enrolled in an open-
label, prospective cohort study. The number of falls in the past month
and FoF were recorded at baseline, 1, 3, and 6 months using a falls
questionnaire and the Short Falls Efficacy Scale-International,
respectively. P values were calculated using paired t test for contin-
uous measures and generalized estimating equations with multinomial
distributions for categorical measures.
Results: 179 patients were enrolled (Parkinson’s disease: 33%, pure
autonomic failure: 65%, other: 2%). Patients reported fewer falls in
the previous month compared with baseline at 1, 3, and 6 months
(n = 135, n = 119, and n = 105, respectively; all P\ 0.05). Among
those who fell C 1 time, patients reported fewer falls during droxi-
dopa treatment. At baseline, 57% of patients with C 1 fall fell C 3
times; at 6 months, only 35% fell C 3 times. At 1, 3, and 6 months,
patients reported significantly less concern about falling than at
baseline (n = 126, n = 112, and n = 98; all P\ 0.0001). The level of
concern about falling was significantly decreased at 1, 3, and
6 months (all P\ 0.01).
Conclusions: In this ‘‘real-world’’ study patients taking droxidopa
were at significantly lower risk of falling after 1, 3, and 6 months of
treatment and those falling C 1 time in the prior month reported
fewer falls/month compared with baseline. Patients reported reduced
FoF during treatment. These results suggest persistence of beneficial
effects at 6 months of treatment, but conclusions are limited by the
lack of a control cohort.
Funding: This work was supported by Lundbeck.
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Diagnosis and treatment of neurogenic orthostatic hypotension:
online, case-based education successfully improved knowledge
and competence of cardiologists and neurologists
T. Finnegan1, J. Maeglin1, C. Murray1, S.R. Raj2
1Medscape Education, New York, NY, USA; 2University of Calgary,
Calgary, AB, Canada
Introduction: Neurogenic orthostatic hypotension (NOH) is a com-
mon feature of conditions that are associated with autonomic
dysfunction, including Parkinson’s disease (PD). Clinicians may
misdiagnose NOH and there is evidence that overall management is
suboptimal. To address this, we investigated whether a case-based
educational activity was able to improve the knowledge and
competence of specialists regarding both the diagnosis and manage-
ment of NOH.
Methods: An online, text-based educational intervention comprising 2
patient case scenarios was developed. Using a ‘‘test and teach’’
approach, clinicians were presented with multiple-choice questions to
evaluate their application of evidence-based recommendations. Each
response was followed by detailed, referenced, feedback to teach.
Educational effect was evaluated with a repeated-pairs pre- to post-
assessment study design in which each individual learner acts as his/
her own control. A paired 2-tailed t test evaluated whether the mean
pre- and post-assessment scores significantly differed from one
another. Cramer’s V was used to calculate the effect size of the
intervention. Data were collected between March 28, 2018 and May
02, 2018.
Results: The education resulted in an extensive educational effect for
both cardiologists (n = 437; V = 0.456; P\ 0.05) neurologists
(n = 333; V = 0.411; P\ 0.05). Significant improvements were
observed in several areas for both groups (P\ 0.05 for all compar-
isons) including: the blood pressure reading after standing indicative
of NOH; selection of non-pharmacologic treatments for NOH; the
role of dopamine on blood pressure regulation and; pharmacotherapy
for the management of NOH in patients with PD and comorbidities.
Conclusion: This study demonstrated the success of a targeted, online,
interactive, case-based educational intervention on improving the
knowledge and competence of both cardiologists and neurologists
regarding the care of patients with NOH. Both clinician groups would
benefit from continued education on the clinical recognition and
management of NOH based on the magnitude of the educational
effect.
Funding: The education and outcomes analysis were funded through
an unrestricted educational grant from Lundbeck.
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Polymorphic ventricular tachycardia associated with an episode
of reflex syncope: is this the needle in the haystack?
M.A. Tester1, B.C.D. Hockin2, T. David1, S. Franciosi1, K. Harris1,
V.E. Claydon2, S. Sanatani1
1Division of Cardiology, Department of Pediatrics, University of
British Columbia, Vancouver, BC, Canada; 2Department of
Biomedical Physiology and Kinesiology, Simon Fraser University,
Burnaby, BC, Canada
We present an unusual case of seemingly typical reflex syncope, in
the form of defecation syncope, in a 17-year-old female with a
pacemaker in situ for congenital heart block. Device interrogation
demonstrated normal pacemaker function with a short run of poly-
morphic ventricular tachycardia (PVT) coinciding with the syncope.
The patient was upgraded to an implantable defibrillator and under-
went subsequent echocardiography and stress testing which were both
normal, with no evidence of cardiomyopathy and no induced arry-
thmia. There is no family history of sudden cardiac arrest (SCA) or
suspicious deaths. Screening for genetic causes of arrhythmia was
negative. Given the autonomic trigger for her event, she was referred
for autonomic function testing with non-invasive beat-to-beat blood
pressure (BP) and electrocardiographic monitoring (Finometer
ProTM). Her supine heart rate (HR) variability was reduced in the
very low (1798 ms2), low (LF: 672 ms2) and high (HF: 107 ms2)
frequency ranges, but with a normal LF:HF ratio (6.3). Vagal
baroreflex control (cross-spectral analysis) was impaired, with normal
delay (2.2 s) but low sensitivity (3.8 ms mmHg-1); HR responses to
deep breathing were also small (± 16 bpm). An active stand from the
supine position revealed a borderline abnormal initial BP decrease (-
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38/- 19 mmHg) that was associated with light-headedness and
accompanied by an excessive HR response (? 50 bpm). The BP
decline was well recovered within 3 min of standing, but the HR
remained excessive (? 40 bpm). Her QT variability index was -
0.325, which reflects high susceptibility to ventricular arrhythmia. HR
and BP responses to the Valsalva maneuver were normal, but in each
of four repetitions there were associated non-conducted atrial ectopics
and ventricular ectopy, consistently triggered during phase 2A. In
susceptible individuals, autonomic stimuli may trigger significant
arrhythmia, with the potential of progressing into a SCA. This case
may provide insight into the 50% of individuals who experience SCA
with no identifiable cause.
Poster #74
Droxidopa and midodrine treatment persistence in patients
with orthostatic hypotension
S. Kymes1, K. Jackson1, M. Widolff1, C. Sullivan1, L.A. Hewitt1, S.R.
Raj2
1Lundbeck, Deerfield, IL, USA; 2University of Calgary, Calgary, AB,
Canada
Objective: Determine the treatment persistence of no-cost droxidopa
and midodrine in patients with orthostatic hypotension (OH) or
neurogenic orthostatic hypotension (nOH).
Background: nOH is a sustained drop in blood pressure upon standing
that can lead to falls and other poor outcomes. Droxidopa and
midodrine are approved to treat symptomatic nOH and symptomatic
OH, respectively. We compared treatment persistence over 1 year in
patients taking droxidopa or midodrine with no copay.
Methods: Retrospective data were collected from Symphony Health
Solutions Database (Symphony Health; Conshohocken, PA, USA).
Inclusion criteria were continuous healthcare coverage from Sept 1
2014, to June 30 2017, an active prescription for droxidopa or
midodrine of C 30 days during that window, and no copay for the
medications. Persistence was capped at 365 days for an unbiased
comparison between midodrine (introduced in 1996) and droxidopa
(introduced in 2014). The difference between estimated survival
curves for droxidopa and midodrine was calculated using a log-rank
test and a multivariable Cox regression analysis.
Results: Data from 688 patients on droxidopa (mean ± SD age,
63.8 ± 16 years; 48% women) and 1888 patients on midodrine
(55.2 ± 16 years; 62% women) were included. Of patients on drox-
idopa, 12% had a diagnosis of Parkinson disease (PD), 34%
cardiovascular disease (CVD), 18% both PD and CVD, and 35%
unknown. Of patients on midodrine, 1% had a diagnosis of PD, 69%
CVD, 3% both PD and CVD, and 26% unknown. Median persistence
was significantly longer for droxidopa [240 days; 95% confidence
interval (CI), 210–299] versus midodrine (180 days; 95% CI,
160–183; P\ 0.0001). Patients on midodrine were 27.4% more likely
to discontinue than those on droxidopa (P = 0.002).
Conclusions: When insurance covered medication cost, patients were
more likely to remain on droxidopa than on midodrine. Possible
reasons for this could be enhanced efficacy or fewer side effects.
Funding: This work was supported by Lundbeck.
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Why do syncope patients go to the Emergency Department? …
Or not?
M. Runte1, R. Sheldon2, T. Campbell3, T. Williamson3, T. Runte2, K.
King-Shier3, S. Raj2
1Dhillon School of Business, University of Lethbridge, Lethbridge,
AB, Canada; 2Cardiac Sciences, University of Calgary, AB, Canada;
3University of Calgary, Calgary, AB, Canada
Background: Syncope causes 1–3% of emergency department (ED)
admissions with 65% of syncope patients seen in ED arriving by
ambulance. Little is known about the motivations prompting syncope
patients to access emergency services (ES).
Objective: Exploratory qualitative research identified the factors
prompting syncope patients to access ES. Results informed devel-
opment of a paramedic-run ED ‘‘treat and refer’’ (T ? R) for syncope
patients, whereby they will receive assessment, education and follow-
up facilitated by paramedic services.
Methods: A convenience snowball sample of self-identified ‘‘repeat
fainters’’ (aged 18–67 years) were interviewed. Participants were
asked to discuss their reasons for contacting or not contacting ES and
their perception of the process in terms of meeting needs and
expectations. Participants were then asked to discuss the potential for
a T ? R program administered by paramedic services.
Results: Patients who accessed emergency services expressed fear that
their faint was a symptom of graver illness, fear due to ambiguity of
symptoms, had been injured during fall, were seen because a
bystander or family member called ES, or accessed care as a way to
facilitate assessment. Also expressed was a sense of embarrassment
and frustration over paramedics being called given that symptoms
were generally resolved by the time they were seen. A paramedic-run
T ? R program was a supported concept, although patients expressed
the need for referring paramedics to communicate the diversion as a
completed assessment with protocols for follow-up care as many felt
patients would see the decision not to transport to the ED as invali-
dating of their initial decision to seek ES care. Patients identified the
need for decision matrices, accurate information for themselves and
bystanders, and patient support resources.
Conclusions: Syncope patients contacted paramedics or attend the ED
due to fear, injury, bystander concern or with hope of documenting
symptoms to facilitate diagnosis. Patients are supportive of a T ? R
program that provides education, assessment and follow-up in the
absence of an ED visit.
Funding: Cardiac Arrhythmia Network of Canada (CANet).
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Orthostatic intolerance syndrome after bariatric surgery
J.B. Zhang, R.A. Tamboli, V.L. Albaugh, D.M. Kilkelly, C.G.
Grijalva, C.A. Shibao
Department of Surgery, Vanderbilt University, Nashville, TN, USA
Background: This year over 200,000 individuals in the U.S. will likely
undergo bariatric surgery for the treatment of morbid obesity. Several
small case series and retrospective studies describe the occurrence of an
orthostatic intolerance (OI) syndrome after bariatric surgery. However,
the incidence of this syndrome remains unknown.
Methods: We used the Vanderbilt Metabolic and Bariatric Surgery
Quality, Efficacy, and Safety Database (VMBSD), a prospective, de-
identified registry of 4547 patients who have undergone bariatric
surgery at Vanderbilt, to identify cases of post-bariatric surgery OI
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syndrome. Chart review was conducted for all subjects who reported
OI symptoms. Cases of OI were confirmed using a protocol developed
by the Vanderbilt Autonomic Dysfunction Center, and data from
available autonomic function tests were extracted from medical
records for evidence of impaired autonomic function. The cumulative
incidence of post-bariatric surgery OI syndrome was estimated using
a life table.
Results: Of 4547 bariatric surgery patients, 741 patients reported OI
symptoms. We confirmed the presence of post-bariatric surgery OI
syndrome in 85 patients, including 14 with severe OI requiring pressor
agents. By the end of 5 years post-operation, the estimated cumulative
incidence of OI syndrome was 4.2%, after accounting for loss to follow-
up. The majority of OI cases occurred after weight reductions post-
operation, during relatively weight-stable months. At the time of iden-
tification, 52% of OI cases with available autonomic function test data
(11 of 21) showed evidence of impaired sympathetic vasoconstrictor
activity. The baseline pre-operation prevalence of neuropathy, coronary
artery disease, and arrhythmias were significantly higher among patients
who developed OI syndrome than among those who did not.
Conclusion: Orthostatic intolerance is relatively frequent in the bar-
iatric surgery population, affecting 4.2% of patients within the first
5 years after their operation. Some patients with OI exhibit evidence
of impaired sympathetic vasoconstriction activity.
Funding: C.A.S. was supported by National Institute of Health (NIH)
Grant K23 HL103976-02 and by PHRMA Foundation Career
Development Award, and Doris Duke Foundation Career Develop-
ment Award. R.A.T. was supported by NIH Grant R01 DK100431.
V.L.A. was supported by F32DK103474. The dataset(s) used for the
analyses described were obtained from Vanderbilt University Medical
Center’s Synthetic Derivative which is supported by institutional
funding and by the Vanderbilt CTSA Grant ULTR000445 from
NCATS/NIH.
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The impact of nausea in pediatric patients with chronic
overlapping pain conditions
R. Deshpande, P. Simpson, M. Feng, J. Barbeau, T. Chelimsky, G.
Chelimsky
Department of Neurology and Pediatrics, Medical College of
Wisconsin and Children’s Hospital of Wisconsin, Milwaukee, WI,
USA
Introduction: Despite its frequency in chronic overlapping pain con-
ditions (COPC), nausea is rarely studied, particularly regarding
triggers and co-morbid symptoms.
Methods: Retrospective chart review of pediatric patients in the
Autonomic Registry who had filled out a questionnaire regarding
symptoms, family history, and co-morbidities. Patients with and
without nausea were included for comparison. The two groups were
separated and compared using a pooled t-test.
Results: Of 39 patients, 25 identified nausea as a symptom. The mean
functional disability inventory (FDI, range limits 0–60) was signifi-
cantly higher in patients with nausea with a median 29 (range 16–54)
vs. 13.5 (0–33) (p\ 0.01). The nausea group had more frequent
headache (p = 0.01), sleep disruption (p = 0.03), and aches and pains
(p = 0.02). Interestingly, mental health conditions such as depression,
anxiety, and PTSD did not differ between groups, nor did hypermo-
bility or joint dislocation. Family history was only significant for
gastroesophageal reflux disease in the nausea group (p = 0.02), and
specifically there was no difference for migraine.
Conclusion: When nausea is present, children with COPC have
greater disability, suggesting a high impact on their daily function.
COPC with nausea also has more headaches, sleep issues, and aches
and pains. Interestingly, nausea was not associated with higher
prevalence of migraine in the family.
Poster #78
Reduced heart rate variability at the time of PICU admission
improves with recovery from critical illness
L.E. Marsillio, T. Manghi, M.S. Carroll, L.C. Balmert, M.S.
Wainwright
Department of Pediatrics, Ann and Robert H. Lurie Children’s
Hospital of Chicago, Chicago, IL, USA
Background: Autonomic nervous system dysregulation (ANSD) is
common in critical illness. Changes in heart rate variability (HRV)
reflect ANSD, often precede clinical deterioration, and are associated
with poor outcomes. However, data associating HRV with recovery
from critical illness in children are lacking.
Objective: HRV derived from electrocardiogram (ECG) data from
bedside monitors can be calculated in children using an automated,
streaming analytics platform. Determine if changes in HRV can be
detected with recovery from critical illness by comparing HRV from
the time of pediatric intensive care unit (PICU) admission with HRV
immediately prior to discharge.
Methods: Retrospective, observational pilot study examining HRV in
17 patients ages 0 to 18 years admitted to the PICU at a tertiary-care
children’s hospital. Three time-domain measures of HRV were cal-
culated in real-time from bedside monitor ECG data and stored for
analysis. Measures included: root mean square of successive differ-
ences between NN intervals (rMSSD), % of successive NN interval
differences over 50 ms (pNN50), and standard deviation of NN
intervals (SDNN). Values from the first and last 24 h of PICU stay
were analyzed.
Results: Mixed models demonstrated that all three measures of HRV
were significantly lower during the first 24 h compared to the last
24 h of PICU admission (p\ 0.001 for all three measures). In models
exploring the relationship between time from admission and log HRV
values, the predicted average HRV remained consistently higher in
the last 24 h of PICU stay compared to the first 24 h.
Conclusion: HRV was significantly lower in the first 24 h compared
to the 24 h preceding PICU discharge, after resolution of critical
illness. This demonstrates that it is feasible to detect changes in HRV
using an automated, streaming analytics platform. Continuous track-
ing of HRV may serve as a biomarker of recovery in critically-ill
children.
Funding: Department of Pediatrics, Ann and Robert H. Lurie Chil-
dren’s Hospital of Chicago, Ruth D. and Ken M. Davee Pediatric
Neurocritical Care Program.
Poster #79
NIH Toolbox application of cognition assessment in congenital
central hypoventilation syndrome
A. Zhou1, J.M. Torres1, L. Garcia1, R. Patel1, S.R. Fair1, F.A. Zelko1,
C.M. Rand1, K. Bijawat1, D. Forbush1, S. Tsao1, M.L. Chen2, I.A.
Perez3, D.E. Weese-Mayer1
1Ann and Robert H. Lurie Children’s Hospital of Chicago and Stanley
Manne Children’s Research Institute, Northwestern University,
Evanton, IL, USA; 2Seattle Children’s Hospital, Seattle, WA, USA;
3Children’s Hospital Los Angeles, Los Angeles, CA, USA
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Introduction: Congenital central hypoventilation syndrome (CCHS) is
a neurocristopathy characterized by autonomic nervous system dys-
regulation, including a control of breathing deficit and risk of repeated
hypoxic exposure. Formal neurocognitive testing indicates mid-av-
erage or better development in a subset of preschool-age CCHS
children, and low-average results in most school-age children. The
NIH Toolbox Cognition Battery (NTCB) is a highly portable vali-
dated tool that measures six cognitive domains (executive function,
attention, episodic memory, language, processing speed, working
memory), with application across a broad age range for longitudinal
purposes. NTCB summary scores are generated for overall cognitive
total composite based on fluid (measures cognitive abilities related to
capacity for new learning and information processing in novel situ-
ations) and crystallized (measures cognitive abilities dependent upon
past learning experiences) composite scores.
Methods: 62 CCHS subjects (35 females; mean age 15.7 ± 10 years)
were recruited and administered NTCB via an iPad. Two-sided one-
sample t-tests were performed on age-corrected standard scores
compared to the population mean (100 ± 15), and a fully-corrected
T-score compared to a population mean (50 ± 10). Significance was
applied to p B 0.05.
Results: Age-corrected standard scores and fully-corrected T-scores
were frequently reduced in CCHS (fluid composite scores for both
and cognition total composite score for fully-corrected are C 1 SD
below the population mean). However, the crystallized fluid com-
posite did not differ from the population mean.
Conclusions: The NIH Toolbox Cognition Battery effectively and
objectively measures neurocognition in CCHS. Crystallized com-
posite scores indicate normal mean values in CCHS. However, fluid
composite scores are significantly below normative values, as are
overall fully-corrected cognition total composite scores. These NTCB
results within the largest CCHS cohort reported to date for neu-
rocognitive testing support previously published formal
neurocognitive testing results. This suggests that the NTCB has utility
in longitudinal testing and determination of specific modifiers of
neurocognitive development before and after intervention strategies.
Funding: National Institutes of Health’s National Center for
Advancing Translational Sciences, Grant Number UL1TR001422;
PHOX2B Patent Fund at Chicago Community Trust Foundation.
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Case report of uccessful May-Thurner syndrome (MTS) surgery
in postural orthostatic tachycardia syndrome (POTS)
S. Alam, H. Mistry, W. Almardini, S.B. Alam, N. Noor, M.A. Nasri,
Z. Rehman, M. Rajumon, A. Khan, L.B. Gaied, A. Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Background: POTS is a condition characterized by an abnormal
increase in heart rate upon changes in posture and presents with an
array of symptoms like headache, dizziness, syncope, palpitations,
nausea, abdominal discomfort, fatigue, and blood pooling of hands
and feet. MTS is a compression of the left common iliac vein (LCIV)
by the right common iliac artery (RCIA) and may present with DVT,
leg swelling, varicose veins. Theoretically, treating MTS will improve
venous flow back to the heart, which will reduce the POTS symptoms.
Previously, a case report was presented of a patient who reported no
improvement of their POTS symptoms after MTS surgery without a
hemodynamic study prior to the procedure.
Method: A case of a 38-year-old female with POTS and MTS
symptoms with failure of medical management is presented. Imaging
studies such as mesenteric and renal doppler, and magnetic resonance
venogram-abdomen and pelvis (MRV-AP) were performed prior to
the surgery. Patient proceeded with MTS surgery done through
stenting of LCIV and RCIA known as ‘‘kissing stents’’.
Results: Celiac and renal doppler were normal. MRV-AP showed
narrowing of the proximal LCIV distal to the bifurcation of the
inferior vena cava as it coursed between the lumbar vertebral body
and the RCIA. Significant short-term improvement of the patient’s
symptoms after MTS surgery were noted. She reported a significant
decrease in her fluctuating heart rate, she was able to stop taking the
prescribed Ivabradine; significant decrease in symptoms of dizziness,
chest pressure, and palpitations from postural/positional changes. A
significant decrease in swelling and discoloration of her lower
extremities and slight-moderate increase in her energy levels were
also noted.
Conclusion: MTS surgery using two stents, with prior hemodynamic
study, was found to be beneficial in relieving the POTS symptoms in
this patient. We are currently studying the long term benefits and
management of MTS surgery in POTS patients, while using hemo-
dynamic studies to guide us.
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Abdominal binder with insulin therapy for better glycemic
control in a patient with POTS and DM-Type 1
W. Almardini, H. Mistry, S. Alam, S.B. Alam, N. Noor, M.A. Nasri,
Z. Rehman, M. Rajumon, L.B. Gaied, B. Sheikh, A. Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Introduction: Postural orthostatic tachycardia syndrome (POTS) is a
heterogeneous group of disorders and a form of autonomic dysfunc-
tion that could be associated with other comorbidities. We hereby
present a case of POTS and diabetes mellitus type 1 treated with
subcutaneous insulin injections, and abdominal binder for better
glycemic control.
History: An 18-year-old female with diabetes mellitus type 1 and
postural orthostatic tachycardia syndrome (POTS) presented with
longstanding symptoms of dizziness, lightheadedness, palpitations
and syncope. A detailed workup also revealed a moderate form of
hypermobility. Patient complained of having difficulty in controlling
her blood sugar levels with the use of subcutaneous insulin Lispro
injections after meals, and subcutaneous insulin glargine injections
before going to bed. She used continuous glucose monitoring to check
random blood glucose levels that ranged between 300 and 500 mg/Dl.
A therapeutic trial of using an abdominal binder with insulin injec-
tions for 1 week was suggested to see if this could help in achieving
better glycemic control. Theoretically, the abdominal binder should
help with improving circulation and decreasing the effect of blood
pooling associated with POTS, and possibly improving absorption of
insulin to the circulatory system. During the therapeutic trial, the
patient used an elastic abdominal binder during the day, Lispro
insulin was injected after meals, and Glargine insulin was injected
before bed time. On day 4 post treatment, normalization in blood
glucose levels were appreciated using a continuous glucose moni-
toring device. The patient continued using the abdominal binder with
her insulin therapy, and her average random blood glucose level was
170 mg/DL post treatment.
Conclusion: In patients with POTS and DM type 1, the use of an
abdominal binder along with insulin injections may help in achieving
better glycemic control. This could be explained by increasing cir-
culation in POTS patients, which may facilitate the absorption of
insulin subcutaneously injected in the abdominal area. Therefore, we
suggest that patients with POTS and signs of blood pooling may
benefit from the use of abdominal binder in combination with the
insulin therapy to achieve a tighter blood glucose control. Further
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studies should be conducted in order to better understand this
implementation.
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Ehlers-Danlos syndrome and mast cell activation syndrome
in postural tachycardia syndrome: contributions to a sicker
phenotype?
K. Bourne1, L. Stiles2, B.H. Shaw1, C.A. Shibao3, L.E. Okamoto3,
E.M. Garland3, A. Gamboa3, A. Peltier3, A. Diedrich3, I. Biaggioni3,
D. Robertson3, S.R. Raj1,3
1University of Calgary, Calgary, AB, Canada; 2Dysautonomia
International, East Moriches, NY, USA; 3Vanderbilt University,
Nashville, TN, USA
Background: Postural tachycardia syndrome (POTS) is a common
form of orthostatic intolerance. Some POTS patients also have Ehlers-
Danlos syndrome (EDS), a heritable connective tissue disorder, and/
or a mast cell activation syndrome (MCAS), an allergy spectrum
disorder with gastrointestinal and neurological involvement. This
relationship is not well understood and we hypothesize the presence
of EDS and/or MCAS is associated with greater symptom burden.
Methods: The ‘‘Diagnosis and Impact of POTS’’ is an IRB approved,
patient-community based online self-reported survey. Surveyed
between Jul2015 and Feb2018, 4740 patients with physician-diag-
nosed POTS were included.
Results: Four groups: 289 (6%) diagnosed with both EDS and MCAS
(POTS ? EDS ? MCAS), 918 (19%) with EDS but not MCAS
(POTS ? EDS), 174 (4%) with MCAS but not EDS (POTS ?
MCAS) and 3359 (71%) with POTS alone (POTS). Classic POTS
symptoms including lightheadedness, chest pain, tachycardia and
palpitations were not different between the 4 groups. Presyncope was
significantly higher in POTS ? EDS than POTS (96% vs. 93%,
p = 0.004). Allergic symptoms including skin flushing and hives were
higher in POTS ? EDS ? MCAS and POTS ? MCAS when com-
pared to both POTS and POTS ? EDS (p\ 0.001). Skin flushing
was also significantly higher in the POTS ? EDS group when com-
pared to POTS (74% vs. 66%, p\ 0.001). Gastrointestinal symptoms
were most common in POTS ? EDS ? MCAS including nausea
(97%), vomiting (46%), and diarrhea (81%), and significantly higher
than POTS (p\ 0.001 for each). Neurological symptoms including
tingling (82%) and numbness (73%) in the feet were most common in
the POTS ? EDS ? MCAS group, significantly higher than POTS
(65% and 56%, p\ 0.001), POTS ? EDS (73%, p = 0.001 and 64%,
p = 0.005), and POTS ? MCAS (71% and 60%, p = 0.003).
Conclusions: MCAS was seen in 10% of the POTS population, and
the majority of this subgroup also reported EDS. MCAS ? EDS
patients reported a higher rate of allergic, gastrointestinal, and neu-
rological symptoms than those patients with POTS alone. Future
mechanistic studies are needed to better understand pathophysiology.
Poster #83
Sensory functioning in postural orthostatic tachycardia syndrome
and the relationship with autonomic symptom burden
A.M. Herrera, D. Gibbs
School of Occupational Therapy, Belmont University, Nashville, TN,
USA
The purposes of this study were to form a comprehensive, founda-
tional understanding of sensory functioning, specifically sensitivity to
sensory stimulation, in adults with postural orthostatic tachycardia
syndrome (POTS) and identify if there is a relationship between
individual’s sensory functioning and severity of autonomic symp-
toms. Adults diagnosed with POTS were surveyed on autonomic
symptom severity using the Composite Autonomic Symptom Score
31 (COMPASS-31) and sensory functioning using the Sensory Per-
ception Quotient (SPQ). Spearman’s correlations were performed to
analyze the relationship between the measures. 756 participants
completed the survey. Of these, 2.6% had autism spectrum disorder,
all of whom were female. Sensory hypersensitivities were identified
in all senses. Touch was the most hypersensitive sense and hearing
was the least sensitive. All correlations between COMPASS-31 and
SPQ scores were weak despite reaching statistical significance pro-
vided the large sample size, however, several trends emerged from the
data. Pupliomotor was the COMPASS-31 domain with the highest
number of statistically significant correlations with sense subcate-
gories. Touch and vision were the senses with the highest number of
statistically significant correlations with COMPASS-31 domains. This
study provides preliminary evidence of sensory hypersensitivities in
individuals with POTS across all five major senses.
Funding: Research completed as part of doctoral work in the School
of Occupational Therapy, Belmont University, Nashville, TN, USA.
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Small vessel vasculitis associated with small fiber neuropathy
featuring worsening of postural orthostatic tachycardia syndrome
A.A. Memon, M. Kazamel
Department of Neurology, University of Alabama at Birmingham,
Birmingham, AL, USA
Introduction: The prevalence of postural orthostatic tachycardia
syndrome (POTS) is estimated to be 0.1–1%. About 50% of POTS
patients were found to be of the neuropathic type. The estimated
sensitivity of sural nerve and combined superficial peroneal nerve and
peroneus brevis muscle biopsies in diagnosing non-systemic vas-
culitic neuropathy is 50%.
Objective: To report subacute worsening of manifestations of POTS
in the setting of non-systemic small vessel vasculitis associated with
small fiber neuropathy.
Methods: Case report.
Results: A 45-year-old woman with remote history of POTS as a
teenager who presented with subacute recurrence of her orthostatic
symptoms and new onset diffuse neuropathic pain in 2015. The onset
was associated with new complaints of dry eyes, early satiety, and
several weeks of night sweats. Her neurologic examination was
remarkable for decreased temperature sensation up to ankles bilater-
ally. Laboratory workup for causes of acquired neuropathy including
vitamin B complex levels, heavy metal screen, inflammatory markers,
and paraneoplastic panel were unremarkable. Nerve conduction
studies and electromyography were normal. Quantitative sudomotor
axonal reflex testing showed reduced sweat output on the forearm.
Head up tilt table test showed reproduction of some of her symptoms
with rise of heart rate from 80 (baseline supine) to 124 bpm after
9 min of tilt with no significant change in blood pressure. Ther-
moregulatory sweat test showed symmetric areas of anhidrosis over
the forearms and toes. Skin punch biopsy showed reduced epidermal
nerve fiber density in a non-length dependent manner. There were
multiple moderate inflammatory mononuclear cellular collections
surrounding and invading small dermal blood vessels.
Conclusion: This case highlights the importance of pathologic eval-
uation of POTS patients, especially the neuropathic type, via skin
punch biopsy. Clues for more aggressive search for an underlying
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cause could include subacute onset, non-length dependent distribution
of neuropathic manifestations, and presence of systemic symptoms at
time of onset.
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Incidence of May-Thurner syndrome in postural orthostatic
tachycardia syndrome (POTS) patients
A. Khan, M. Rajumon, Z. Rehman, S.B. Alam, H. Mistry, W.
Almardini, N. Noor, L.B. Gaied, S. Alam, M.A. Nasri, B. Sheikh, A.
Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Background: Patients with autonomic dysfunction, such as POTS,
often have co-existing vascular disorders. May-Thurner syndrome
refers to a condition where the left iliac vein is compressed by the
right iliac artery, which increases the risk of deep vein thrombosis
(DVT) in the left extremity. Often, the syndrome acts as a permissive
lesion and becomes symptomatic when something else happens such
as, following trauma or a change in functional status. An incidental
compression of 50% or more in the left iliac vein is seen in about a
quarter of the general population.
Objective: We aim to study the prevalence of May-Thurner syndrome
in POTS patients.
Method: We did a retrospective study of 876 patients randomly
selected from our pool of POTS patients. Their electronic medical
records were reviewed and the CT angiogram abdomen and pelvis
were evaluated for their diagnosis. Patients were diagnosed based on a
compression of 50% or more of the left iliac vein.
Results: 209 (23.74%) out of 876 POTS patients (age = 32.94 ±
12.21) were tested for May-Thurner syndrome. 33 of 209 (15.79%)
tested positive whereas 176 of 209 patients (84.21%) tested negative
for May-Thurner. Out of the 33 patients that tested positive for May-
Thurner; 2 (6.06%) were male (age 31.5 ± 4.95) whereas 31
(93.94%) were female (ages 30.97 ± 11.11). 2 out of 33 (6.06%) had
leg edema and 0 out of 33 (0.00%) had a DVT.
Conclusion: Our study reports show that out of 209 POTS patients
that had CT abdomen and pelvis for May-Thurner testing, approxi-
mately 15.79% tested positive. Therefore, we do not see an increased
incidence of May-Thurner syndrome in POTS patients compared to
the general population. Further studies must be conducted in order to
better understand this relationship.
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A comparison study of heart rate with deep breathing variability
(HRVdb) in female patients with intermediate tilt table test
results vs. postural orthostatic tachycardia syndrome patients
H. Mistry, B. Sheikh, S. Alam, W. Almardini, M.A. Nasri, S.B. Alam,
N. Noor, Z. Rehman, M. Rajumon, L.B. Gaied, A. Khan, A. Suleman
Department of Cardiology, Heartbeat Clinic, McKinney, TX, USA
Background: Often, patients with orthostatic intolerance (OI) do not
meet criteria for postural orthostatic tachycardia syndrome (POTS) or
orthostatic hypotension. There was one previous study that showed
relative inability to increase HR upon posture changes. This was
attributed to enhanced vagal tone. That study used frequency domain
analysis for HRVdb. HRVdb is a non-specific but reproducible
marker to check for parasympathetic cardiac function.
Objective: We aim to study whether time-domain analysis for HRVdb
also shows enhanced cardiovagal tone in female patients who have
intermediate tilt test response, compared to female POTS patients.
Methods: A retrospective study was performed by randomly selecting
41 OI female patients using the intermediate tilt table test criteria (HR
increase between 15 and 30 bpm within 10 min of tilt) as our case
group. We selected our control group as 50 POTS female patients
(HR increase[ 30 bpm or exceeds[ 120 bpm within 10 min of tilt)
minimizing the confounders like age and gender. We utilized time-
domain analysis for HRVdb results and performed a Chi square test to
see if there are any significant differences between case and control
group.
Results: Our study identified a total of 41 female OI patients (age =
36.5 years ? 10.4). Their tilt table test results had: mean HR
change = 24.225 bpm ? 4.393, SEM = 0.694, and HRVdb mean =
19.014 ? 8.633, SEM = 1.365. The study had a total of 50 female
POTS patients (age = 31.372 years ? 11.549). Tilt table test results
had: mean HR change = 45.725 bpm ? 13.523, SEM = 1.893 and
HRVdb mean = 21.675 ? 8.175, SEM = 1.144. Comparing HRVdb
among these two groups showed Chi square statistic of 1.7144 and
p-value of 0.190412.
Conclusion: Our study showed that there was no statistically signifi-
cant difference in the case group vs. control group and did not show
there was enhanced vagal tone in patients with OI symptoms (non-
POTS patients). This is a preliminary study and further studies need to
be conducted for better understanding.
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Compression and velocity of the left renal vein as a measure
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tachycardia syndrome (POTS) patients
Z. Rehman, M. Rajumon, B. Sheikh, S.B. Alam, W. Almardini, H.
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Background: Previously, we have seen a relationship between Nut-
cracker syndrome and POTS. Nutcracker syndrome is the
compression of left renal vein between the abdominal aorta (AA) and
superior mesenteric artery (SMA) causing symptoms such as flank
pain, lower abdominal pain, hematuria, pelvic congestion, varicocele
and varicose veins due to the disturbance of blood flow from the left
renal vein (LRV) into the inferior vena cava.
Objective: We aim to study the compression and velocity of the left
renal vein in POTS patients as a possible indicator of the severity of
Nutcracker syndrome based on prevalence of symptoms.
Methods: We did a retrospective study of 876 POTS patients referred
to our clinic. Electronic medical records were reviewed and the CT
angiograms of abdomen (w/and w/o contrast) evaluated for Nut-
cracker syndrome and its respective symptoms. Renal dopplers were
assessed and left renal vein velocities were collected. The findings
from both tests were compared to each other.
Results: 208 (23.74%) out of 876 POTS patients were tested for
Nutcracker syndrome. 24 of 208 (11.54%) Patients were diagnosed
with Nutcracker syndrome and had data on their systolic velocity. Out
of the 24 patients that had Nutcracker syndrome; 1 (4.17%) was male
(age 37) whereas 23 (95.83%) were female (ages 28.96 ± 10.59). Our
findings showed that 5 out of 24 patients suffered from lower
abdominal pain (20.83%); 6 out of 24 patients suffered from leg pain
[(25%) 3 in only the left leg and 3 in both legs]; 6 out of 24 patients
showed pelvic congestion (25%); 4 out of 24 patients had flank pain
[(16.67%) 3-left flank and 1-right flank]; 3 out of 24 patients had
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varicose veins (12.50%); and 2 out of 24 patients suffered from
hematuria (8.33%). 7 out of 24 (29.17%) patients had mild com-
pression; 17 out of 24 (70.83%) patients had 50% or more
compression. Mean systolic LRV velocity = (31.33); No correlation
was observed between degree of compression and LRV/RRV velocity
ratio (R2 = 0.053); No correlation was observed between degree of
compression and LRV systolic velocity (R2 = 0.021) and a Pearson
correlation coefficient (R Value = - 0.145) was obtained for the
same.
Conclusion: Our study showed that there is no correlation between the
compression and velocity of the left renal vein and symptoms of
Nutcracker syndrome. This is a preliminary study and further studies
need to be conducted for a better understanding.
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Validation of the German version of the Composite Autonomic
Symptom Score 31
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Background: The Composite Autonomic Symptom Score 31 (COM-
PASS 31) is a validated, 31 item self-assessment questionnaire,
developed by the Mayo Clinic autonomic group from their more time-
consuming 169-item Autonomic Symptom Profile and 72-item
COMPASS questionnaires. The 31 items assess autonomic symptoms
in 6 domains, orthostatic intolerance, vasomotor, secretomotor, gas-
trointestinal, bladder, and pupillomotor functions. So far, there is no
validated German version of the Compass 31.
Objective: To establish a validated German version of the COMPASS
31.
Methods: Two neurologists with autonomic expertise (WS and MJH)
independently translated the original questionnaire into German; then,
this version was translated back into English to assure conformity of
the German with the original version. 20 patients with autonomic
dysfunction and 20 age- and gender-matched healthy controls com-
pleted the COMPASS 31 twice, 4 weeks ± 1 week apart, once in
German and once in English. The order was randomized at the Mayo
Clinic, Rochester, MN. The validation of the German version of
COMPASS 31 was evaluated by correlating its total and sub-scores
with those of the original English COMPASS 31 using Pearson’s
correlation test. Significance was set as p-value\ 0.05.
Results: The German version of COMPASS 31 significantly and
positively correlated with the English version of COMPASS 31 in
scores of orthostatic intolerance (coefficient = 0.919, p\ 0.001),
vasomotor function (coefficient = 0.934, p\ 0.001), secretomotor
function (coefficient = 0.741, p\ 0.001), gastrointestinal function
(coefficient = 0.896, p\ 0.001), bladder function (coefficient =
0.864, p\ 0.001), pupillomotor function (coefficient = 0.776,
p\ 0.001), and total scores (coefficient = 0.934, p\ 0.001).
Conclusions: Total- and sub-scores of the German Version of
COMPASS 31 correlated well with those of the original English
version of COMPASS 31. These data indicate that the German ver-
sion of COMPASS 31 is a validated tool to assess autonomic
involvement in both clinical and research applications.
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Assessment of postural orthostatic tachycardia syndrome (POTS)
in adolescents and young adults using pupillometric parameters:
a pilot study
E.A. Bettini1, K. Jackson1, B.C. Greenspun2, Y. Wang1, J.C. Finkel1,2
1Children’s National Medical Center, Washington, DC, USA; 2The
George Washington University, Washington, DC, USA
Purpose: To observe differences in 8 pupillometry variables before
and after orthostatic stress in adolescents and young adults with a
diagnosis of POTS in comparison to control subjects without a
diagnosis of dysautonomia.
Methods: Pupillometry data were collected using an infrared pupil-
lometer (Neuroptics PLR-200) in 20 adolescents and young adult
subjects with a diagnosis of POTS and 20 similarly aged controls.
Pupillometry data for each participant were recorded at three time
points: lying supine for 10 min for a baseline measurement, and then
documented at 5 and 10 min under orthostatic stress in the standing
position. The 8 pupillometry parameters collected were: the initial
pupil diameter (MAX), the smallest diameter of pupillary constriction
(MIN), the amplitude of constriction as a percent (CON), the latency
of the pupil to constrict (LAT), the maximum speed of pupillary
constriction (MCV), the average velocity of pupillary constriction
(ACV), the average velocity of pupillary re-dilation (ADV) and the
time to re-dilate 75% (T75).
Results: This study was analyzed using SAS 9.4 with a significance
level of p\ 0.05. A total of 40 subjects (65% female, ages 12–22)
were enrolled in the study. After adjusting for age and gender, there
were significant differences between the POTS and control groups in
3 pupillometry outcomes. The CON for POTS subjects was signifi-
cantly smaller at each time point. The MIN was significantly larger at
5 and 10 min post orthostatic stress. LAT was significantly higher in
POTS than controls at 10 min after orthostatic stress.
Conclusion: Based on the results of this pilot study, pupillometry has
potential as a tool to screen for autonomic nervous system disorders
such as POTS in adolescents. Further research is required to develop
an algorithm based on pupillometry parameters that can be utilized in
assessing patients with signs of dysautonomia.
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Healthcare related costs of autonomic disorders in MHS
beneficiaries
G.A. Cook1, A. Bogacki2, E. Williams IV2
1Department of Neurology, Uniformed Services University of the
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Medical Center Portsmouth; 2Health Analysis Department, Navy and
Marine Corps Public Health Center, Portsmouth, VA, USA
Objective: Describe healthcare related costs in Military Healthcare
System (MHS) beneficiaries diagnosed with various autonomic
disorders.
Background: The MHS has one of the largest cradle-to-grave health
systems in the United States with over 9.7 million patients. Healthcare
related costs in individuals diagnosed with autonomic disorders in the
MHS have not been explored.
Methods: The MHS Data Repository (MDR) was queried for patients
with at least two ICD-9 diagnostic codes for autonomic disorders
between the dates of January 1, 2009 and September 30, 2015.
Individuals with any diagnosis of diabetes mellitus were excluded.
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Results: Diagnosis of tachycardia, unspecified, was most common,
with 165,484 cases over the period with total healthcare costs of $14.8
billion, or $15,066 per beneficiary per year. Number of cases of other
autonomic disorders, total costs, and beneficiary per year costs were:
orthostatic hypotension, 54,642, $3.95 billion, $11,752; idiopathic
peripheral autonomic neuropathy, 8314, $661 million, $12,087;
autonomic neuropathy in diseases classified elsewhere, 3470, $313
million, $14,082; disorder of the ANS, unspecified, 7145, $699 mil-
lion, $15,644; other degenerative changes of the basal ganglia/MSA,
3619, $262 million, $12,556; and hereditary sensory neuropathy
2463, $200 million, $12,533. Costs for encounters directly related to
autonomic disorders were, respectively (in millions), $761, $214,
$21.1, $12.2, $67.1, $21.3, and $5.5.
Conclusions: Disorders of the autonomic nervous system are preva-
lent among MHS beneficiaries and reflect substantial cost. Costs
directly related to autonomic disorders are lower than overall costs.
Funding: The views expressed in this abstract reflect the results of
research conducted by the author(s) and do not necessarily reflect the
official policy or position of the Department of the Navy, Department
of Defense, or the United States Government. We are military service
members or contractors of the U.S. Government. This work was
prepared as part of official duties. Title 17 U.S.C. 105 provides that
‘Copyright protection under this title is not available for any work of
the United States Government.’ Title 17 U.S.C. 101 defines a United
States Government work as a work prepared by a military service
member or employee of the United States Government as part of that
person’s official duties. The study protocol was approved by the
Naval Medical Center Portsmouth Institutional Review Board in
compliance with all applicable Federal regulations governing the
protection of human subjects. Research data derived from an
approved Naval Medical Center, Portsmouth, Virginia IRB, protocol
number NMCP.2017.0035.
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Sudoscan utility in sudomotor function assessment in patients
referred for autonomic evaluation in a Chilean neurology clinic
J. Idiaquez, R. Fadic, R. Iturriaga
Departments of Neurology and Physiology, Pontificia Universidad
Catolica de Chile, Santiago, Chile
Introduction: Sudoscan is a noninvasive sudomotor test based on
electrochemical skin conductance (ESC) measurement. The aim of
this observational study was to describe ECS testing utility in patients
referred for autonomic function evaluation.
Patients and Methods: 46 consecutive patients, grouped in: syncope
(21), peripheral neuropathy (PN) (8), Parkinson’s disease (PD) (13),
multiple system atrophy (MSA) (4). Autonomic tests: Blood pressure
(BP) and heart rate (HR) change on standing, Cardiovagal: Valsalva
ratio (VR), HR change on deep breathing (HRDB), sympathetic skin
responses (SSR) and ESC in palm (P) and sole (S). Data: Mean ±
SEM, One-way Anova followed by Dunnet multiple comparisons.
Results: Mean P-ESC and S-ESC were different among groups
(p\ 0.01), in PN mean P-ESC = 45.6 ± 19 uS was lower than in
syncope = 67.9 ± 16 uS. In PN mean S-ESC = 51.8 ± 18 uS was
lower than in syncope = 83.6 ± 7.2 uS, PD = 77.4 ± 9 uS and MSA
73.8 ± 11 uS. Mean P-ESC and S-ESC in PD and MSA did not show
significant difference. In PN mean P-SSR = 1.6 ± 2.3 mV and mean
S-SSR = 1.4 ± 2 mV did not differ significantly from syncope, PD
and MSA. Number of patients with orthostatic systolic BP fall
C 20 mmHg: syncope n = 0, PN n = 4, PD n = 0, MSA n = 2. In PN
the VR and HRDB were lower than in syncope and PD.
Conclusions: This study shows that S-ESC assessment is more sen-
sitive than SSR and useful to detect sudomotor dysfunction in patients
with peripheral neuropathies.
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